𐋇 ¦severe¦ ¦ac ute¦ ¦respiratory¦ ¦sy nd r ome¦ ¦coronavirus¦ ¦2¦ ▁( 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ )▁ ¦is¦ ¦a¦ ¦no ve l¦ ¦virus¦ ,▁ ¦first¦ ¦isol ated¦ ¦from¦ ¦three¦ ¦people¦ ¦with¦ ¦p ne um o nia¦ ¦con n ected¦ ¦to¦ ¦the¦ ¦cl us ter¦ ¦of¦ ¦ac ute¦ ¦respiratory¦ ¦ ill ness¦ ¦cases¦ ¦in¦ 𐋇¦w uhan¦ .
𐋇¦on¦ 𐋇¦th ur s day¦ ,▁ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦coronavirus¦ ¦infections¦ ¦sur p as sed¦ ¦one¦ ¦million¦ ¦wor l d w ide¦ ,▁ 𐋇 ¦jo h ns¦ 𐋇¦h op k ins¦ 𐋇¦university¦ ¦data¦ ¦ind ic ated¦ .
𐋇 ¦before¦ ¦the¦ ¦first¦ ¦isol ation¦ ¦of¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦str ain¦ 𐋇¦b 8 1 4¦ ¦from¦ ¦the¦ ¦n as al¦ ¦dis c har ge¦ ¦of¦ ¦patients¦ ¦who¦ ¦had¦ ¦contr acted¦ ¦comm on¦ ¦co ld¦ ,▁ ¦different¦ 𐋇¦c o𐋇vs¦ ¦had¦ ¦been¦ ¦isol ated¦ ¦in¦ ¦various¦ ¦infected¦ ¦ani m als¦ ,▁ ¦including¦ ¦ tur ke y¦ ,▁ ¦mo use¦ ,▁ ¦co w¦ ,▁ ¦ pi g¦ ,▁ ¦c at¦ ¦and¦ ¦do g¦ .
𐋇 ¦fe line¦ ¦coronavirus¦ ▁( 𐊣 ¦f c𐊼 o 𐋇 v¦ )▁ ¦cau ses¦ ¦mi ld¦ ¦en teri ti s¦ ¦in¦ ¦ca ts¦ ¦as¦ ¦well¦ ¦as¦ ¦severe¦ 𐋇 ¦fe line¦ ¦in fe ct ious¦ ¦per it o niti s¦ ▁( ¦other¦ ¦v ari a nts¦ ¦of¦ ¦the¦ ¦same¦ ¦virus¦ ).
𐋇¦the¦ 𐋇¦chinese¦ ¦government¦ ' ¦s¦ ¦se ni or¦ ¦medical¦ ¦ad v is er¦ 𐋇¦z h ong¦ 𐋇¦na ns han¦ ¦ar g u ed¦ ¦that¦ ▁" ¦it¦ ¦could¦ ¦be¦ ¦over¦ ¦by¦ 𐋇¦j une¦ "▁ ¦if¦ ¦all¦ ¦countries¦ ¦can¦ ¦be¦ ¦mo bi li zed¦ ¦to¦ ¦follow ¦ ¦the¦ 𐊣¦who¦𐊼 ' ¦s¦ ¦ad v ice¦ ¦on¦ ¦measures¦ ¦to¦ ¦sto p¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦surveillance¦ ¦is¦ ¦exp ected¦ ¦to¦ ¦monit or¦ ¦epi dem io log ical¦ ¦tre nds¦ ,▁ ¦rapidly¦ ¦det ect¦ ¦new¦ ¦cases¦ ,▁ ¦and¦ ¦based¦ ¦on¦ ¦this¦ ¦information¦ ,▁ ¦provide¦ ¦epi dem io log ical¦ ¦information¦ ¦to¦ ¦conduc t¦ ¦risk¦ ¦ass ess ment¦ ¦and¦ ¦guid e¦ ¦disease¦ ¦pre par ed ness¦ .
𐋇 ¦based¦ ¦on¦ ¦clinical¦ ¦stud ies¦ ¦reported¦ ¦th us¦ ¦far¦ ,▁ ¦the¦ ¦follow ing¦ ¦fa ct ors¦ ¦may¦ ¦a ff ect¦ ¦or¦ ¦be¦ ¦associ ated¦ ¦with¦ ¦the¦ ¦pro g no sis¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦patients¦ ▁( 𐋇¦t able¦ ▁ ​ ( 𐋇¦t ab le 3 3¦ ) :
𐋇 ¦given¦ ¦such¦ ¦rap id¦ ¦pro gr ess¦ ¦in¦ ¦research¦ ¦on¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦several¦ ¦cr itical¦ ¦issu es¦ ¦rem ain¦ ¦to¦ ¦be¦ ¦s ol ved¦ ,▁ ¦as¦ ¦follow s¦ :
𐋇¦on¦ ¦1 3¦ 𐋇¦march¦ ,▁ ¦he¦ ¦dec l ared¦ ¦a¦ ¦n ational¦ ¦emergency¦ ,▁ ¦which¦ ¦made¦ ¦f ed er al¦ ¦f u nds¦ ¦available¦ ¦to¦ ¦respon d¦ ¦to¦ ¦the¦ ¦crisis¦ .
𐋇¦chinese¦ ¦clinical¦ ¦trials¦ ¦in¦ 𐋇¦w uhan¦ ¦and¦ 𐋇¦sh en z h en¦ ¦clai med¦ ¦to¦ ¦sho w¦ ¦that¦ ¦fa vi pi ra vir¦ ¦was¦ ▁" ¦cle ar ly¦ ¦effective¦ " .
𐋇¦ma u ri z i o¦ 𐋇¦m as s ar i¦ ,▁ 𐋇¦ita ly¦ ' ¦s¦ ¦a mb as s a d or¦ ¦to¦ ¦the¦ 𐊣 ¦e u¦𐊼 ,▁ ¦said¦ ¦that¦ ▁" 𐋇 ¦only¦ 𐋇¦china¦ ¦respon ded¦ ¦b il at er ally¦ .
𐋇¦some¦ ¦can¦ ¦k ill¦ ¦more¦ ¦than¦ ¦30¦ %▁ ¦of¦ ¦those¦ ¦infected¦ ,▁ ¦such¦ ¦as¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦and¦ ¦some¦ ¦are¦ ¦rel ati ve ly¦ ¦ har m l ess¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦comm on¦ ¦co ld¦ .
𐋇¦the¦ 𐋇¦ u¦ . 𐋇¦s¦ .▁ ¦administration¦ ¦of¦ 𐋇 ¦do na ld¦ 𐋇 ¦tr um p¦ ¦has¦ ¦ ref er r ed¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦as¦ ▁" 𐋇¦chinese¦ ¦virus¦ "▁ ¦or¦ ▁" 𐋇¦w uhan¦ ¦virus¦ "▁ ¦sa ying¦ ¦that¦ 𐋇¦china¦ ' ¦s¦ ▁" ¦ce ns or s hi p¦ ¦su p er c har ged¦ ¦a¦ ¦virus¦ ¦that¦ ¦has¦ ¦now¦ ¦ tur ned¦ ¦into¦ ¦a¦ ¦g lobal¦ ¦pandemic¦ " ,▁ ¦which¦ ¦has¦ ¦in¦ ¦ tur n¦ ¦been¦ ¦c ri ti ci zed¦ ¦by¦ ¦some¦ ¦c rit ics¦ ¦as¦ ¦r ac is m¦ ¦and¦ ▁" ¦dis tr act¦ [ ¦ ing¦ ] ▁ ¦from¦ ¦his¦ ¦administration¦ ' ¦s¦ ¦fa il ure¦ ¦to¦ ¦cont ain¦ ¦the¦ ¦disease¦ " .
𐋇¦in¦ ¦addition¦ ¦to¦ ¦rep lic a ting¦ ¦in¦ ¦the¦ ¦l ow er¦ ¦respiratory¦ ¦tr act¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦can¦ ¦e ffic ie ntly¦ ¦rep lic ate¦ ¦in¦ ¦the¦ ¦u pp er¦ ¦respiratory¦ ¦tr act¦ ¦and¦ ¦cau ses¦ ¦mi ld¦ ¦or¦ ¦no¦ ¦symptoms¦ ¦in¦ ¦the¦ ¦early¦ ¦phase¦ ¦of¦ ¦infection¦ ,▁ ¦simil ar¦ ¦to¦ ¦other¦ 𐋇¦c o𐋇vs¦ ¦that¦ ¦cause¦ ¦comm on¦ ¦c ol ds¦ .
𐋇¦c lu st ered¦ ¦o ns et¦ ¦o f ten¦ ¦happ e ns¦ ¦in¦ ¦the¦ ¦same¦ ¦family¦ ¦or¦ ¦from¦ ¦the¦ ¦same¦ ¦ga th ering¦ ¦or¦ ¦ve h ic le¦ ¦such¦ ¦as¦ ¦a¦ ¦c ru ise¦ ¦s hi p¦ .
𐋇¦au th or ities¦ ¦wor l d w ide¦ ¦have¦ ¦respon ded¦ ¦by¦ ¦imple m en ting¦ ¦travel¦ ¦restrictions¦ ,▁ ¦qu ara nt ines¦ ,▁ ¦cur fe ws¦ ,▁ ¦wor k p l ace¦ ¦ha z ard¦ ¦contr ols¦ ,▁ ¦and¦ ¦facil ity¦ ¦closures¦ .
𐋇¦a¦ ¦more¦ ¦rec ent¦ ¦study¦ ,▁ ¦as¦ ¦d es c rib ed¦ ¦ab o ve¦ ,▁ ¦ dem on stra tes¦ ¦that¦ ¦the¦ ¦inc ub ation¦ ¦period¦ ¦was¦ ¦4¦ . ¦8¦ ▁( ¦3¦ . ¦ 0¦ - ¦7¦ . ¦2¦ )▁ ¦days¦ ¦based¦ ¦on¦ ¦the¦ ¦ dem o g rap hy¦ ¦of¦ ¦8¦ , ¦8 6 6¦ ¦cases¦ .
𐋇¦in¦ ¦severe¦ ¦cases¦ ,▁ ¦patients¦ ¦qu ic k ly¦ ¦pro g res sed¦ ¦to¦ ¦develop ¦ ¦ac ute¦ ¦respiratory¦ ¦sy nd r ome¦ ,▁ ¦se p tic¦ ¦sh oc k¦ ,▁ ¦me t ab ol ic¦ ¦ac id o sis¦ ,▁ ¦and¦ ¦co a g ul op at hy¦ .
𐋇 ¦supp r ess ion¦ ¦can¦ ¦be¦ ¦p ref er r ed¦ ¦but¦ ¦nee ds¦ ¦to¦ ¦be¦ ¦ma in ta ined¦ ¦for¦ ¦as¦ ¦long¦ ¦as¦ ¦the¦ ¦virus¦ ¦is¦ ¦c ir c u la ting¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ▁( ¦or¦ ¦un ti l¦ ¦a¦ ¦vaccine¦ ¦b ec om es¦ ¦available¦ ,▁ ¦if¦ ¦that¦ ¦com es¦ ¦first¦ ),▁ ¦as¦ ¦transmission¦ ¦o th er w ise¦ ¦qu ic k ly¦ ¦re b ou nds¦ ¦when¦ ¦measures¦ ¦are¦ ¦re la x ed¦ .
𐋇¦p res um ab ly¦ ,▁ ¦it¦ ¦has¦ ¦al rea dy¦ ¦been¦ ¦ad ap ted¦ ¦to¦ ¦another¦ ¦h ost¦ ¦cl ose¦ ¦to¦ ¦hum ans¦ .
𐋇¦in¦ ¦this¦ ¦study¦ ,▁ ¦we¦ ¦ass ess¦ ¦the¦ ¦tre nds¦ ¦in¦ ¦the¦ ¦c um u la tive¦ ¦in ci dence¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦in¦ ¦each¦ 𐋇¦e ur op e an¦ 𐋇¦union¦ / 𐋇¦e ur op e an¦ 𐋇 ¦econom ic¦ 𐋇 ¦area¦ ▁( 𐊣 ¦e u¦ / ¦e ea ¦𐊼 )▁ ¦country¦ ¦and¦ ¦the¦ 𐋇¦united¦ 𐋇 ¦ki ng d om¦ ▁( 𐊣¦uk¦𐊼 )▁ ¦and¦ ¦comp are¦ ¦them¦ ¦to¦ ¦that¦ ¦of¦ 𐋇¦h ub e i¦ 𐋇 ¦pro vi nce¦ ,▁ 𐋇¦china¦ .
𐋇¦the¦ ¦two¦ ¦typ es¦ ¦of¦ ¦can ine¦ ¦coronavirus¦ ▁( 𐊣¦c c𐊼 o 𐋇 v¦ ) ▁( ¦one¦ ¦ca us ing¦ ¦en teri ti s¦ ,▁ ¦the¦ ¦other¦ ¦found¦ ¦in¦ ¦respiratory¦ ¦dis eases¦ ).
𐋇¦the¦ ¦same¦ ¦day¦ ¦travel¦ ¦restrictions¦ ¦were¦ ¦ea sed¦ ¦in¦ 𐋇¦h ub e i¦ ,▁ ¦ ap art¦ ¦from¦ 𐋇¦w uhan¦ ,▁ ¦two¦ ¦months¦ ¦after¦ ¦the¦ ¦lockdown¦ ¦was¦ ¦imposed¦ . 𐋇¦the¦ 𐋇¦chinese¦ 𐋇¦ministry¦ ¦of¦ 𐋇 ¦fo re i g n¦ 𐋇¦a ff a ir s¦ ¦announced¦ ¦on¦ ¦2 6¦ 𐋇¦march¦ ¦2020¦ ¦that¦ ¦en try¦ ¦for¦ ¦v is a¦ ¦or¦ ¦re si dence¦ ¦p erm it¦ ¦h ol ders¦ ¦would¦ ¦be¦ ¦susp e nded¦ ¦from¦ ¦2 8¦ 𐋇¦march¦ ¦on w ar ds¦ ,▁ ¦with¦ ¦no¦ ¦speci fic¦ ¦de ta il s¦ ¦on¦ ¦when¦ ¦this¦ ¦po lic y¦ ¦will¦ ¦ end¦ .
𐋇¦d a ma ge¦ ¦to¦ ¦the¦ ¦g lobal¦ ¦econom y¦ ¦has¦ ¦been¦ ¦f el t¦ ¦in¦ 𐋇¦china¦ :▁ ¦according¦ ¦to¦ ¦a¦ ¦media¦ ¦report¦ ¦on¦ ¦1 6¦ 𐋇¦march¦ ,▁ ¦the¦ ¦econom y¦ ¦in¦ 𐋇¦china¦ ¦was¦ ¦very¦ ¦h ard¦ ¦h it¦ ¦in¦ ¦the¦ ¦first¦ ¦two¦ ¦months¦ ¦of¦ ¦2020¦ ¦due¦ ¦to¦ ¦the¦ ¦measures¦ ¦taken¦ ¦by¦ ¦the¦ ¦government¦ ¦to¦ ¦cur t ai l¦ ¦virus¦ ¦spread¦ ,▁ ¦and¦ ¦re t ai l¦ ¦sa les¦ ¦pl un ged¦ ¦20¦ . ¦5¦ % .
𐋇¦the¦ ¦2019¦ ¦no ve l¦ 𐊣¦h c𐊼 o 𐋇 v¦ ▁( ¦2019¦ - ¦n 𐋇 co 𐋇 v¦ ),▁ ¦which¦ ¦has¦ ¦sub se que ntly¦ ¦been¦ ¦re na med¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦is¦ ¦the¦ ¦ca us a tive¦ ¦ag ent¦ ¦of¦ ¦the¦ ¦o ng o ing¦ ¦epi demic¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ ),▁ ¦which¦ ¦has¦ ¦clai med¦ ¦more¦ ¦than¦ ¦3¦ , ¦1 2 0¦ ¦li ves¦ ¦and¦ ¦infected¦ ¦more¦ ¦than¦ ¦9 1¦ , ¦000¦ ¦people¦ ¦as¦ ¦of¦ 𐋇¦march¦ ¦3¦ ,▁ ¦2020¦ .
𐋇¦p res um ab ly¦ ,▁ ¦the¦ ¦inter medi ate¦ ¦ani mal¦ ¦hos ts¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦should¦ ¦be¦ ¦among¦ ¦the¦ ¦w il d li fe¦ ¦speci es¦ ¦so ld¦ ¦and¦ ¦ki lled¦ ¦at¦ ¦the¦ 𐋇¦h u an an¦ 𐋇¦s ea f o od¦ 𐋇¦w h ol es a le¦ 𐋇 ¦marke t¦ ,▁ ¦with¦ ¦which¦ ¦many¦ ¦of¦ ¦the¦ ¦initi al¦ ¦cases¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦were¦ ¦associ ated¦ ,▁ ¦ind ic a tive¦ ¦of¦ ¦a¦ ¦pro b able¦ ¦ani mal¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦e v ent¦ .
𐋇¦s outh¦ 𐋇¦k o re a¦ ' ¦s¦ ¦pro gr am me¦ ¦is¦ ¦consid ered¦ ¦to¦ ¦be¦ ¦a¦ ¦s uc c ess¦ ¦in¦ ¦cont ro lling¦ ¦the¦ ¦outbreak¦ ¦d esp ite¦ ¦not¦ ¦qu ar an ti ning¦ ¦ent ire¦ ¦c ities¦ . 𐋇¦the¦ 𐋇¦s outh¦ 𐋇¦k o re an¦ ¦s oc ie ty¦ ¦was¦ ¦initi ally¦ ¦pol ari zed¦ ¦on¦ 𐋇 ¦president¦ 𐋇 ¦mo on¦ 𐋇¦j a e¦ - ¦in¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦crisis¦ .
𐋇¦ne ver th el ess¦ ,▁ ¦the¦ ¦fe at ures¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦including¦ ¦its¦ ¦trans m is sib ility¦ ,▁ ¦p at ho g en ic ity¦ ¦and¦ ¦s us ta in able¦ ¦sprea ding¦ ¦after¦ ¦pas s a ges¦ ¦in¦ ¦hum ans¦ ¦will¦ ¦be¦ ¦inf lu enti al¦ ¦on¦ ¦the¦ ¦ ul tim ate¦ ¦f ate¦ ¦of¦ ¦the¦ ¦o ng o ing¦ ¦outbreak¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇 ¦mo re o ver¦ ,▁ ¦the¦ ¦high¦ ¦level¦ ¦of¦ ¦re ac tive¦ ¦oxygen¦ ¦speci es¦ ▁( 𐊣¦r os ¦𐊼 )▁ ¦gen er ated¦ ¦from¦ ¦high¦ ¦me t ab ol ic¦ ¦ac tiv ity¦ ¦of¦ ¦ba ts¦ ¦could¦ ¦both¦ ¦supp r ess¦ 𐋇¦co𐋇v¦ ¦rep lic ation¦ ¦and¦ ¦a ff ects¦ ¦pro o f rea ding¦ ¦by¦ ¦ex o rib on uc le ase¦ ,▁ ¦th us¦ ¦pro vi ding¦ ¦the¦ ¦se le ction¦ ¦pr ess ure¦ ¦for¦ ¦the¦ ¦gen er ation¦ ¦of¦ ¦virus¦ ¦stra ins¦ ¦high ly¦ ¦p at ho g en ic¦ ¦when¦ ¦in tr od uc ed¦ ¦into¦ ¦a¦ ¦new¦ ¦h ost¦ .
𐋇 ¦several¦ ¦tr ain¦ ¦st ations¦ ¦and¦ ¦f er r y¦ ¦ por ts¦ ¦have¦ ¦also¦ ¦been¦ ¦closed¦ .
𐋇¦co ro na vi ruses¦ ¦v ary¦ ¦si gni fic a ntly¦ ¦in¦ ¦risk¦ ¦fa ctor¦ .
𐋇¦for¦ ¦cl ar ity¦ ,▁ ¦the¦ ¦current¦ ¦kno w l ed ge¦ ¦on¦ ¦ani mal¦ ¦o ri g ins¦ ¦of¦ ¦known¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦is¦ ¦s um m ari zed¦ ¦in¦ 𐋇 ¦fi g ure¦ ▁ ​ ¦1¦ ¦and¦ 𐋇¦t able¦ ¦2¦ .
𐋇¦in¦ ¦both¦ ¦cases¦ ,▁ ¦the¦ ¦hos ts¦ ¦are¦ ¦n atur ally¦ ¦infected¦ ¦and¦ ¦are¦ ¦the¦ ¦n atur al¦ ¦hos ts¦ ¦of¦ 𐊣¦h c𐊼 o 𐋇 v¦ ¦or¦ ¦its¦ ¦par en tal¦ ¦virus¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦2 1 5¦ 𐋇¦ca na di ans¦ ▁( ¦1 7 6¦ ¦from¦ ¦the¦ ¦first¦ ¦pl ane¦ ,▁ ¦and¦ ¦3 9¦ ¦from¦ ¦a¦ ¦second¦ ¦pl ane¦ ¦ch art ered¦ ¦by¦ ¦the¦ 𐋇¦ u¦ . 𐋇¦s¦ .▁ ¦government¦ )▁ ¦were¦ ¦e v ac u ated¦ ¦from¦ 𐋇¦w uhan¦ ¦to¦ 𐊣¦c f b ¦𐊼 𐋇 ¦tre nt on¦ ¦to¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇¦the¦ ¦pol y p ro te in¦ ¦has¦ ¦its¦ ¦ own¦ ¦prot eases¦ ¦which¦ ¦cl ea ve¦ ¦the¦ ¦pol y p ro te in¦ ¦into¦ ¦m ul ti p le¦ ¦no ns tr uc tur al¦ ¦prote ins¦ .
𐋇¦the¦ 𐋇¦b har ati ya¦ 𐋇¦j an at a¦ 𐋇 ¦par ty¦ ' ¦s¦ 𐋇¦state¦ ¦un it¦ ¦president¦ ¦in¦ 𐋇¦w est¦ 𐋇 ¦be ng al¦ 𐋇¦di li p¦ 𐋇¦ gh os h¦ ¦st ated¦ ¦that¦ ¦the¦ 𐋇¦chinese¦ ¦had¦ ¦d est ro y ed¦ ¦n at ure¦ ¦and¦ ▁" ¦that¦ ' ¦s¦ ¦w hy¦ ¦the¦ 𐋇¦g od¦ ¦to ok¦ ¦re v en ge¦ ¦against¦ ¦them¦ ."
𐋇 ¦stud ies¦ ¦have¦ ¦found¦ ¦that¦ ¦an¦ ¦u nc ov ered¦ ¦c ou g hing¦ ¦can¦ ¦le ad¦ ¦to¦ ¦dr op le ts¦ ¦tra ve lling¦ ¦up¦ ¦to¦ ¦4¦ . ¦5¦ ¦me tr es¦ ▁( ¦15¦ ¦fe et¦ )▁ ¦to¦ ¦8¦ . ¦2¦ ¦me tr es¦ ▁( ¦2 7¦ ¦fe et¦ ).
𐋇¦in¦ ¦ch ic ke ns¦ ,▁ ¦the¦ ¦in fe ct ious¦ ¦b ro nc hi ti s¦ ¦virus¦ ▁( 𐊣¦i b v ¦𐊼 ),▁ ¦a¦ ¦coronavirus¦ ,▁ ¦t ar ge ts¦ ¦not¦ ¦only¦ ¦the¦ ¦respiratory¦ ¦tr act¦ ¦but¦ ¦also¦ ¦the¦ ¦u ro ge ni tal¦ ¦tr act¦ .
𐋇 ¦inter es ti ng ly¦ ,▁ ¦the¦ ¦n uc le o t ide¦ ¦a na log ue¦ 𐋇 ¦rem desivir¦ ¦is¦ ¦known¦ ¦to¦ ¦supp r ess¦ 𐋇¦co𐋇v¦ ¦rep lic ation¦ ¦through¦ ¦in hi b ition¦ ¦of¦ ¦this¦ ¦ex o rib on uc le ase¦ ¦and¦ ¦the¦ 𐊣¦r na ¦𐊼 - ¦dep e nd ent¦ 𐊣¦r na ¦𐊼 ¦pol y mer ase¦ .
𐋇 ¦taking¦ ¦over¦ - ¦the¦ - ¦c oun ter¦ ¦co ld¦ ¦medic ations¦ ,▁ ¦dr in king¦ ¦f lu i ds¦ ,▁ ¦and¦ ¦res ting¦ ¦may¦ ¦help¦ ¦al le vi ate¦ ¦symptoms¦ .
𐋇¦th us¦ ,▁ ¦if¦ ¦nee ded¦ ,▁ ¦s te ro i ds¦ ¦should¦ ¦be¦ ¦used¦ ¦at¦ ¦low¦ ¦d os a ge¦ ¦and¦ ¦for¦ ¦a¦ ¦sh ort¦ ¦time¦ ¦in¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦patients¦ .
𐋇¦in¦ 𐋇¦se p te mber¦ ¦201 2¦ ,▁ ¦a¦ ¦new¦ ¦typ e¦ ¦of¦ ¦coronavirus¦ ¦was¦ ¦ id enti fied¦ ,▁ ¦initi ally¦ ¦called¦ 𐋇 ¦no ve l¦ 𐋇 ¦coronavirus¦ ¦201 2¦ ,▁ ¦and¦ ¦now¦ ¦offi ci ally¦ ¦na med¦ 𐋇¦m id d le¦ 𐋇 ¦ea st¦ ¦respiratory¦ ¦sy nd r ome¦ ¦coronavirus¦ ▁( 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ).
𐋇¦a¦ 𐊣¦c n n ¦𐊼 ¦report¦ ¦ind ic ated¦ ¦that¦ ¦the¦ ¦co mb ination¦ ¦of¦ 𐋇¦ita ly¦ ' ¦s¦ ¦large¦ ¦el d er ly¦ ¦population¦ ¦and¦ ¦in ab ility¦ ¦to¦ ¦test¦ ¦all¦ ¦who¦ ¦have¦ ¦the¦ ¦virus¦ ¦to¦ ¦d ate¦ ¦may¦ ¦be¦ ¦cont rib u ting¦ ¦to¦ ¦the¦ ¦high¦ ¦f at ality¦ ¦rate¦ .
𐋇¦on¦ 𐋇¦january¦ ¦20¦ ,▁ ¦the¦ ¦infection¦ ¦of¦ ¦health¦ - ¦care¦ ¦pro vi ders¦ ¦was¦ ¦reported¦ ,▁ ¦su gg es ting¦ ¦that¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦was¦ ¦possible¦ .
𐋇 ¦sur g ical¦ ¦masks¦ ¦are¦ ¦recomme nded¦ ¦for¦ ¦those¦ ¦who¦ ¦may¦ ¦be¦ ¦infected¦ ,▁ ¦as¦ ¦we ar ing¦ ¦a¦ ¦mask¦ ¦can¦ ¦li m it¦ ¦the¦ ¦v o lu me¦ ¦and¦ ¦travel¦ ¦distance¦ ¦of¦ ¦exp ir atory¦ ¦dr op le ts¦ ¦dis p er sed¦ ¦when¦ ¦t al king¦ ,▁ ¦s n ee z ing¦ ,▁ ¦and¦ ¦c ou g hing¦ .
𐋇¦we¦ ¦also¦ ¦re v iew¦ ¦the¦ ¦tr end¦ ¦of¦ 𐊣¦h c𐊼 o 𐋇 v¦ ¦e v o lu tion¦ ¦in¦ ¦which¦ ¦the¦ ¦increase¦ ¦in¦ ¦trans m is sib ility¦ ¦o f ten¦ ¦com es¦ ¦with¦ ¦the¦ ¦d ecre ase¦ ¦in¦ ¦p at ho g en ic ity¦ .
𐋇 ¦since¦ ¦cases¦ ¦have¦ ¦so¦ ¦far¦ ¦c lu st ered¦ ¦in¦ ¦c er t ain¦ ¦regi ons¦ ¦in¦ 𐊣 ¦e u¦ / ¦e ea ¦𐊼 ¦countries¦ ¦and¦ ¦the¦ 𐊣¦uk¦𐊼 ,▁ ¦and¦ ¦hospitals¦ ¦and¦ ¦int en sive¦ ¦care¦ ¦u ni ts¦ ¦us u ally¦ ¦ser ve¦ ¦a¦ ¦de f ined¦ ¦regi onal¦ ¦c at ch ment¦ ¦population¦ ,▁ ¦information¦ ¦about¦ ¦cases¦ ¦and¦ ¦int en sive¦ ¦care¦ ¦beds¦ ¦should¦ ¦p ref er ab ly¦ ¦be¦ ¦made¦ ¦available¦ ¦at¦ ¦the¦ 𐋇 ¦no me nc l at ure¦ ¦of¦ ¦ter rit o ri al¦ ¦u ni ts¦ ¦for¦ ¦st ati st ics¦ ¦2¦ ▁( 𐊣 ¦n ut s ¦𐊼 - ¦2¦ )▁ ¦level¦ .
𐋇¦it¦ ¦is¦ ¦the ref ore¦ ¦not¦ ¦to o¦ ¦sur p r is ing¦ ¦that¦ ¦ba ts¦ ¦mi ght¦ ¦trans m it¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦to¦ ¦hum ans¦ ¦dire ctly¦ .
𐋇 ¦three¦ ¦maj or¦ ¦risk¦ ¦fa ct ors¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦were¦ ¦se x¦ ▁( ¦ma le¦ ),▁ ¦age¦ ▁( ≥ ¦6 0¦ ),▁ ¦and¦ ¦severe¦ ¦p ne um o nia¦ .
𐋇¦according¦ ¦to¦ ¦a¦ ¦human¦ ¦v ol un te er¦ ¦study¦ ,▁ ¦heal t hy¦ ¦in di v id u als¦ ¦infected¦ ¦with¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦developed¦ ¦mi ld¦ ¦comm on¦ ¦co ld¦ .
𐋇¦some¦ ¦ art ists¦ ¦have¦ ¦exp l or ed¦ ¦wa ys¦ ¦to¦ ¦continue¦ ¦to¦ ¦produc e¦ ¦and¦ ¦sh are¦ ¦work¦ ¦over¦ ¦the¦ ¦intern et¦ ¦as¦ ¦an¦ ¦al t er na tive¦ ¦to¦ ¦tra di ti onal¦ ¦li ve¦ ¦per for ma nce¦ ,▁ ¦such¦ ¦as¦ ¦li ve¦ ¦st re am ing¦ ¦conc er ts¦ ¦or¦ ¦c rea ting¦ ¦we b ¦ - ¦based¦ ▁" ¦f es tiv als¦ "▁ ¦for¦ ¦ art ists¦ ¦to¦ ¦per for m¦ ,▁ ¦dist rib ute¦ ,▁ ¦and¦ ¦p ub li ci z e¦ ¦their¦ ¦work¦ .
𐋇¦on¦ 𐋇¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ 𐋇¦b ol i¦ 𐋇¦z h an g¦ ¦and¦ ¦c ow or k ers¦ ¦p ub lish ed¦ ¦a¦ ¦study¦ ¦to¦ ¦comp are¦ ¦w est ern¦ ¦medic ine¦ ▁( 𐊣 ¦w m ¦𐊼 )▁ ¦treatment¦ ¦al one¦ ¦with¦ ¦co mb ined¦ ¦treatment¦ ¦of¦ 𐊣 ¦w m ¦𐊼 ¦and¦ 𐊣 ¦t c m ¦𐊼 .
𐋇¦the¦ ¦cases¦ ¦mo st ly¦ ¦had¦ ¦l in ks¦ ¦to¦ ¦the¦ 𐋇¦h u an an¦ 𐋇¦s ea f o od¦ 𐋇¦w h ol es a le¦ 𐋇 ¦marke t¦ ¦and¦ ¦so¦ ¦the¦ ¦virus¦ ¦is¦ ¦th ought¦ ¦to¦ ¦have¦ ¦a¦ ¦ z o o no tic¦ ¦o ri g in¦ .
𐋇¦the¦ ¦ex o rib on uc le ase¦ ¦no ns tr uc tur al¦ ¦prote in¦ ,▁ ¦for¦ ¦ins ta nce¦ ,▁ ¦prov id es¦ ¦ex tr a¦ ¦f id el ity¦ ¦to¦ ¦rep lic ation¦ ¦by¦ ¦pro vi ding¦ ¦a¦ ¦pro o f rea ding¦ ¦f un ction¦ ¦which¦ ¦the¦ 𐊣¦r na ¦𐊼 - ¦dep e nd ent¦ 𐊣¦r na ¦𐊼 ¦pol y mer ase¦ ¦l ac ks¦ . 𐋇 ¦one¦ ¦of¦ ¦the¦ ¦m ain¦ ¦f u nc tions¦ ¦of¦ ¦the¦ ¦comple x¦ ¦is¦ ¦to¦ ¦rep lic ate¦ ¦the¦ ¦v iral¦ ¦gen ome¦ .
𐋇¦se v en¦ ¦trials¦ ¦were¦ ¦e v a lu a ting¦ ¦rep ur p osed¦ ¦d ru gs¦ ¦al rea dy¦ ¦approved¦ ¦to¦ ¦t reat¦ ¦m al ari a¦ ,▁ ¦including¦ ¦four¦ ¦stud ies¦ ¦on¦ ¦hy d ro x y ch lo ro qu ine¦ ¦or¦ ¦ch lo ro qu ine¦ ¦ph os p h ate¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦rapidly¦ ¦increasing¦ ¦number¦ ¦of¦ ¦p ub lic ations¦ ¦on¦ ¦the¦ ¦e mer g ing¦ ¦disease¦ ,▁ ¦this¦ ¦ art ic le¦ ¦att e mp ts¦ ¦to¦ ¦provide¦ ¦a¦ ¦ ti me ly¦ ¦and¦ ¦comp re h en sive¦ ¦re v iew¦ ¦of¦ ¦the¦ ¦sw i f t ly¦ ¦develop ing¦ ¦research¦ ¦sub j ect¦ .
𐋇¦it¦ ¦is¦ ¦dire ctly¦ ¦inv ol ved¦ ¦in¦ ¦the¦ ¦rep lic ation¦ ¦and¦ ¦trans c ri p tion¦ ¦of¦ 𐊣¦r na ¦𐊼 ¦from¦ ¦an¦ 𐊣¦r na ¦𐊼 ¦str and¦ .
𐋇¦the¦ 𐊣¦sars¦𐊼 ¦epi demic¦ ¦resul ted¦ ¦in¦ ¦8¦ , ¦ 0 9 6¦ ¦reported¦ ¦cases¦ ¦with¦ ¦7 7 4¦ ¦deaths¦ ,▁ ¦sprea ding¦ ¦across¦ ¦many¦ ¦countries¦ ¦and¦ ¦con ti ne nts¦ .
𐋇 ¦most¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦o ri g in ated¦ ¦from¦ ¦ba ts¦ ¦where¦ ¦they¦ ¦are¦ ¦n on¦ - ¦p at ho g en ic¦ .
𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦al though¦ ¦related¦ ¦to¦ ¦several¦ ¦b at¦ ¦coronavirus¦ ¦speci es¦ ,▁ ¦appe ar s¦ ¦to¦ ¦have¦ ¦di ver ged¦ ¦from¦ ¦these¦ ¦several¦ ¦c en tur ies¦ ¦ag o¦ .
𐋇 ¦ph y s ical¦ ¦dis ta ncing¦ ¦measures¦ ¦are¦ ¦also¦ ¦recomme nded¦ ¦to¦ ¦prevent¦ ¦transmission¦ . 𐋇¦many¦ ¦go ver n ments¦ ¦have¦ ¦res tric ted¦ ¦or¦ ¦ad vi sed¦ ¦against¦ ¦all¦ ¦n on¦ - ¦essential¦ ¦travel¦ ¦to¦ ¦and¦ ¦from¦ ¦countries¦ ¦and¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ .
𐋇¦as¦ ¦the¦ ¦situation¦ ¦is¦ ¦rapidly¦ ¦e v ol ving¦ ,▁ ¦the¦ ¦fin al¦ ¦sc op e¦ ¦and¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦rem ain¦ ¦to¦ ¦be¦ ¦det erm ined¦ .
𐋇¦in¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ,▁ ¦over¦ ¦2 4 4¦ ¦thousand¦ ¦coronavirus¦ ¦cases¦ ¦were¦ ¦rec or ded¦ ,▁ ¦l in king¦ ¦to¦ ¦at¦ ¦least¦ ¦5¦ , ¦9 00¦ ¦deaths¦ .
𐋇¦in¦ ¦st ar k¦ ¦cont ra st¦ ,▁ ¦the¦ 𐊣¦r b d 𐊼 s¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ 𐋇¦ra 𐊣 t g 𐊼 1 3¦ ¦are¦ ¦more¦ ¦di ver g ent¦ ,▁ ¦al b e it¦ ¦a¦ ¦higher¦ ¦de g re e¦ ¦of¦ ¦se que nce¦ ¦h om o logy¦ ¦gen ome¦ - ¦w ide¦ .
𐋇¦as¦ ¦of¦ ¦early¦ 𐋇¦april¦ ¦2020¦ ,▁ ¦1 0 3¦ ¦ca nd id ate¦ ¦the rap e ut ics¦ ¦were¦ ¦in¦ ¦pr ec l in ical¦ ¦or¦ ¦a¦ ¦sta ge¦ ¦of¦ 𐋇 ¦phase¦ 𐋇¦i¦ - 𐊣¦i v ¦𐊼 ¦development¦ ,▁ ¦with¦ ¦tri al¦ ¦resul ts¦ ¦for¦ ¦2 9¦ ¦drug¦ ¦ca nd id a tes¦ ¦exp ected¦ ¦during¦ 𐋇¦april¦ .
𐋇¦b at¦ 𐋇¦co𐋇v¦ - 𐊣¦h k u 𐊼 4¦ ¦and¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦u ti li z e¦ ¦the¦ ¦same¦ ¦h ost¦ ¦re ce pt or¦ ,▁ ¦di p e pt id y l¦ ¦p e pt id ase¦ ¦4¦ ▁( 𐊣 ¦d pp 𐊼 4¦ ),▁ ¦for¦ ¦virus¦ ¦en try¦ .
𐋇¦however¦ ,▁ 𐋇¦co𐋇v¦ ¦can¦ ¦in hi b it¦ 𐋇 ¦t¦ ¦c ell¦ ¦f u nc tions¦ ¦by¦ ¦ind uc ing¦ ¦a po pt o sis¦ ¦of¦ 𐋇 ¦t¦ ¦ce lls¦ .
𐋇¦they¦ ¦are¦ ¦en v el op ed¦ ¦vi ruses¦ ¦with¦ ¦a¦ ¦positive¦ - ¦s en se¦ ¦sing le¦ - ¦stra nded¦ 𐊣¦r na ¦𐊼 ¦gen ome¦ ¦and¦ ¦a¦ ¦n uc le oc ap s id¦ ¦of¦ ¦h el ical¦ ¦sy m me try¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦f at al ities¦ ¦in¦ ¦a¦ ¦day¦ ¦due¦ ¦to¦ ¦the¦ ¦virus¦ .
𐋇¦e vi dence¦ ¦to¦ ¦d ate¦ ¦is¦ ¦that¦ ¦c a¦ ¦8 0¦ %▁ ¦of¦ ¦in di v id u als¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦have¦ ¦a¦ ¦mi ld¦ ¦disease¦ ,▁ ¦ i¦ . ¦ e¦ .▁ ¦a¦ ¦respiratory¦ ¦tr act¦ ¦infection¦ ¦with¦ ¦or¦ ¦without¦ ¦p ne um o nia¦ ,▁ ¦and¦ ¦most¦ ¦of¦ ¦these¦ ¦reco ver¦ .
𐋇¦on¦ ¦14¦ 𐋇¦february¦ ,▁ ¦a¦ 𐊣¦who¦𐊼 - ¦l ed¦ 𐋇 ¦jo in t¦ 𐋇¦ mission¦ 𐋇¦t ea m¦ ¦with¦ 𐋇¦china¦ ¦was¦ ¦ac tiv ated¦ ¦to¦ ¦provide¦ ¦intern ational¦ ¦and¦ 𐊣¦who¦𐊼 ¦experts¦ ¦on¦ ¦the¦ ¦gr oun d¦ ¦in¦ 𐋇¦china¦ ¦to¦ ¦as si st¦ ¦in¦ ¦the¦ ¦d om es tic¦ ¦ma na ge ment¦ ¦and¦ ¦e v a lu ate¦ ▁" ¦the¦ ¦se ver ity¦ ¦and¦ ¦the¦ ¦trans m is sib ility¦ ¦of¦ ¦the¦ ¦disease¦ "▁ ¦by¦ ¦hos ting¦ ¦wor k s ho ps¦ ¦and¦ ¦m ee ti ngs¦ ¦with¦ ¦ ke y¦ ¦n ational¦ - ¦level¦ ¦in st itu tions¦ ¦and¦ ¦to¦ ¦conduc t¦ ¦f ield¦ ¦vi si ts¦ ¦to¦ ¦ass ess¦ ¦the¦ ▁" ¦imp act¦ ¦of¦ ¦response¦ ¦ac tiv ities¦ ¦at¦ ¦prov in cial¦ ¦and¦ ¦c oun ty¦ ¦le v els¦ ,▁ ¦including¦ ¦ ur b an¦ ¦and¦ ¦rural¦ ¦se t ti ngs¦ " . 𐋇¦on¦ ¦2 5¦ 𐋇¦february¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦dec l ared¦ ¦that¦ ▁" ¦the¦ ¦world¦ ¦should¦ ¦do¦ ¦more¦ ¦to¦ ¦pre p are¦ ¦for¦ ¦a¦ ¦possible¦ ¦coronavirus¦ ¦pandemic¦ , "▁ ¦sta ting¦ ¦that¦ ¦while¦ ¦it¦ ¦was¦ ¦still¦ ¦to o¦ ¦early¦ ¦to¦ ¦c all¦ ¦it¦ ¦a¦ ¦pandemic¦ ,▁ ¦countries¦ ¦should¦ ¦no ne th el ess¦ ¦be¦ ▁" ¦in¦ ¦a¦ ¦phase¦ ¦of¦ ¦pre par ed ness¦ " .
𐋇 ¦cases¦ ¦beg an¦ ¦to¦ ¦r ise¦ ¦s har p ly¦ ,▁ ¦which¦ ¦pro mp ted¦ ¦the¦ 𐋇¦ita li an¦ ¦government¦ ¦to¦ ¦susp end¦ ¦all¦ ¦f li gh ts¦ ¦to¦ ¦and¦ ¦from¦ 𐋇¦china¦ ¦and¦ ¦dec l are¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ .
𐋇¦a¦ ¦v ar ie ty¦ ¦of¦ ¦ z o o no tic¦ 𐋇¦c o𐋇vs¦ ¦are¦ ¦c ir c u la ting¦ ¦in¦ ¦the¦ ¦wi ld¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦experie nce¦ ¦from¦ 𐋇¦ita ly¦ ,▁ ¦countries¦ ,▁ ¦hospitals¦ ¦and¦ ¦int en sive¦ ¦care¦ ¦u ni ts¦ ¦should¦ ¦increase¦ ¦their¦ ¦pre par ed ness¦ ¦for¦ ¦a¦ ¦sur ge¦ ¦of¦ ¦patients¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦who¦ ¦will¦ ¦requir e¦ ¦heal th c are¦ ,▁ ¦and¦ ¦in¦ ¦part icul ar¦ ¦int en sive¦ ¦care¦ .
𐋇 ¦to¦ ¦conc lu de¦ ,▁ ¦we¦ ¦h op e¦ ¦more¦ ¦d ir ect¦ ¦e vi dence¦ ¦com ing¦ ¦up¦ ¦and¦ ¦c all¦ ¦for¦ ¦rea ders¦ ¦to¦ ¦provide¦ ¦their¦ ¦com ments¦ .
𐋇 ¦in di v id u als¦ ¦may¦ ¦app ly¦ ¦social¦ ¦dis ta ncing¦ ¦me t ho ds¦ ¦by¦ ¦sta ying¦ ¦at¦ ¦home¦ ,▁ ¦li mi ting¦ ¦travel¦ ,▁ ¦avo i ding¦ ¦crow ded¦ ¦areas¦ ,▁ ¦using¦ ¦no¦ - ¦contact¦ ¦gr ee ti ngs¦ ,▁ ¦and¦ ¦ph y s ically¦ ¦dis ta ncing¦ ¦the m s el ves¦ ¦from¦ ¦o thers¦ .
𐋇¦di a gn os ing¦ ¦the¦ ¦confirmed¦ ¦case¦ ¦should¦ ¦b ase¦ ¦on¦ ¦susp ected¦ ¦case¦ ¦with¦ ¦any¦ ¦one¦ ¦i te m¦ ¦of¦ ¦p at ho g en ic¦ ¦or¦ ¦se ro log ical¦ ¦e vi dence¦ ¦as¦ ¦follow ing¦ : ▁( ¦1¦ )▁ ¦re al¦ - ¦time¦ 𐊣¦p cr¦𐊼 ¦test¦ ¦positive¦ ¦for¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ; ▁( ¦2¦ )▁ ¦v iral¦ ¦w ho le¦ ¦gen ome¦ ¦se que ncing¦ ¦sh owing¦ ¦high¦ ¦h om o ge ne ity¦ ¦to¦ ¦the¦ ¦known¦ ¦no ve l¦ ¦coron a vi ruses¦ ; ▁( ¦3¦ )▁ ¦positive¦ ¦for¦ ¦the¦ ¦speci fic¦ 𐋇¦i g 𐋇 m¦ ¦antib o dy¦ ¦and¦ 𐋇¦i g 𐋇 g¦ ¦antib o dy¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦in¦ ¦ser um¦ ¦test¦ ;▁ ¦or¦ ¦a¦ ¦chan ge¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦speci fic¦ 𐋇¦i g 𐋇 g¦ ¦antib o dy¦ ¦from¦ ¦ne ga tive¦ ¦to¦ ¦positive¦ ,▁ ¦or¦ ¦ ti ter¦ ¦r is ing¦ ▁ ≥ ¦4¦ ¦ times¦ ¦in¦ ¦the¦ ¦reco very¦ ¦phase¦ ¦ab o ve¦ ¦that¦ ¦in¦ ¦the¦ ¦ac ute¦ ¦phase¦ .
𐋇¦e i ght¦ ¦of¦ ¦these¦ ¦doctors¦ ,▁ ¦including¦ 𐋇¦l i¦ 𐋇¦w en li an g¦ ,▁ ¦were¦ ¦ad m on ish ed¦ ¦by¦ ¦the¦ ¦police¦ ¦for¦ ¦sprea ding¦ ¦f al se¦ ¦r um o ur s¦ ,▁ ¦and¦ ¦another¦ ,▁ 𐋇¦a i¦ 𐋇¦f en¦ ,▁ ¦was¦ ¦rep ri ma nded¦ ¦by¦ ¦h er¦ ¦su p e ri ors¦ ¦for¦ ¦ra is ing¦ ¦the¦ ¦al ar m¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦was¦ ¦in formed¦ ¦on¦ ¦the¦ ¦same¦ ¦day¦ .
𐋇¦when¦ ¦this¦ ¦ch est¦ ¦p ain¦ ¦started¦ ?
𐋇¦s hi a¦ ¦sh r ines¦ ¦in¦ 𐋇¦ q om¦ ¦re ma ined¦ ¦open¦ ¦to¦ ¦p il g ri ms¦ ¦un ti l¦ ¦1 6¦ 𐋇¦march¦ ¦2020¦ . 𐋇¦ ir an¦ ¦b ec a me¦ ¦a¦ ¦c en tr e¦ ¦of¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦after¦ 𐋇¦china¦ ¦during¦ 𐋇¦february¦ .
𐋇 ¦long¦ - ¦ter m¦ ¦int erv ention¦ ¦to¦ ¦supp r ess¦ ¦the¦ ¦pandemic¦ ¦cau ses¦ ¦social¦ ¦and¦ ¦econom ic¦ ¦c os ts¦ .
𐋇¦i¦ ' ¦ ve¦ ¦very¦ ¦conc er ned¦ ¦of¦ ¦this¦ ¦ch est¦ ¦p ain¦
𐊣¦us ¦𐊼 ¦a u th or ities¦ ¦have¦ ¦also¦ ¦been¦ ¦acc u sed¦ ¦of¦ ¦di ver ting¦ ¦a id¦ ¦me ant¦ ¦for¦ ¦other¦ ¦n ations¦ ¦to¦ ¦their¦ ¦ own¦ ¦country¦ .
𐋇¦the¦ ¦de te ction¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ 𐊣¦r na ¦𐊼 ¦vi a¦ ¦re ver se¦ - ¦trans c ri pt ase¦ ¦pol y mer ase¦ ¦ch ain¦ ¦rea ction¦ ▁( 𐊣¦r t¦ - ¦p cr¦𐊼 )▁ ¦was¦ ¦used¦ ¦as¦ ¦the¦ ¦maj or¦ ¦c ri teri a¦ ¦for¦ ¦the¦ ¦di a g no sis¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇¦e mer g ing¦ ¦in fe ct ious¦ ¦disease¦ ▁ – ▁ 𐋇 ¦in fe ct ious¦ ¦disease¦ ¦of¦ ¦e mer g ing¦ ¦p at ho g en¦ ,▁ ¦o f ten¦ ¦no ve l¦ ¦in¦ ¦its¦ ¦outbreak¦ ¦r an ge¦ ¦or¦ ¦transmission¦ ¦mo de¦
𐋇 ¦ki mb er ly¦ - 𐋇 ¦cl ar k¦ ,▁ ¦which¦ ¦ma k es¦ 𐋇¦k l ee ne x¦ 𐋇 ¦to il et¦ 𐋇¦t is s ue¦ ,▁ ¦and¦ 𐋇¦s ol ari s¦ 𐋇¦p ap er¦ ¦which¦ ¦ma k es¦ 𐋇¦s or b ent¦ ,▁ ¦emp ha si zed¦ ¦they¦ ¦were¦ ¦working¦ ¦24¦ / ¦7¦ ¦to¦ ¦m ai nt ain¦ ¦the¦ ¦supply¦ ,▁ ¦according¦ ¦to¦ ¦the¦ 𐋇¦ne ws¦ . ¦c om¦ . ¦a u¦ ¦report¦ .
𐋇¦the¦ 𐋇¦au st ri an¦ ¦government¦ ¦ma nd ated¦ ¦that¦ ¦everyone¦ ¦ent ering¦ ¦a¦ ¦gr oc er y¦ ¦st ore¦ ¦m ust¦ ¦we ar¦ ¦a¦ ¦face¦ ¦mask¦ .
𐋇 ¦based¦ ¦on¦ ¦these¦ ,▁ 𐋇 ¦gi le ad¦ ¦has¦ ¦prov ided¦ ¦the¦ ¦comp oun d¦ ¦to¦ 𐋇¦china¦ ¦to¦ ¦conduc t¦ ¦a¦ ¦pa ir¦ ¦of¦ ¦trials¦ ¦on¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦infected¦ ¦in di v id u als¦ ,▁ ¦and¦ ¦the¦ ¦resul ts¦ ¦are¦ ¦high ly¦ ¦an ti cip ated¦ .
𐋇¦as¦ ¦of¦ ¦2 2¦ 𐋇¦february¦ ,▁ ¦among¦ ¦9¦ , ¦3 3 6¦ ¦follow ers¦ ¦of¦ ¦the¦ ¦ch ur ch¦ ,▁ ¦1¦ , ¦2 6 1¦ ¦or¦ ¦about¦ ¦1 3¦ %▁ ¦reported¦ ¦symptoms¦ . 𐋇¦s outh¦ 𐋇¦k o re a¦ ¦dec l ared¦ ¦the¦ ¦high est¦ ¦level¦ ¦of¦ ¦al er t¦ ¦on¦ ¦2 3¦ 𐋇¦february¦ ¦2020¦ .
𐋇 ¦glob a li z ation¦ ¦and¦ ¦disease¦ ▁ – ▁ 𐋇¦ ov erv iew¦ ¦of¦ ¦glob a li z ation¦ ¦and¦ ¦disease¦ ¦transmission¦
𐋇¦at¦ ¦least¦ ¦12¦ ¦si tting¦ ¦or¦ ¦for m er¦ 𐋇¦i ra ni an¦ ¦po li ti ci ans¦ ¦and¦ ¦government¦ ¦offi ci als¦ ¦had¦ ¦died¦ ¦from¦ ¦the¦ ¦disease¦ ¦by¦ ¦1 7¦ 𐋇¦march¦ .
𐋇¦it¦ ¦is¦ ¦the ref ore¦ ¦imp os sib le¦ ¦to¦ ¦s ac ri f ice¦ ¦all¦ ¦c am els¦ ¦for¦ ¦the¦ ¦control¦ ¦of¦ 𐊣¦m ers¦ 𐊼 ,▁ ¦as¦ ¦what¦ ¦was¦ ¦done¦ ¦in¦ ¦wi ld¦ ¦ani mal¦ ¦marke ts¦ ¦in¦ 𐋇¦china¦ ¦to¦ ¦prevent¦ ¦the¦ ¦sprea ding¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦this¦ ¦is¦ ¦because¦ ¦out s ide¦ ¦the¦ ¦human¦ ¦body¦ ,▁ ¦the¦ ¦virus¦ ¦is¦ ¦ki lled¦ ¦by¦ ¦h ou se ho ld¦ ¦soap¦ ,▁ ¦which¦ ¦b ur s ts¦ ¦its¦ ¦prot ec tive¦ ¦b ub b le¦ .
𐋇¦the¦ 𐊣¦c d c¦𐊼 ¦recomme nds¦ ¦that¦ ¦people¦ ¦was h¦ ¦hands¦ ¦o f ten¦ ¦with¦ ¦soap¦ ¦and¦ ¦water¦ ¦for¦ ¦at¦ ¦least¦ ¦tw en ty¦ ¦se co nds¦ ,▁ ¦ esp eci ally¦ ¦after¦ ¦going¦ ¦to¦ ¦the¦ ¦to il et¦ ¦or¦ ¦when¦ ¦hands¦ ¦are¦ ¦vi sib ly¦ ¦d ir ty¦ ;▁ ¦before¦ ¦ea ting¦ ;▁ ¦and¦ ¦after¦ ¦b l owing¦ ¦one¦ ' ¦s¦ ¦n ose¦ ,▁ ¦c ou g hing¦ ,▁ ¦or¦ ¦s n ee z ing¦ .
𐋇 ¦rapidly¦ ¦increasing¦ ¦c um u la tive¦ ¦in ci dence¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ )▁ ¦in¦ ¦the¦ 𐋇¦e ur op e an¦ 𐋇¦union¦ / 𐋇¦e ur op e an¦ 𐋇 ¦econom ic¦ 𐋇 ¦area¦ ¦and¦ ¦the¦ 𐋇¦united¦ 𐋇 ¦ki ng d om¦ ,▁ ¦1¦ 𐋇¦january¦ ¦to¦ ¦15¦ 𐋇¦march¦ ¦2020¦
𐋇¦the¦ ¦high¦ - ¦th r ou gh p ut¦ ¦a ut om ated¦ ¦sy s te ms¦ ¦in¦ ¦many¦ ¦clinical¦ ¦labor at ories¦ ¦will¦ ¦be¦ ¦ able¦ ¦to¦ ¦per for m¦ ¦these¦ ¦ass a ys¦ ¦but¦ ¦their¦ ¦ av a il ab ility¦ ¦will¦ ¦dep end¦ ¦on¦ ¦the¦ ¦rate¦ ¦of¦ ¦production¦ ¦for¦ ¦each¦ ¦system¦ .
𐋇¦the¦ ¦a ve ra ge¦ ¦time¦ ¦from¦ ¦o ns et¦ ¦to¦ ¦death¦ ¦was¦ ¦9¦ . ¦5¦ ▁( ¦4¦ . ¦8¦ - ¦1 3¦ )▁ ¦days¦ .
𐋇¦people¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦disease¦ ¦up¦ ¦to¦ ¦three¦ ¦days¦ ¦before¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ ¦su gg es ting¦ ¦transmission¦ ¦is¦ ¦possible¦ ¦before¦ ¦develop ing¦ ¦si gni fic ant¦ ¦symptoms¦ .
𐋇¦the¦ ¦virus¦ ¦can¦ ¦spread¦ ¦to¦ ¦different¦ ¦or g ans¦ ¦th r ou g ho ut¦ ¦the¦ ¦ch ic k en¦ .
𐋇¦the¦ ¦a u th or ities¦ ¦also¦ ¦announced¦ ¦the¦ ¦con stru ction¦ ¦of¦ ¦a¦ ¦te m por ary¦ ¦hospital¦ ,▁ 𐋇¦h u os he ns han¦ 𐋇¦hospital¦ ,▁ ¦which¦ ¦was¦ ¦comple ted¦ ¦in¦ ¦10¦ ¦days¦ .
𐋇 ¦int ri g u i ng ly¦ ,▁ ¦ser a¦ ¦of¦ ¦con v al es c ent¦ 𐊣¦sars¦𐊼 ¦patients¦ ¦were¦ ¦cap able¦ ¦of¦ ¦ne ut ra li z ing¦ 𐊣 ¦wi v 𐊼 1¦ .
𐋇 ¦to¦ ¦further¦ ¦al le vi ate¦ ¦the¦ ¦shortage¦ ,▁ 𐋇¦co les¦ ¦or d ered¦ ¦bi gg er¦ ¦p ack a ges¦ ¦from¦ ¦supp li ers¦ ¦and¦ ¦increased¦ ¦de li very¦ ¦fre que nc y¦ ,▁ 𐋇¦w o ol w or th s¦ ¦or d ered¦ ¦ex tr a¦ ¦st oc k¦ ,▁ ¦while¦ 𐊣 ¦al di ¦𐊼 ¦made¦ ¦st oc ks¦ ¦for¦ ¦a¦ ¦plan ned¦ 𐋇¦w ed n es day¦ ¦speci al¦ ¦available¦ ¦early¦ .
𐋇¦there¦ ¦are¦ ¦two¦ ¦typ es¦ ¦of¦ ¦can ine¦ ¦coronavirus¦ ▁( 𐊣¦c c𐊼 o 𐋇 v¦ ),▁ ¦one¦ ¦that¦ ¦cau ses¦ ¦mi ld¦ ¦ga st ro i nt est in al¦ ¦disease¦ ¦and¦ ¦one¦ ¦that¦ ¦has¦ ¦been¦ ¦found¦ ¦to¦ ¦cause¦ ¦respiratory¦ ¦disease¦ .
𐋇 ¦while¦ ¦int act¦ 𐊣 ¦or f 𐊼 4¦ ¦could¦ ¦be¦ ¦ob s er ved¦ ¦in¦ ¦b at¦ ¦and¦ ¦ca me l¦ ¦vi ruses¦ ¦related¦ ¦to¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ,▁ ¦the¦ ¦al p ac a¦ ¦al p ha¦ - 𐋇¦co𐋇v¦ ¦dis p la ys¦ ¦a¦ ¦sing le¦ ¦n uc le o t ide¦ ¦ins er tion¦ ,▁ ¦resul ting¦ ¦in¦ ¦a¦ ¦f r am es hi f t¦ .
𐋇¦some¦ ¦countries¦ ¦in¦ 𐋇¦a f r ic a¦ ¦have¦ ¦also¦ ¦seen¦ ¦a¦ ¦r ise¦ ¦in¦ ¦a nt i¦ - 𐋇¦chinese¦ ¦s enti ment¦ .
𐋇¦these¦ ¦c am els¦ ¦ser ve¦ ¦as¦ ¦an¦ ¦important¦ ¦to ol¦ ¦for¦ ¦trans por t ation¦ ¦as¦ ¦well¦ ¦as¦ ¦a¦ ¦m ain¦ ¦so ur ce¦ ¦of¦ ¦me at¦ ,▁ ¦m il k¦ ,▁ ¦lea ther¦ ¦and¦ ¦w o ol¦ ¦produc ts¦ ¦for¦ ¦the¦ ¦local¦ ¦people¦ .
𐋇¦however¦ ,▁ ¦their¦ ¦work¦ ¦also¦ ¦nee ds¦ ¦up d ate¦ ¦according¦ ¦to¦ ¦the¦ ¦l at est¦ 𐋇¦di a g no sis¦ ¦and¦ 𐋇 ¦treatment¦ 𐋇 ¦guid el ines¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ▁( 𐋇 ¦tri al¦ ¦se v en th¦ ¦ vers ion¦ )▁ ¦and¦ ¦re ce ntly¦ ¦stud ies¦ .
𐋇¦co ro na vi ruses¦ ¦can¦ ¦cause¦ ¦c ol ds¦ ¦with¦ ¦maj or¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦fever¦ ,▁ ¦and¦ ¦a¦ ¦s ore¦ ¦th ro at¦ ¦from¦ ¦sw olle n¦ ¦a de no i ds¦ .
𐋇¦a¦ ¦study¦ ¦p ub lish ed¦ ¦by¦ ¦the¦ 𐊣¦us ¦𐊼 𐋇¦center¦ ¦for¦ 𐋇 ¦disease¦ 𐋇 ¦control¦ ¦and¦ 𐋇 ¦prev ention¦ ¦has¦ ¦conc lu ded¦ ¦that¦ ¦it¦ ¦may¦ ¦be¦ ¦5¦ . ¦7¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦is¦ ¦more¦ ¦p at ho g en ic¦ ¦than¦ ¦comm unity¦ - ¦ac qu ir ed¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦and¦ ¦less¦ ¦p at ho g en ic¦ ¦than¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦or¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦at¦ ¦least¦ ¦5 2¦ ¦thousand¦ ¦deaths¦ ¦were¦ ¦l in ked¦ ¦to¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦the¦ ¦disease¦ ¦caused¦ ¦by¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦four¦ ¦of¦ ¦these¦ ¦coron a vi ruses¦ ¦cont in u ally¦ ¦c ir c ul ate¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ¦and¦ ¦produc e¦ ¦the¦ ¦gen er ally¦ ¦mi ld¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦comm on¦ ¦co ld¦ ¦in¦ ¦ad ul ts¦ ¦and¦ ¦children¦ ¦wor l d w ide¦ :▁ - 𐊣¦ oc 4 3¦ ,▁ - ¦h k u 1¦ ,▁ ¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ,▁ - 𐊣 ¦n l 𐊼 6 3¦ .
𐋇¦as¦ ¦of¦ 𐋇¦april¦ ¦7¦ ,▁ ¦2020¦ ,▁ ¦only¦ ¦a¦ ¦sing le¦ ¦test¦ ¦has¦ ¦been¦ ¦approved¦ ¦by¦ ¦the¦ 𐊣 ¦f d a ¦𐊼 ¦under¦ ¦an¦ ¦emergency¦ ¦use¦ ¦a ut ho ri z ation¦ . 𐋇¦in¦ ¦l ate¦ 𐋇¦march¦ ¦2020¦ ,▁ 𐋇¦e u ro i m m u n¦ 𐋇 ¦medical¦ 𐋇 ¦labor atory¦ 𐋇¦di a g no st ics¦ ¦and¦ 𐋇¦e p it op e¦ 𐋇¦di a g no st ics¦ ¦recei ved¦ 𐋇¦e ur op e an¦ ¦appro v als¦ ¦for¦ ¦their¦ ¦test¦ ¦ki ts¦ ,▁ ¦which¦ ¦can¦ ¦det ect¦ 𐋇¦i g 𐋇 g¦ ¦and¦ 𐋇¦i g 𐋇 a¦ ¦antib odies¦ ¦against¦ ¦the¦ ¦virus¦ ¦in¦ ¦blood¦ ¦samples¦ .
𐋇¦z o o no tic¦ ¦o ri g ins¦ ¦of¦ ¦human¦ ¦coron a vi ruses¦
𐋇 ¦an y one¦ ¦in¦ ¦the¦ ¦family¦ ¦have¦ ¦a¦ ¦heart¦ ¦proble m¦ ¦heart¦ ¦disease¦ ¦heart¦ ¦att ack¦ ¦high¦ ¦ch ol est er ol¦ ¦high¦ ¦blood¦ ¦pr ess ure¦
𐋇 ¦sho w¦ ¦ me¦ ¦on¦ ¦this¦ ¦i ma ge¦ ¦where¦ ¦you¦ ¦f ee l¦ ¦the¦ ¦p ain¦
𐋇¦all¦ ¦of¦ ¦them¦ ¦had¦ ¦li ve¦ ¦b ir th¦ ¦pre g na nc ies¦ ¦and¦ ¦no¦ ¦severe¦ ¦ne o na tal¦ ¦as p h y xi a¦ ¦was¦ ¦ob s er ved¦ .
𐋇¦in¦ ¦cont ra st¦ ,▁ ¦high ly¦ ¦p at ho g en ic¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦have¦ ¦not¦ ¦ad ap ted¦ ¦to¦ ¦hum ans¦ ¦well¦ ¦and¦ ¦their¦ ¦transmission¦ ¦within¦ ¦hum ans¦ ¦can no t¦ ¦be¦ ¦s us ta ined¦ .
𐋇¦b ¦ ' 𐋇¦co ro na vi ruses¦ ¦are¦ ¦a¦ ¦group¦ ¦of¦ ¦related¦ ¦vi ruses¦ ¦that¦ ¦cause¦ ¦dis eases¦ ¦in¦ ¦m am m als¦ ¦and¦ ¦b ir ds¦ .
𐋇 ¦three¦ ¦fe et¦ ¦is¦ ¦consid ered¦ ¦an¦ ¦appro p ri ate¦ ¦distance¦ ¦for¦ ¦people¦ ¦to¦ ¦st ay¦ ¦a way¦ ¦from¦ ¦a¦ ¦patient¦ .
𐋇 ¦from¦ ¦another¦ ¦pers p ec tive¦ ,▁ ¦it¦ ¦mi ght¦ ¦also¦ ¦be¦ ¦tr ue¦ ¦that¦ ¦hum ans¦ ¦have¦ ¦been¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦these¦ ¦four¦ 𐊣¦h c𐊼 o𐋇vs¦ .
𐋇¦as¦ ¦of¦ 𐋇¦th ur s day¦ ,▁ 𐋇 ¦associ ated¦ 𐋇¦pr ess¦ ¦reported¦ ¦there¦ ¦were¦ ¦at¦ ¦least¦ ¦1 2 6¦ , ¦000¦ ¦cases¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦wor l d w ide¦ ,▁ ¦resul ting¦ ¦in¦ ¦over¦ ¦4¦ , ¦6 00¦ ¦deaths¦ .
𐋇¦china¦ ¦has¦ ¦also¦ ¦called¦ ¦for¦ ¦the¦ 𐊣¦us ¦𐊼 ¦to¦ ¦li f t¦ ¦its¦ ¦sa nc tions¦ ¦o ff¦ ¦of¦ 𐋇 ¦sy ri a¦ ,▁ 𐋇 ¦ve ne z u el a¦ ¦and¦ 𐋇¦ ir an¦ ,▁ ¦while¦ ¦re por t ed ly¦ ¦s en ding¦ ¦a id¦ ¦to¦ ¦the¦ ¦la tter¦ ¦two¦ ¦countries¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦cau ses¦ ¦severe¦ ¦respiratory¦ ¦infection¦ ¦like¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦p res ented¦ ¦as¦ ¦fever¦ ,▁ ¦c ough¦ ¦and¦ ¦d y s p ne a¦ .
𐋇¦me an w hi le¦ ,▁ ¦the¦ ¦epi demic¦ ¦rapidly¦ ¦spread¦ ¦to¦ ¦the¦ ¦ne i gh b or ing¦ ¦c ities¦ ,▁ ¦prov in ces¦ ,▁ ¦and¦ ¦countries¦ .
𐋇¦s por ts¦ ¦e ve nts¦ ¦and¦ ¦se as ons¦ ¦were¦ ¦can ce lled¦ . 𐋇¦on¦ ¦11¦ 𐋇¦march¦ ,▁ 𐋇 ¦tr um p¦ ¦announced¦ ¦travel¦ ¦restrictions¦ ¦for¦ ¦most¦ ¦of¦ 𐋇¦e ur op e¦ ,▁ ¦ex c lu ding¦ ¦the¦ 𐋇¦united¦ 𐋇 ¦ki ng d om¦ ,▁ ¦for¦ ¦30¦ ¦days¦ ,▁ ¦effective¦ ¦1 3¦ 𐋇¦march¦ .
𐋇 ¦by¦ ¦1 3¦ 𐋇¦march¦ ,▁ ¦more¦ ¦than¦ ¦for ty¦ ¦countries¦ ¦and¦ ¦ter rit ories¦ ¦had¦ ¦reported¦ ¦deaths¦ ,▁ ¦on¦ ¦every¦ ¦cont in ent¦ ¦ex cep t¦ 𐋇¦a nt ar ct ic a¦ . 𐋇 ¦several¦ ¦measures¦ ¦are¦ ¦comm on ly¦ ¦used¦ ¦to¦ ¦qu an ti f y¦ ¦mor t ality¦ .
𐋇¦ ir a¦ 𐋇 ¦lo ng in i¦ ,▁ ¦ et¦ ¦ al¦ . ,▁ ¦ est ab lish ed¦ ¦a¦ ¦mo de l¦ ¦to¦ ¦pr ed ic t¦ ¦the¦ ¦out c ome¦ ¦of¦ ¦the¦ ¦epi demic¦ ¦and¦ ¦su gg es ted¦ ¦that¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦could¦ ¦inf ect¦ ¦two¦ - ¦th ir ds¦ ¦of¦ ¦the¦ ¦g lobal¦ ¦population¦ .
𐋇¦on¦ ¦3 1¦ 𐋇¦de ce mber¦ ¦2019¦ ,▁ ¦the¦ ¦outbreak¦ ¦was¦ ¦tr ac ed¦ ¦to¦ ¦a¦ ¦no ve l¦ ¦str ain¦ ¦of¦ ¦coronavirus¦ ,▁ ¦which¦ ¦was¦ ¦given¦ ¦the¦ ¦in teri m¦ ¦na me¦ ¦2019¦ - ¦n 𐋇 co 𐋇 v¦ ¦by¦ ¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ▁( 𐊣¦who¦𐊼 ),▁ ¦la ter¦ ¦re na med¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦by¦ ¦the¦ 𐋇 ¦intern ational¦ 𐋇¦comm it te e¦ ¦on¦ 𐋇 ¦ta x on om y¦ ¦of¦ 𐋇¦vi ruses¦ .
𐋇¦f ol low¦ - ¦up¦ ¦i ma ges¦ ¦after¦ ¦de li very¦ ¦sh ow ed¦ ¦no¦ ¦pro gr ess ion¦ ¦of¦ ¦p ne um o nia¦ . 𐋇 ¦media¦ ¦re por ts¦ ¦ind ic ate¦ ¦that¦ ¦over¦ ¦100¦ ¦women¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦mi ght¦ ¦have¦ ¦de li v ered¦ ,▁ ¦and¦ ¦in¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦no¦ ¦m at er n al¦ ¦deaths¦ ¦were¦ ¦reported¦ .
𐋇¦as¦ ¦ma in l and¦ 𐋇¦china¦ ¦is¦ ¦a¦ ¦maj or¦ ¦econom y¦ ¦and¦ ¦manufactur ing¦ ¦h ub ¦ ,▁ ¦the¦ ¦v iral¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦seen¦ ¦to¦ ¦p ose¦ ¦a¦ ¦maj or¦ ¦d es ta bi li z ing¦ ¦th reat¦ ¦to¦ ¦the¦ ¦g lobal¦ ¦econom y¦ .
𐋇¦in¦ 𐋇¦china¦ ,▁ ¦es ti ma tes¦ ¦for¦ ¦the¦ ¦death¦ - ¦to¦ - ¦case¦ ¦r ati o¦ ¦dec rea sed¦ ¦from¦ ¦1 7¦ . ¦3¦ % ▁( ¦for¦ ¦those¦ ¦with¦ ¦sy m pt om¦ ¦o ns et¦ ¦1¦ – ¦10¦ 𐋇¦january¦ ¦2020¦ )▁ ¦to¦ ¦ 0¦ . ¦7¦ % ▁( ¦for¦ ¦those¦ ¦with¦ ¦sy m pt om¦ ¦o ns et¦ ¦after¦ ¦1¦ 𐋇¦february¦ ¦2020¦ ). 𐋇 ¦other¦ ¦measures¦ ¦include¦ ¦the¦ ¦case¦ ¦f at ality¦ ¦rate¦ ▁( 𐊣¦c f r¦𐊼 ),▁ ¦which¦ ¦ ref l ects¦ ¦the¦ ¦percent¦ ¦of¦ ¦di a gn osed¦ ¦people¦ ¦who¦ ¦di e¦ ¦from¦ ¦a¦ ¦disease¦ ,▁ ¦and¦ ¦the¦ ¦infection¦ ¦f at ality¦ ¦rate¦ ▁( 𐊣¦i f r¦𐊼 ),▁ ¦which¦ ¦ ref l ects¦ ¦the¦ ¦percent¦ ¦of¦ ¦infected¦ ▁( ¦di a gn osed¦ ¦and¦ ¦un di a gn osed¦ )▁ ¦who¦ ¦di e¦ ¦from¦ ¦a¦ ¦disease¦ .
𐋇 ¦currently¦ ,▁ ¦due¦ ¦to¦ ¦the¦ ¦l ack¦ ¦of¦ ¦effective¦ ¦and¦ ¦speci fic¦ ¦the rap y¦ ¦for¦ 𐊣 ¦covid¦ - ¦19¦ ,▁ ¦t c m ¦𐊼 ¦has¦ ¦become¦ ¦one¦ ¦of¦ ¦the¦ ¦maj or¦ ¦al t er na tive¦ ¦tre at ments¦ ¦for¦ ¦patients¦ ¦with¦ ¦li ght¦ ¦to¦ ¦m od er ate¦ ¦symptoms¦ ¦or¦ ¦for¦ ¦those¦ ¦who¦ ¦have¦ ¦rec ov ered¦ ¦from¦ ¦severe¦ ¦sta ges¦ .
𐋇¦t ha il and¦ ¦is¦ ¦using¦ ¦an¦ ¦app¦ ¦and¦ 𐊣 ¦si m ¦𐊼 ¦car ds¦ ¦for¦ ¦all¦ ¦tr av el ers¦ ¦to¦ ¦en for ce¦ ¦their¦ ¦quarantine¦ .
𐋇 ¦more¦ ¦than¦ ¦30¦ %▁ ¦of¦ ¦patients¦ ¦present¦ ¦with¦ ¦ga st ro i nt est in al¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦di ar r he a¦ ¦and¦ ¦v o mi ting¦ .
𐋇¦m is in for m ation¦ ¦about¦ ¦the¦ ¦virus¦ ¦has¦ ¦spread¦ ¦on line¦ ,▁ ¦and¦ ¦there¦ ¦have¦ ¦been¦ ¦in ci de nts¦ ¦of¦ ¦ x en op ho bi a¦ ¦and¦ ¦dis c ri m ination¦ ¦against¦ 𐋇¦chinese¦ ¦people¦ ,▁ ¦other¦ ¦people¦ ¦of¦ 𐋇 ¦ea st¦ ¦and¦ 𐋇¦s ou th ea st¦ 𐋇¦a si an¦ ¦d es c ent¦ ¦and¦ ¦appe ara nce¦ ,▁ ¦and¦ ¦o thers¦ ¦from¦ ¦areas¦ ¦with¦ ¦si gni fic ant¦ ¦virus¦ ¦cases¦ .
𐋇¦ad ap tive¦ ¦de si g ns¦ ¦within¦ ¦o ng o ing¦ 𐋇 ¦phase¦ 𐊣¦i i¦ - ¦i i i ¦𐊼 ¦clinical¦ ¦trials¦ ¦on¦ ¦ca nd id ate¦ ¦the rap e ut ics¦ ¦may¦ ¦sh or ten¦ ¦tri al¦ ¦d ur ations¦ ¦and¦ ¦use¦ ¦fe w er¦ ¦sub j ects¦ ,▁ ¦pos sib ly¦ ¦exp e di ting¦ ¦d eci sions¦ ¦for¦ ¦early¦ ¦t erm ination¦ ¦or¦ ¦s uc c ess¦ ,▁ ¦and¦ ¦co or di na ting¦ ¦de si g n¦ ¦chan ges¦ ¦for¦ ¦a¦ ¦speci fic¦ ¦tri al¦ ¦across¦ ¦its¦ ¦intern ational¦ ¦loc ations¦ .
𐋇¦the¦ ¦u pp er¦ ¦es tim ate¦ ¦of¦ ¦this¦ ¦r an ge¦ ¦is¦ ¦con si st ent¦ ¦with¦ ¦the¦ ¦resul ts¦ ¦from¦ ¦the¦ ¦first¦ ¦ra nd om¦ ¦testing¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦in¦ 𐋇¦g erm an y¦ ,▁ ¦and¦ ¦a¦ ¦st ati st ical¦ ¦study¦ ¦an al y s ing¦ ¦the¦ ¦imp act¦ ¦of¦ ¦testing¦ ¦on¦ 𐊣¦c f r¦𐊼 ¦es ti ma tes¦ .
𐋇 ¦other¦ ¦countries¦ ¦also¦ ¦ad op ted¦ ¦a¦ ¦v ar ie ty¦ ¦of¦ ¦measures¦ ¦ ai med¦ ¦at¦ ¦li mi ting¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦some¦ ¦sc ie nt ists¦ ¦ch ose¦ ¦to¦ ¦sh are¦ ¦their¦ ¦resul ts¦ ¦qu ic k ly¦ ¦on¦ ¦pre p r in t¦ ¦s erv ers¦ ¦such¦ ¦as¦ ¦b io 𐋇 r xi v¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦in¦ 𐊣 ¦e u¦ / ¦e ea ¦𐊼 ¦countries¦ ¦and¦ ¦the¦ 𐊣¦uk¦𐊼
𐋇 ¦both¦ ¦d ru gs¦ ¦have¦ ¦ext en sive¦ ¦inter ac tions¦ ¦with¦ ¦p res c ri p tion¦ ¦d ru gs¦ ,▁ ¦a ff ec ting¦ ¦the¦ ¦the rap e u tic¦ ¦dose¦ ¦and¦ ¦disease¦ ¦mi tig ation¦ .
𐋇¦al though¦ ¦ba ts¦ ¦have¦ ¦many¦ ¦fe at ures¦ ¦that¦ ¦f av o ur s¦ ¦the¦ ¦sprea ding¦ ¦of¦ ¦vi ruses¦ ,▁ ¦the¦ ¦cha nce¦ ¦for¦ ¦hum ans¦ ¦to¦ ¦be¦ ¦in¦ ¦contact¦ ¦with¦ ¦ba ts¦ ¦and¦ ¦other¦ ¦w il d li fe¦ ¦speci es¦ ¦can¦ ¦be¦ ¦mi ni mi zed¦ ¦if¦ ¦people¦ ¦are¦ ¦ ed uc ated¦ ¦to¦ ¦st ay¦ ¦a way¦ ¦from¦ ¦them¦ .
𐋇 ¦fin ally¦ ,▁ ¦al p ac a¦ ¦al p ha¦ - 𐋇¦co𐋇v¦ ¦has¦ ¦not¦ ¦been¦ ¦found¦ ¦in¦ ¦f er al¦ ¦ani m als¦ .
𐋇¦many¦ ¦d io ce ses¦ ¦have¦ ¦recomme nded¦ ¦ ol der¦ 𐋇¦ch r is ti ans¦ ¦to¦ ¦st ay¦ ¦at¦ ¦home¦ ¦ra ther¦ ¦than¦ ¦att en ding¦ 𐋇¦m as s¦ ¦on¦ 𐋇 ¦su nd a ys¦ ;▁ ¦some¦ ¦ch ur ch es¦ ¦have¦ ¦made¦ ¦ch ur ch¦ ¦services¦ ¦available¦ ¦vi a¦ ¦ra di o¦ ,▁ ¦on line¦ ¦li ve¦ ¦st re am ing¦ ¦or¦ ¦te le v is ion¦ ¦while¦ ¦o thers¦ ¦are¦ ¦off ering¦ ¦d ri ve¦ - ¦in¦ ¦wor s hi p¦ .
𐋇¦ ten¦ ¦years¦ ¦la ter¦ ,▁ ¦the¦ 𐋇¦m id d le¦ 𐋇 ¦ea st¦ ¦respiratory¦ ¦sy nd r ome¦ ▁( 𐊣¦m ers¦ 𐊼 )▁ ¦outbreak¦ ¦resul ted¦ ¦in¦ ¦a¦ ¦per si st ent¦ ¦epi demic¦ ¦in¦ ¦the¦ 𐋇¦ ara bi an¦ 𐋇¦p e ni ns ul a¦ ¦with¦ ¦s po ra d ic¦ ¦sprea ding¦ ¦to¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦world¦ .
𐋇 ¦only¦ ¦few¦ ¦re por ts¦ ¦of¦ ¦labor atory¦ - ¦confirmed¦ ¦as y m pt o ma tic¦ ¦cases¦ ¦e xi st¦ ,▁ ¦but¦ ¦as y m pt o ma tic¦ ¦transmission¦ ¦has¦ ¦been¦ ¦ id enti fied¦ ¦by¦ ¦some¦ ¦countries¦ ¦during¦ ¦contact¦ ¦tr ac ing¦ ¦inv es tig ations¦ .
𐋇¦the¦ ¦h ost¦ ¦ rib os ome¦ ¦trans la tes¦ ¦the¦ ¦initi al¦ ¦over la pp ing¦ ¦open¦ ¦rea ding¦ ¦f ra me¦ ¦of¦ ¦the¦ ¦virus¦ ¦gen ome¦ ¦and¦ ¦for ms¦ ¦a¦ ¦long¦ ¦pol y p ro te in¦ .
𐋇¦on¦ ¦2 9¦ 𐋇¦march¦ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦beg in ning¦ ¦1¦ 𐋇¦april¦ ¦all¦ ¦new¦ ¦over se as¦ ¦ar ri v als¦ ¦will¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇 ¦most¦ ¦no ve l¦ ¦drug¦ ¦ca nd id a tes¦ ▁( 𐊣 ¦n ce 𐊼 s¦ )▁ ¦f ai l¦ ¦during¦ ¦drug¦ ¦development¦ ,▁ ¦e i ther¦ ¦because¦ ¦they¦ ¦have¦ ¦un ac ce pt able¦ ¦to x ic ity¦ ¦or¦ ¦because¦ ¦they¦ ¦si mp ly¦ ¦do¦ ¦not¦ ¦pro ve¦ ¦e ffic ac y¦ ¦on¦ ¦the¦ ¦t ar ge ted¦ ¦disease¦ ,▁ ¦as¦ ¦sh own¦ ¦in¦ 𐋇 ¦phase¦ 𐊣¦i i¦ - ¦i i i ¦𐊼 ¦clinical¦ ¦trials¦ .
𐊣 ¦e u¦𐊼 ¦fo re i g n¦ ¦po lic y¦ ¦ch ie f¦ 𐋇 ¦jo se p¦ 𐋇¦b or r ell¦ ¦w ar ned¦ ¦that¦ ¦there¦ ¦is¦ ▁" ¦a¦ ¦ge o¦ - ¦pol itical¦ ¦comp on ent¦ ¦including¦ ¦a¦ ¦ stru gg le¦ ¦for¦ ¦inf lu e nce¦ ¦through¦ ¦sp in ning¦ ¦and¦ ¦the¦ ▁' ¦pol it ics¦ ¦of¦ ¦gen er os ity¦ ' " .
𐋇¦al though¦ ¦several¦ ¦countries¦ ¦use¦ ¦ch lo ro qu ine¦ ¦or¦ ¦hy d ro x y ch lo ro qu ine¦ ¦for¦ ¦treatment¦ ¦of¦ ¦pers ons¦ ¦hos pi ta li zed¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦as¦ ¦of¦ 𐋇¦march¦ ¦2020¦ ¦the¦ ¦drug¦ ¦has¦ ¦not¦ ¦been¦ ¦for m ally¦ ¦approved¦ ¦through¦ ¦clinical¦ ¦trials¦ ¦in¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ .
𐋇¦ne ver th el ess¦ ,▁ ¦respiratory¦ ¦d y s f un ction¦ ¦and¦ ¦fa il ure¦ ¦are¦ ¦the¦ ¦maj or¦ ¦th reat¦ ¦to¦ ¦the¦ ¦patients¦ ¦and¦ ¦the¦ ¦maj or¦ ¦cause¦ ¦of¦ ¦death¦ .
𐋇 ¦first¦ ,▁ ¦hum ans¦ ¦but¦ ¦not¦ ¦al p ac as¦ ¦mi ght¦ ¦have¦ ¦contact¦ ¦with¦ ¦ba ts¦ ¦in¦ ¦a¦ ¦sh ared¦ ¦e co log ical¦ ¦ ni ch e¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦a¦ ¦b at¦ 𐋇¦co𐋇v¦ ¦ter med¦ 𐊣 ¦ar c𐊼 o 𐋇 v¦ . ¦2¦ ▁( 𐋇 ¦app al ac hi an¦ 𐋇¦r id ge¦ 𐋇¦co𐋇v¦ )▁ ¦det ected¦ ¦in¦ 𐋇¦n or th¦ 𐋇¦a mer ic an¦ ¦ tric ol or ed¦ ¦b at¦ ¦dis p la y ed¦ ¦cl ose¦ ¦rel at io ns hi p¦ ¦with¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦n l 𐊼 6 3¦ .
𐋇¦vi ro log ical¦ ¦surveillance¦ ¦is¦ ¦done¦ ¦by¦ ¦using¦ ¦m ol ec ul ar¦ ¦tests¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇¦there¦ ¦has¦ ¦been¦ ¦supp ort¦ ¦for¦ ¦the¦ 𐋇¦chinese¦ ,▁ ¦both¦ ¦on¦ ¦and¦ ¦off line¦ ,▁ ¦and¦ ¦t ow ar ds¦ ¦those¦ ¦in¦ ¦virus¦ - ¦s tric k en¦ ¦areas¦ .
𐋇¦vi ruses¦ ¦can¦ ¦also¦ ¦inf ect¦ ¦an¦ ¦in di v id u al¦ ¦through¦ ¦the¦ ¦e y es¦ .
𐋇¦on¦ ¦20¦ 𐋇¦march¦ ,▁ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦beg an¦ ¦to¦ ¦par ti ally¦ ¦with d ra w al¦ ¦its¦ ¦t ro o ps¦ ¦from¦ 𐋇¦i ra q ¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ,▁ ¦the¦ ¦government¦ ¦recei ved¦ ¦c rit ic is m¦ ¦for¦ ¦the¦ ¦per ce i ved¦ ¦l ack¦ ¦of¦ ¦p ace¦ ¦and¦ ¦in te ns ity¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦conc er ns¦ ¦f ac ed¦ ¦by¦ ¦the¦ ¦public¦ . 𐋇¦on¦ ¦1 6¦ 𐋇¦march¦ ,▁ 𐋇¦prime¦ 𐋇¦minister¦ 𐋇 ¦bo ri s¦ 𐋇 ¦jo h ns on¦ ¦made¦ ¦an¦ ¦an n oun ce ment¦ ¦ad v is ing¦ ¦against¦ ¦all¦ ¦n on¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦social¦ ¦contact¦ ,▁ ¦su gg es ting¦ ¦people¦ ¦work¦ ¦from¦ ¦home¦ ¦where¦ ¦possible¦ ¦and¦ ¦avo id¦ ¦v en u es¦ ¦such¦ ¦as¦ ¦p ub s¦ ,▁ ¦res ta u ra nts¦ ,▁ ¦and¦ ¦th ea tr es¦ .
𐋇¦on¦ ¦11¦ 𐋇¦march¦ ¦2020¦ ,▁ 𐊣¦who¦𐊼 ¦c har ac teri zed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦as¦ ¦a¦ ¦pandemic¦ .
𐋇¦for¦ ¦exa mple¦ ,▁ 𐋇 ¦be i j ing¦ ¦has¦ ¦imposed¦ ¦a¦ ¦14¦ - ¦day¦ ¦ma nd atory¦ ¦quarantine¦ ¦for¦ ¦all¦ ¦intern ational¦ ¦tra ve ll ers¦ ¦ent ering¦ ¦the¦ ¦city¦ . 𐋇¦on¦ ¦2 3¦ 𐋇¦march¦ ,▁ ¦ma in l and¦ 𐋇¦china¦ ¦only¦ ¦one¦ ¦case¦ ¦had¦ ¦trans m it ted¦ ¦d om est ically¦ ¦in¦ ¦the¦ ¦five¦ ¦days¦ ¦pri or¦ ,▁ ¦in¦ ¦this¦ ¦ins ta nce¦ ¦vi a¦ ¦a¦ ¦tra ve ll er¦ ¦re tur ning¦ ¦to¦ 𐋇¦g u a ng z ho u¦ ¦from¦ 𐋇¦i st an b ul¦ .
𐋇¦in¦ ¦the¦ ¦pa st¦ ¦dec a d es¦ ,▁ ¦se v en¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦have¦ ¦been¦ ¦ id enti fied¦ .
𐋇¦b at¦ ¦al p ha¦ - 𐋇¦c o𐋇vs¦ ¦clos e ly¦ ¦related¦ ¦to¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦have¦ ¦been¦ ¦found¦ .
𐋇¦however¦ ,▁ ¦on¦ ¦12¦ 𐋇¦may¦ ¦201 3¦ ,▁ ¦a¦ ¦case¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦in¦ 𐋇¦f ra nce¦ ¦was¦ ¦confirmed¦ ¦by¦ ¦the¦ 𐋇¦f r en ch¦ 𐋇¦ministry¦ ¦of¦ 𐋇 ¦social¦ 𐋇¦a ff a ir s¦ ¦and¦ 𐋇¦health¦ .
𐋇¦the¦ 𐋇¦ita li an¦ 𐋇¦ra d io log ical¦ 𐋇¦s oc ie ty¦ ¦is¦ ¦comp il ing¦ ¦an¦ ¦intern ational¦ ¦on line¦ ¦d at ab ase¦ ¦of¦ ¦i ma g ing¦ ¦fin di ngs¦ ¦for¦ ¦confirmed¦ ¦cases¦ .
𐋇¦on¦ ¦2 8¦ 𐋇¦february¦ ,▁ 𐋇 ¦sc op e¦ 𐋇¦r ati ngs¦ 𐋇¦g mb 𐋇 h¦ ¦a ff ir med¦ 𐋇¦china¦ ' ¦s¦ ¦so ve re i g n¦ ¦cr ed it¦ ¦ra ting¦ ,▁ ¦but¦ ¦ma in ta ined¦ ¦a¦ 𐋇¦ne ga tive¦ 𐋇 ¦out lo ok¦ .
𐋇¦the¦ ¦epi demic¦ ¦co i nc ided¦ ¦with¦ ¦the¦ 𐋇¦ch un y u n¦ ,▁ ¦a¦ ¦maj or¦ ¦travel¦ ¦se as on¦ ¦associ ated¦ ¦with¦ ¦the¦ 𐋇¦chinese¦ 𐋇 ¦new¦ 𐋇 ¦year¦ ¦ho li day¦ .
𐋇¦the¦ ¦m il est one¦ ¦ca me¦ ¦the¦ ¦same¦ ¦day¦ 𐋇¦ma la w i¦ ¦confirmed¦ ¦its¦ ¦first¦ ¦coronavirus¦ ¦infections¦ ¦and¦ 𐋇¦z am bi a¦ ¦had¦ ¦its¦ ¦first¦ ¦coronavirus¦ - ¦related¦ ¦death¦ .
𐋇¦the¦ ¦virus¦ ¦that¦ ¦caused¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦known¦ ¦as¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦a¦ ¦ne w ly¦ ¦dis c ov ered¦ ¦virus¦ ¦clos e ly¦ ¦related¦ ¦to¦ ¦b at¦ ¦coron a vi ruses¦ ,▁ ¦pa ng ol in¦ ¦coron a vi ruses¦ ,▁ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ . 𐋇¦the¦ ¦e ar li est¦ ¦known¦ ¦person¦ ¦with¦ ¦symptoms¦ ¦was¦ ¦la ter¦ ¦dis c ov ered¦ ¦to¦ ¦have¦ ¦fa ll en¦ ¦ ill¦ ¦on¦ ¦1¦ 𐋇¦de ce mber¦ ¦2019¦ ,▁ ¦and¦ ¦that¦ ¦person¦ ¦did¦ ¦not¦ ¦have¦ ¦vi sib le¦ ¦con n ections¦ ¦with¦ ¦the¦ ¦la ter¦ ¦w et¦ ¦marke t¦ ¦cl us ter¦ .
𐋇¦th us¦ ,▁ ¦they¦ ¦are¦ ¦tra di ti onal¦ ¦marke r s¦ ¦for¦ ¦heart¦ ¦or¦ ¦li ver¦ ¦d y s f u nc tions¦ .
𐋇¦in¦ 𐋇¦j ap an¦ ,▁ ¦the¦ ¦h as h ta g¦ ▁ # 𐋇¦c hi ne se 𐋇 d o nt 𐋇 co me 𐋇 t o 𐋇 j ap an¦ ¦tre nded¦ ¦on¦ 𐋇 ¦tw i tter¦ .
𐋇¦b es id es¦ ,▁ ¦there¦ ¦are¦ ¦more¦ ¦and¦ ¦more¦ ¦e vi dence¦ ¦that¦ ¦rem in d¦ ¦ us¦ ¦to¦ ¦cau tion¦ ¦with¦ ¦the¦ ¦ at y p ical¦ ¦sy m pt o ma tic¦ ¦and¦ ¦as y m pt o ma tic¦ ¦patients¦ .
𐋇 ¦sub se qu ent¦ ¦ser op re v a le nce¦ ¦inv es tig ations¦ ¦ind ic ated¦ ¦that¦ ¦ani mal¦ ¦tra ders¦ ¦had¦ ¦a¦ ¦higher¦ ¦prev a le nce¦ ¦of¦ ¦a nt i¦ - 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ 𐋇¦i g 𐋇 g¦ ¦comp ared¦ ¦with¦ ¦that¦ ¦of¦ ¦the¦ ¦general¦ ¦population¦ .
𐋇¦on¦ ¦3 1¦ 𐋇¦de ce mber¦ ¦2019¦ ,▁ ¦a¦ ¦cl us ter¦ ¦of¦ ¦p ne um o nia¦ ¦cases¦ ¦of¦ ¦un k n own¦ ¦a e t io logy¦ ¦was¦ ¦reported¦ ¦in¦ 𐋇¦w uhan¦ ,▁ 𐋇¦h ub e i¦ 𐋇 ¦pro vi nce¦ ,▁ 𐋇¦china¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦no ted¦ ¦the¦ ¦cont ra st¦ ¦between¦ ¦the¦ ¦20 0 2¦ – ¦20 0 4¦ 𐊣¦sars¦𐊼 ¦outbreak¦ ,▁ ¦where¦ 𐋇¦chinese¦ ¦a u th or ities¦ ¦were¦ ¦acc u sed¦ ¦of¦ ¦s ecre c y¦ ¦that¦ ¦imp e ded¦ ¦prev ention¦ ¦and¦ ¦conta in ment¦ ¦e f for ts¦ ,▁ ¦and¦ ¦the¦ ¦current¦ ¦crisis¦ ¦where¦ ¦the¦ ¦central¦ ¦government¦ ▁" ¦has¦ ¦prov ided¦ ¦regul ar¦ ¦up d a tes¦ ¦to¦ ¦avo id¦ ¦p an ic¦ ¦a he ad¦ ¦of¦ 𐋇¦l un ar¦ 𐋇 ¦new¦ 𐋇 ¦year¦ ¦h ol id a ys¦ " .
𐋇¦however¦ ,▁ ¦there¦ ¦are¦ ¦some¦ ¦rem ar k able¦ ¦di ff er en ces¦ ¦between¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦and¦ 𐊣¦sars¦𐊼 ,▁ ¦which¦ ¦are¦ ¦essential¦ ¦for¦ ¦cont aining¦ ¦the¦ ¦epi demic¦ ¦and¦ ¦t rea ting¦ ¦the¦ ¦patients¦ .
𐋇 ¦patients¦ ¦o f ten¦ ¦develop ¦ ¦an¦ ¦ at y p ical¦ ¦p ne um o nia¦ ,▁ ¦ac ute¦ ¦l un g¦ ¦inj ur y¦ ,▁ ¦and¦ ¦ac ute¦ ¦respiratory¦ ¦dis tr ess¦ ¦sy nd r ome¦ ▁( 𐊣 ¦ar ds¦ 𐊼 ).
𐋇 ¦ph y lo ge nt ically¦ ,▁ ¦mo use¦ ¦he p ati ti s¦ ¦virus¦ ▁( 𐋇¦m ur ine¦ ¦coronavirus¦ ),▁ ¦which¦ ¦inf ects¦ ¦the¦ ¦mo use¦ ' ¦s¦ ¦li ver¦ ¦and¦ ¦the¦ ¦central¦ ¦n erv o us¦ ¦system¦ ,▁ ¦is¦ ¦related¦ ¦to¦ ¦human¦ ¦coronavirus¦ 𐊣 ¦o c𐊼 4 3¦ ¦and¦ ¦b ov ine¦ ¦coronavirus¦ .
𐋇 ¦on line¦ ,▁ ¦n u me ro us¦ ¦coronavirus¦ - ¦the med¦ 𐋇 ¦intern et¦ ¦me m es¦ ¦have¦ ¦spread¦ ¦as¦ ¦many¦ ¦ tur n¦ ¦to¦ ¦hum o ur¦ ¦and¦ ¦di stra ction¦ ¦ am id¦ ¦u nc er ta in ty¦ .
𐋇¦some¦ ¦of¦ ¦those¦ ¦infected¦ ¦may¦ ¦be¦ ¦as y m pt o ma tic¦ ,▁ ¦with¦ ¦no¦ ¦clinical¦ ¦symptoms¦ ¦but¦ ¦with¦ ¦test¦ ¦resul ts¦ ¦that¦ ¦confir m¦ ¦infection¦ ,▁ ¦so¦ ¦re se ar ch ers¦ ¦have¦ ¦issued¦ ¦ad v ice¦ ¦that¦ ¦those¦ ¦with¦ ¦cl ose¦ ¦contact¦ ¦to¦ ¦confirmed¦ ¦infected¦ ¦people¦ ¦should¦ ¦be¦ ¦clos e ly¦ ¦monit or ed¦ ¦and¦ ¦exam ined¦ ¦to¦ ¦ ru le¦ ¦out¦ ¦infection¦ .
𐋇 ¦and¦ ¦al ong¦ ¦with¦ ¦a¦ ¦fever¦
𐋇¦l ed¦ ¦by¦ ¦the¦ 𐋇¦b ill¦ ¦and¦ 𐋇¦me li nd a¦ 𐋇 ¦ga tes¦ 𐋇¦f ou nd ation¦ ¦with¦ ¦part n ers¦ ¦inv es ting¦ 𐊣¦us ¦𐊼 $ ¦1 2 5¦ ¦million¦ ¦and¦ ¦co or di na ting¦ ¦with¦ ¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ,▁ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ 𐋇 ¦the rap e ut ics¦ 𐋇 ¦acc el er ator¦ ¦beg an¦ ¦in¦ 𐋇¦march¦ ,▁ ¦facil i ta ting¦ ¦drug¦ ¦development¦ ¦re se ar ch ers¦ ¦to¦ ¦rapidly¦ ¦ id enti f y¦ ,▁ ¦ass ess¦ ,▁ ¦develop ¦ ,▁ ¦and¦ ¦sc a le¦ ¦up¦ ¦po t enti al¦ ¦tre at ments¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦tr ue¦ ¦f at al ities¦ ¦from¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦may¦ ¦be¦ ¦much¦ ¦higher¦ ,▁ ¦as¦ ¦it¦ ¦may¦ ¦not¦ ¦include¦ ¦people¦ ¦who¦ ¦di e¦ ¦without¦ ¦testing¦ ▁-▁ ¦ e¦ . ¦ g¦ .▁ ¦at¦ ¦home¦ ,▁ ¦in¦ ¦n ur s ing¦ ¦h om es¦ ,▁ ¦e t c ¦ .
𐋇¦c er ta in ly¦ ,▁ ¦this¦ ¦is¦ ¦not¦ ¦a¦ ¦go od¦ ¦sig n¦ ¦of¦ 𐋇¦e ur op e an¦ ¦s ol id ar ity¦ ."
𐋇¦a¦ ¦ medi an¦ ¦c ost¦ ¦es tim ate¦ ¦of¦ ¦201 5¦ - ¦1 6¦ ¦trials¦ ¦for¦ ¦development¦ ¦of¦ ¦10¦ ¦a nt i¦ - ¦ca nc er¦ ¦d ru gs¦ ¦was¦ ▁ $ ¦6 4 8¦ ¦million¦ .
𐋇¦in¦ ¦addition¦ ,▁ ¦given¦ ¦the¦ ¦the rap e u tic¦ ¦effec ts¦ ,▁ ¦some¦ ¦dis a d v an ta ges¦ ¦associ ated¦ ¦with¦ ¦the¦ ¦pl as ma¦ ¦should¦ ¦be¦ ¦consid ered¦ ¦ca ref ul ly¦ .
𐋇¦the¦ 𐋇 ¦campaign¦ ¦for¦ 𐋇¦n uc le ar¦ 𐋇 ¦dis ar ma ment¦ ' ¦s¦ ¦general¦ ¦s ecre t ary¦ 𐋇¦k ate¦ 𐋇¦h u d s on¦ ¦c ri ti ci zed¦ ¦the¦ 𐋇¦de f en der¦ ¦2020¦ ¦ex er c ise¦ : ▁" 𐋇¦in¦ ¦the¦ ¦current¦ ¦public¦ - ¦health¦ ¦crisis¦ ,▁ ¦it¦ ¦j e o par di z es¦ ¦the¦ ¦li ves¦ ¦not¦ ¦only¦ ¦of¦ ¦the¦ ¦t ro o ps¦ ¦from¦ ¦the¦ 𐊣¦us ¦𐊼 ¦and¦ ¦the¦ ¦many¦ 𐋇¦e ur op e an¦ ¦countries¦ ¦par ti cip a ting¦ ¦but¦ ¦the¦ ¦in ha bi ta nts¦ ¦of¦ ¦the¦ ¦countries¦ ¦in¦ ¦which¦ ¦they¦ ¦are¦ ¦op e ra ting¦ ." 𐋇¦the¦ 𐋇¦i ra ni an¦ ¦government¦ ¦has¦ ¦been¦ ¦h ea vi ly¦ ¦affected¦ ¦by¦ ¦the¦ ¦virus¦ ,▁ ¦with¦ ¦around¦ ¦two¦ ¦do z en¦ ¦par li a ment¦ ¦me mb ers¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦fi f te en¦ ¦other¦ ¦current¦ ¦or¦ ¦for m er¦ ¦pol itical¦ ¦fi g ures¦ .
𐋇¦as¦ ¦a¦ ¦comm on¦ ¦p ra ct ice¦ ,▁ ¦in di v id u als¦ ¦exp osed¦ ¦to¦ ,▁ ¦or¦ ¦infected¦ ¦by¦ ,▁ ¦the¦ ¦virus¦ ¦are¦ ¦us u ally¦ ¦requir ed¦ ¦to¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦the¦ ¦vi ru le nce¦ ¦of¦ ¦the¦ ¦co me b ack¦ ¦would¦ ¦dep end¦ ¦on¦ ¦h er d¦ ¦imm unity¦ ¦and¦ ¦the¦ ¦ext ent¦ ¦of¦ ¦mut ation¦ .
𐋇¦however¦ ,▁ ¦they¦ ¦are¦ ¦e qu ally¦ ¦clos e ly¦ ¦related¦ ¦to¦ 𐋇¦ra 𐊣 t g 𐊼 1 3¦ ¦with¦ ¦about¦ ¦9 0¦ %▁ ¦i de nt ity¦ ¦at¦ ¦the¦ ¦level¦ ¦of¦ ¦n uc le o t ide¦ ¦se que nce¦ .
𐋇¦some¦ 𐋇¦chinese¦ ¦students¦ ¦at¦ 𐋇¦a mer ic an¦ ¦u ni vers ities¦ ¦jo ined¦ ¦to ge ther¦ ¦to¦ ¦help¦ ¦s end¦ ¦a id¦ ¦to¦ ¦virus¦ - ¦s tric k en¦ ¦par ts¦ ¦of¦ 𐋇¦china¦ ,▁ ¦with¦ ¦a¦ ¦jo in t¦ ¦group¦ ¦in¦ ¦the¦ ¦g rea ter¦ 𐋇¦ch ic a g o¦ ¦area¦ ¦re por t ed ly¦ ¦ma na g ing¦ ¦to¦ ¦s end¦ ¦50¦ , ¦000¦ 𐋇¦n 9 5¦ ¦masks¦ ¦to¦ ¦hospitals¦ ¦in¦ ¦the¦ 𐋇¦h ub e i¦ ¦pro vi nce¦ ¦on¦ ¦30¦ 𐋇¦january¦ . 𐋇¦the¦ ¦hum an it ari an¦ ¦a id¦ ¦or ga ni z ation¦ 𐋇¦d ir ect¦ 𐋇 ¦rel ie f¦ ,▁ ¦in¦ ¦co or d ination¦ ¦with¦ 𐋇¦f ed 𐋇 e x¦ ,▁ ¦sent¦ ¦2 00¦ , ¦000¦ ¦face¦ ¦masks¦ ¦al ong¦ ¦with¦ ¦other¦ ¦pers onal¦ ¦prot ec tive¦ ¦e qu i p ment¦ ,▁ ¦including¦ ¦g lo ves¦ ¦and¦ ¦g ow ns¦ ,▁ ¦by¦ ¦emergency¦ ¦a ir li f t¦ ¦to¦ ¦the¦ 𐋇¦w uhan¦ 𐋇¦union¦ 𐋇¦hospital¦ ¦by¦ ¦30¦ 𐋇¦january¦ .
𐋇¦in¦ ¦hum ans¦ ,▁ ¦coron a vi ruses¦ ¦cause¦ ¦respiratory¦ ¦tr act¦ ¦infections¦ ¦that¦ ¦can¦ ¦r an ge¦ ¦from¦ ¦mi ld¦ ¦to¦ ¦le th al¦ .
𐋇¦the¦ ¦e mer ge nce¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦in¦ ¦central¦ 𐋇¦china¦ ¦at¦ ¦the¦ ¦ end¦ ¦of¦ ¦2019¦ ¦has¦ ¦th r us ted¦ 𐋇¦c o𐋇vs¦ ¦into¦ ¦the¦ ¦s po t li ght¦ ¦again¦ ¦and¦ ¦sur p ri sed¦ ¦ us¦ ¦with¦ ¦its¦ ¦high¦ ¦trans m is sib ility¦ ¦but¦ ¦reduc ed¦ ¦p at ho g en ic ity¦ ¦comp ared¦ ¦to¦ ¦its¦ ¦s is ter¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦for¦ 𐊣¦m ers¦ 𐊼 ,▁ ¦based¦ ¦on¦ ¦a¦ ¦ dem o g rap h ic¦ ¦study¦ ¦in¦ 𐋇¦j une¦ ¦201 2¦ ,▁ ¦the¦ ¦mor t ality¦ ¦was¦ ¦3 7¦ %▁ ¦of¦ ¦2¦ , ¦4 9 4¦ ¦confirmed¦ ¦cases¦ .
𐋇¦some¦ ¦re se ar ch ers¦ ¦have¦ ¦su gg es ted¦ ¦the¦ 𐋇¦h u an an¦ 𐋇¦s ea f o od¦ 𐋇¦w h ol es a le¦ 𐋇 ¦marke t¦ ¦may¦ ¦not¦ ¦be¦ ¦the¦ ¦o ri g in al¦ ¦so ur ce¦ ¦of¦ ¦v iral¦ ¦transmission¦ ¦to¦ ¦hum ans¦ . 𐋇¦as¦ ¦of¦ ¦1 7¦ 𐋇¦april¦ ¦2020¦ ,▁ ¦there¦ ¦have¦ ¦been¦ ¦at¦ ¦least¦ ¦1 5 3¦ , ¦8 2 2¦ ¦confirmed¦ ¦deaths¦ ¦and¦ ¦more¦ ¦than¦ ¦2¦ , ¦2 4 0¦ , ¦1 9 1¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦the¦ ¦coronavirus¦ ¦p ne um o nia¦ ¦pandemic¦ .
𐋇¦i m por ta ntly¦ ,▁ ¦we¦ ¦comp are¦ ¦and¦ ¦cont ra st¦ ¦the¦ ¦different¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦from¦ ¦a¦ ¦pers p ec tive¦ ¦of¦ ¦virus¦ ¦e v o lu tion¦ ¦and¦ ¦gen ome¦ ¦reco mb ination¦ .
𐋇¦the¦ ¦di vers ity¦ ¦of¦ ¦b at¦ 𐋇¦c o𐋇vs¦ ¦prov id es¦ ¦a mple¦ ¦op por t un ities¦ ¦for¦ ¦the¦ ¦e mer ge nce¦ ¦of¦ ¦no ve l¦ 𐊣¦h c𐊼 o𐋇vs¦ .
𐋇 ¦second¦ ,▁ ¦pa ng ol ins¦ ¦could¦ ¦be¦ ¦one¦ ¦of¦ ¦inter medi ate¦ ¦a mp li f ying¦ ¦h ost¦ ¦to¦ ¦which¦ ¦a¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦related¦ ¦virus¦ ¦had¦ ¦been¦ ¦ne w ly¦ ¦in tr od uc ed¦ .
𐋇¦for¦ ¦many¦ ¦years¦ ,▁ ¦the¦ ¦four¦ ¦comm unity¦ - ¦ac qu ir ed¦ 𐋇¦c o𐋇vs¦ ¦c ir c ul ate¦ ¦in¦ ¦human¦ ¦p op ul ations¦ ,▁ ¦tri gg ering¦ ¦comm on¦ ¦co ld¦ ¦in¦ ¦imm u no co mp e t ent¦ ¦sub j ects¦ .
𐋇¦the¦ ¦clinical¦ ¦fe at ures¦ ¦of¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦o c𐊼 4 3¦ ¦infection¦ ¦appe ar¦ ¦to¦ ¦be¦ ¦simil ar¦ ¦to¦ ¦those¦ ¦caused¦ ¦by¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ,▁ ¦which¦ ¦are¦ ¦sy m pt om at ically¦ ¦ind is ti ng u ish able¦ ¦from¦ ¦infection¦ ¦with¦ ¦other¦ ¦respiratory¦ ¦tr act¦ ¦p at ho ge ns¦ ¦such¦ ¦as¦ ¦inf lu en z a¦ 𐋇¦a¦ ¦vi ruses¦ ¦and¦ ¦r hi no vi ruses¦ .
𐋇¦in¦ 𐊣¦sars¦𐊼 ¦patients¦ ,▁ ¦it¦ ¦has¦ ¦been¦ ¦ dem on stra ted¦ ¦that¦ ¦fever¦ ▁( ¦9 9¦ % - ¦100¦ % ),▁ ¦dr y¦ ¦c ough¦ ▁( ¦2 9¦ % - ¦7 5¦ % ),▁ ¦d y s p ne a¦ ▁( ¦4 0¦ % - ¦4 2¦ % ),▁ ¦di ar r he a¦ ▁( ¦20¦ - ¦2 5¦ % ),▁ ¦and¦ ¦s ore¦ ¦th ro at¦ ▁( ¦1 3¦ - ¦2 5¦ % )▁ ¦were¦ ¦the¦ ¦maj or¦ ¦symptoms¦ ¦and¦ ¦ventil ation¦ ¦supp ort¦ ¦was¦ ¦requir ed¦ ¦for¦ ¦appro xi ma tely¦ ¦14¦ % - ¦20¦ %▁ ¦of¦ ¦the¦ ¦patients¦ .
𐋇¦the¦ ¦v iral¦ 𐊣¦r na ¦𐊼 ¦gen ome¦ ¦is¦ ¦rel ea sed¦ ¦into¦ ¦the¦ ¦cy t op l as m¦ ;▁ ¦after¦ ¦rep lic ation¦ ¦of¦ ¦the¦ ¦v iral¦ ¦gen ome¦ ,▁ ¦ge no mic¦ 𐊣¦r na ¦𐊼 ¦ac co mp a ni ed¦ ¦by¦ ¦en v el op e¦ ¦g l yc op ro te ins¦ ¦and¦ ¦n uc le oc ap s id¦ ¦prote ins¦ ¦for ms¦ ¦v ir ion¦ - ¦cont aining¦ ¦v es ic les¦ ,▁ ¦which¦ ¦then¦ ¦f use¦ ¦with¦ ¦the¦ ¦pl as ma¦ ¦me mb r ane¦ ¦to¦ ¦re le ase¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ 𐋇¦united¦ 𐋇¦states¦ '▁ 𐋇¦n ational¦ 𐋇¦institute¦ ¦of¦ 𐋇¦a ll er g y¦ ¦and¦ 𐋇 ¦in fe ct ious¦ 𐋇 ¦disease¦ ' ¦s¦ ¦dire ctor¦ ,▁ 𐋇¦dr¦ .▁ 𐋇 ¦an th on y¦ 𐋇¦fa uc i¦ ,▁ ¦said¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁" ¦bo t t om¦ ¦ line¦ ,▁ ¦it¦ ' ¦s¦ ¦going¦ ¦to¦ ¦get¦ ¦wor se¦ ."
𐋇 ¦an¦ ¦ani mal¦ ¦ser ves¦ ¦as¦ ¦the¦ ¦e v o lu ti on ary¦ ¦h ost¦ ¦of¦ ¦an¦ 𐊣¦h c𐊼 o 𐋇 v¦ ¦if¦ ¦it¦ ¦ har b o ur s¦ ¦a¦ ¦clos e ly¦ ¦related¦ ¦a nc est or¦ ¦s har ing¦ ¦high¦ ¦h om o logy¦ ¦at¦ ¦the¦ ¦level¦ ¦of¦ ¦n uc le o t ide¦ ¦se que nce¦ .
𐋇¦the¦ ¦n ation¦ ' ¦s¦ ¦health¦ ¦a ge nc y¦ ¦reported¦ ¦a¦ ¦si gni fic ant¦ ¦increase¦ ¦in¦ ¦confirmed¦ ¦cases¦ ¦on¦ ¦20¦ 𐋇¦february¦ ,▁ ¦l ar ge ly¦ ¦att rib u ted¦ ¦to¦ ¦a¦ ¦ga th ering¦ ¦in¦ 𐋇¦d a e g u¦ ¦of¦ ¦a¦ ¦new¦ ¦re li g ious¦ ¦mo ve ment¦ ¦known¦ ¦as¦ ¦the¦ 𐋇¦s hi nc he on j i¦ 𐋇¦ch ur ch¦ ¦of¦ 𐋇¦j es us¦ .
𐋇¦e mer ge nce¦ ¦of¦ ¦no ve l¦ 𐊣¦h c𐊼 o𐋇vs¦ :▁ ¦b ack¦ ¦to¦ ¦gr oun d¦ ¦ z er o¦
𐋇 ¦tr ac ing¦ ¦the¦ ¦ z o o no tic¦ ¦o ri g ins¦ ¦of¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦prov id es¦ ¦a¦ ¦f ra me w or k¦ ¦to¦ ¦under st and¦ ¦the¦ ¦n atur al¦ ¦hi st ory¦ ,▁ ¦d ri ving¦ ¦force¦ ¦and¦ ¦res tric tion¦ ¦fa ct ors¦ ¦of¦ ¦speci es¦ ¦j u mp ing¦ .
𐋇¦there¦ ,▁ ¦the¦ 𐋇¦ m¦ ¦prote ins¦ ¦d ir ect¦ ¦most¦ ¦prote in¦ - ¦prote in¦ ¦inter ac tions¦ ¦requir ed¦ ¦for¦ ¦as se mb ly¦ ¦of¦ ¦vi ruses¦ ¦follow ing¦ ¦its¦ ¦b in ding¦ ¦to¦ ¦the¦ ¦n uc le oc ap s id¦ .
𐋇 ¦since¦ ¦then¦ ,▁ ¦more¦ ¦kno w l ed ge¦ ¦was¦ ¦acc um ul ated¦ ¦through¦ ¦ext en sive¦ ¦stud ies¦ ¦on¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦and¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦o c𐊼 4 3¦ ,▁ ¦both¦ ¦of¦ ¦which¦ ¦cause¦ ¦s elf¦ - ¦li mi ting¦ ¦symptoms¦ .
𐋇¦d esp ite¦ ¦this¦ ,▁ ¦it¦ ¦appe ar s¦ ¦the¦ ¦virus¦ ¦had¦ ¦t ro ub le¦ ¦sprea ding¦ ¦from¦ ¦human¦ ¦to¦ ¦human¦ ,▁ ¦as¦ ¦most¦ ¦in di v id u als¦ ¦who¦ ¦are¦ ¦infected¦ ¦do¦ ¦not¦ ¦trans m it¦ ¦the¦ ¦virus¦ .
𐋇¦it¦ ¦is¦ ¦a¦ ¦pr ess ure¦ ¦like¦ ¦ch est¦ ¦p ain¦
𐋇 ¦hum ans¦ ¦contr act¦ ¦the¦ ¦virus¦ ¦through¦ ¦b ut ch ering¦ ¦and¦ ¦cons u mp tion¦ ¦of¦ ¦ga me¦ ¦me at¦ .
𐋇 ¦while¦ ¦there¦ ¦are¦ ¦conc er ns¦ ¦it¦ ¦may¦ ¦spread¦ ¦by¦ ¦fa e ces¦ ,▁ ¦this¦ ¦risk¦ ¦is¦ ¦b el ie ved¦ ¦to¦ ¦be¦ ¦low¦ .
𐋇¦therefore¦ ,▁ ¦bu il ding¦ ¦a¦ ¦pro g no sis¦ ¦mo de l¦ ¦for¦ ¦the¦ ¦disease¦ ¦is¦ ¦essential¦ ¦for¦ ¦health¦ - ¦care¦ ¦a ge nc ies¦ ¦to¦ ¦pr io ri ti z e¦ ¦their¦ ¦services¦ ,▁ ¦ esp eci ally¦ ¦in¦ ¦res o ur ce¦ - ¦con stra ined¦ ¦areas¦ .
𐋇 ¦does¦ ¦the¦ ¦virus¦ ¦also¦ ¦b in d¦ 𐊣 ¦a ce 𐊼 2¦ - ¦exp r ess ing¦ ¦ce lls¦ ¦in¦ ¦other¦ ¦or g ans¦ ?
𐋇¦this¦ ¦is¦ ¦doctor¦ ¦ por ter¦ ¦in¦ ¦the¦ ¦emergency¦ ¦ro om¦ ¦tri a ge¦ ¦center¦
𐋇¦in¦ ¦the¦ 𐋇¦ u¦ . 𐋇¦s¦ . ,▁ ¦the¦ 𐊣¦c d c¦𐊼 ¦recomme nds¦ ¦we ar ing¦ ¦n on¦ - ¦medical¦ ¦face¦ ¦mask¦ ¦made¦ ¦out¦ ¦of¦ ¦c lo th¦ . 𐋇¦china¦ ¦has¦ ¦speci f ically¦ ¦recomme nded¦ ¦the¦ ¦use¦ ¦of¦ ¦dis p os able¦ ¦medical¦ ¦masks¦ ¦by¦ ¦heal t hy¦ ¦me mb ers¦ ¦of¦ ¦the¦ ¦public¦ ,▁ ¦part icul ar ly¦ ¦when¦ ¦com ing¦ ¦into¦ ¦cl ose¦ ¦contact¦ ▁( ¦1¦ ¦me tr e¦ ▁( ¦3¦ ¦f t¦ )▁ ¦or¦ ¦less¦ )▁ ¦with¦ ¦other¦ ¦people¦ .
𐋇¦l on ge v ity¦ ,▁ ¦d en se ly¦ ¦p ac ked¦ ¦c ol on ies¦ ,▁ ¦cl ose¦ ¦social¦ ¦inter a ction¦ ¦and¦ ¦str ong¦ ¦ab ility¦ ¦to¦ ¦f ly¦ ¦are¦ ¦all¦ ¦f av o ur able¦ ¦conditions¦ ¦for¦ ¦ba ts¦ ¦to¦ ¦be¦ ¦an¦ ¦i de al¦ ▁' ¦virus¦ ¦sprea der¦ ' .
𐋇¦p ne um o nia¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦severe¦ ¦symptoms¦ ¦and¦ ¦can¦ ¦pro gr ess¦ ¦rapidly¦ ¦to¦ ¦ac ute¦ ¦respiratory¦ ¦dis tr ess¦ ¦sy nd r ome¦ .
𐋇¦in¦ ¦l ate¦ 𐋇¦january¦ ,▁ ¦the¦ 𐋇¦chinese¦ ¦government¦ ¦la un ch ed¦ ¦a¦ ¦ra d ical¦ ¦campaign¦ ¦la ter¦ ¦d es c rib ed¦ ¦by¦ ¦the¦ 𐋇¦chinese¦ 𐋇¦comm u ni st¦ 𐋇 ¦par ty¦ ¦general¦ ¦s ecre t ary¦ 𐋇¦ x i¦ 𐋇¦j in p ing¦ ¦as¦ ¦a¦ ▁" ¦people¦ ' ¦s¦ ¦ war¦ "▁ ¦to¦ ¦cont ain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦prot est ers¦ ¦in¦ 𐋇 ¦u k ra ine¦ ¦att ac ked¦ ¦bu ses¦ ¦car r ying¦ 𐋇 ¦u k r ai ni an¦ ¦and¦ ¦fo re i g n¦ ¦e v ac u e es¦ ¦from¦ 𐋇¦w uhan¦ ¦to¦ 𐋇¦n ov i¦ 𐋇¦s an z h ary¦ .
𐋇¦y est er day¦ ,▁ 𐋇 ¦ba ng la d esh¦ ¦has¦ ¦confirmed¦ ¦five¦ ¦new¦ ¦deaths¦ ¦due¦ ¦to¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦on¦ ¦the¦ ¦day¦ .
𐋇¦this¦ ¦demand¦ ¦has¦ ¦l ed¦ ¦to¦ ¦the¦ ¦increase¦ ¦in¦ ¦pri ces¦ ¦of¦ ¦up¦ ¦to¦ ¦tw en ty¦ ¦ times¦ ¦the¦ ¦n or mal¦ ¦pr ice¦ ¦and¦ ¦also¦ ¦ind uc ed¦ ¦de la ys¦ ¦on¦ ¦the¦ ¦supply¦ ¦of¦ ¦medical¦ ¦i te ms¦ ¦for¦ ¦four¦ ¦to¦ ¦six¦ ¦months¦ .
𐋇¦when¦ ¦it¦ ¦is¦ ¦no¦ ¦lo nger¦ ¦possible¦ ¦to¦ ¦cont ain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦e f for ts¦ ¦then¦ ¦mo ve¦ ¦to¦ ¦the¦ ¦mi tig ation¦ ¦sta ge¦ :▁ ¦measures¦ ¦are¦ ¦taken¦ ¦to¦ ¦s low¦ ¦the¦ ¦spread¦ ¦and¦ ¦mi tig ate¦ ¦its¦ ¦effec ts¦ ¦on¦ ¦the¦ ¦heal th c are¦ ¦system¦ ¦and¦ ¦s oc ie ty¦ .
𐋇 ¦beg in ning¦ ¦on¦ ¦15¦ 𐋇¦march¦ ,▁ ¦many¦ ¦b us in es ses¦ ¦closed¦ ¦or¦ ¦reduc ed¦ ¦hours¦ ¦th r ou g ho ut¦ ¦the¦ 𐋇¦ u¦ . 𐋇¦s¦ .▁ ¦to¦ ¦ try¦ ¦to¦ ¦reduce¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦number¦ ¦v ar ies¦ ¦by¦ ¦reg ion¦ .
𐋇 ¦pro g en y¦ ¦vi ruses¦ ¦are¦ ¦then¦ ¦rel ea sed¦ ¦from¦ ¦the¦ ¦h ost¦ ¦c ell¦ ¦by¦ ¦ex oc y t o sis¦ ¦through¦ ¦s ecre t ory¦ ¦v es ic les¦ .
𐋇 ¦president¦ 𐋇¦h as s an¦ 𐋇¦r ou h an i¦ ¦said¦ ¦on¦ ¦2 6¦ 𐋇¦february¦ ¦2020¦ ¦that¦ ¦there¦ ¦were¦ ¦no¦ ¦pl ans¦ ¦to¦ ¦quarantine¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ ,▁ ¦and¦ ¦only¦ ¦in di v id u als¦ ¦would¦ ¦be¦ ¦qu ara nt ined¦ .
𐋇¦therefore¦ ,▁ ¦infected¦ ¦patients¦ ¦at¦ ¦the¦ ¦early¦ ¦phase¦ ¦or¦ ¦inc ub ation¦ ¦period¦ ¦can¦ ¦produc e¦ ¦a¦ ¦large¦ ¦ am oun t¦ ¦of¦ ¦virus¦ ¦during¦ ¦d ai ly¦ ¦ac tiv ities¦ ,▁ ¦ca us ing¦ ¦g reat¦ ¦difficul ty¦ ¦for¦ ¦the¦ ¦control¦ ¦of¦ ¦the¦ ¦epi demic¦ .
𐋇 ¦ph y lo ge ne tic¦ ¦e vi dence¦ ¦of¦ ¦n atur al¦ ¦reco mb ination¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦both¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣¦h k u 𐊼 1¦ ¦and¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦o c𐊼 4 3¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦ani mal¦ 𐋇¦c o𐋇vs¦ ¦such¦ ¦as¦ ¦b at¦ 𐊣 ¦s l ¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦b at 𐋇 co 𐋇 v¦ - 𐊣¦h k u 𐊼 9¦ .
𐋇¦the¦ ¦high¦ ¦fa il ure¦ ¦ra tes¦ ¦associ ated¦ ¦with¦ ¦p har ma ce ut ical¦ ¦development¦ ¦are¦ ¦ ref er r ed¦ ¦to¦ ¦as¦ ¦an¦ ▁" ¦att r ition¦ ¦rate¦ " ,▁ ¦requir ing¦ ¦d eci sions¦ ¦during¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦drug¦ ¦development¦ ¦to¦ ▁" ¦k ill¦ "▁ ¦pro j ects¦ ¦early¦ ¦to¦ ¦avo id¦ ¦co st ly¦ ¦fa il ures¦ .
𐋇¦the¦ ¦es tim ated¦ ¦me an¦ ¦inc ub ation¦ ¦period¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦1¦ - ¦14¦ ¦days¦ ,▁ ¦mo st ly¦ ¦3¦ - ¦7¦ ¦days¦ ¦based¦ ¦on¦ ¦a¦ ¦study¦ ¦of¦ ¦the¦ ¦first¦ ¦4 2 5¦ ¦cases¦ ¦in¦ 𐋇¦w uhan¦ .
𐋇¦d ub a i¦ ,▁ 𐋇 ¦sy d ne y¦ ,▁ ¦and¦ 𐋇¦m el b o ur n e¦ ¦were¦ ¦also¦ ¦reported¦ ¦as¦ ¦p op ul ar¦ ¦d est in ations¦ ¦for¦ ¦people¦ ¦tra ve lling¦ ¦from¦ 𐋇¦w uhan¦ .
𐋇 ¦and¦ ¦is¦ ¦this¦ ¦the¦ ¦ri ght¦ ¦time¦ ¦for¦ ¦your¦ ¦h ay¦ ¦fever¦
𐋇 ¦by¦ ¦1 3¦ 𐋇¦march¦ ,▁ 𐋇¦the¦ 𐋇¦ at l an tic¦ ¦reported¦ ¦that¦ ¦less¦ ¦than¦ ¦14¦ , ¦000¦ ¦tests¦ ¦had¦ ¦been¦ ¦conduc ted¦ .
𐋇¦the¦ ¦j ur y¦ ¦is¦ ¦still¦ ¦out¦ ¦on¦ ¦the¦ ¦immedi ate¦ ¦ z o o no tic¦ ¦o ri g in¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦e b ol a¦ ¦was¦ ¦o ri g in ally¦ ¦pr ed ic ted¦ ¦to¦ ¦cause¦ ¦up¦ ¦to¦ ¦a¦ ¦million¦ ¦cases¦ ¦with¦ ¦h alf¦ ¦a¦ ¦million¦ ¦deaths¦ .
𐋇¦c or por ations¦ ¦imposed¦ ¦emp loy e e¦ ¦travel¦ ¦restrictions¦ ,▁ ¦can ce lled¦ ¦con fere n ces¦ ,▁ ¦and¦ ¦e nc ou ra ged¦ ¦emp loy e es¦ ¦to¦ ¦work¦ ¦from¦ ¦home¦ .
𐊣¦c b s ¦𐊼 𐋇¦ne ws¦ ¦reported¦ ,▁ ¦ ci ting¦ 𐋇 ¦jo h ns¦ 𐋇¦h op k ins¦ 𐋇¦university¦ ¦data¦ ,▁ ¦there¦ ¦were¦ ¦over¦ ¦1¦ , ¦000¦ 𐊣¦us ¦𐊼 ¦deaths¦ ¦on¦ 𐋇¦w ed n es day¦ ¦caused¦ ¦by¦ ¦coronavirus¦ ¦infections¦ .
𐋇¦the¦ ¦rem ar ks¦ ¦were¦ ¦la ter¦ ¦con dem ned¦ ¦by¦ ¦the¦ 𐋇¦chinese¦ ¦cons ul ate¦ ¦in¦ 𐋇¦k ol k at a¦ ,▁ ¦ca lling¦ ¦it¦ ▁" ¦ er ro ne o us¦ " . 𐋇¦in¦ 𐋇¦china¦ ,▁ ¦ x en op ho bi a¦ ¦and¦ ¦r ac is m¦ ¦a ga ins¦ ¦n on¦ - 𐋇¦chinese¦ ¦re si de nts¦ ¦has¦ ¦been¦ ¦inf la med¦ ¦by¦ ¦the¦ ¦pandemic¦ ,▁ ¦with¦ ¦fo re i gn ers¦ ¦d es c rib ed¦ ¦as¦ ▁" ¦fo re i g n¦ ¦g ar b a ge¦ "▁ ¦and¦ ¦t ar ge ted¦ ¦for¦ ▁" ¦dis p os al¦ " .
𐋇¦the¦ ¦pol y p ro te ins¦ ¦are¦ ¦further¦ ¦pr oc es sed¦ ¦to¦ ¦gen er ate¦ ¦1 6¦ ¦n on¦ - ¦str uc tur al¦ ¦prote ins¦ ,▁ ¦de si gn ated¦ ¦ ns p 1¦ ~ ¦1 6¦ .
𐋇 ¦several¦ ¦comp ou nds¦ ¦that¦ ¦were¦ ¦prev io us ly¦ ¦approved¦ ¦for¦ ¦treatment¦ ¦of¦ ¦other¦ ¦v iral¦ ¦dis eases¦ ¦are¦ ¦being¦ ¦inv es tig ated¦ ¦for¦ ¦use¦ ¦in¦ ¦t rea ting¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦exp a nded¦ ¦in¦ ¦c lu st ers¦ ¦ma in ly¦ ¦in¦ ¦and¦ ¦around¦ 𐋇¦h ub e i¦ .
𐋇 ¦as y m pt o ma tic¦ ¦or¦ ¦only¦ ¦mi ld¦ ¦symptoms¦ ¦were¦ ¦det ected¦ ¦when¦ ¦ba ts¦ ¦were¦ ¦infected¦ ¦with¦ 𐋇¦c o𐋇vs¦ ,▁ ¦ind ic a ting¦ ¦the¦ ¦mut u al¦ ¦ad a pt ation¦ ¦between¦ 𐋇¦c o𐋇vs¦ ¦and¦ ¦ba ts¦ .
𐋇 ¦human¦ ¦ri gh ts¦ ¦or ga ni z ations¦ ¦have¦ ¦c ri ti ci zed¦ ¦some¦ ¦of¦ ¦these¦ ¦measures¦ ,▁ ¦as king¦ ¦the¦ ¦go ver n ments¦ ¦not¦ ¦to¦ ¦use¦ ¦the¦ ¦pandemic¦ ¦as¦ ¦a¦ ¦co ver¦ ¦to¦ ¦in tr od u ce¦ ¦inv a sive¦ ¦di gi tal¦ ¦surveillance¦ .
𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ,▁ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣¦ oc 4 3¦ ,▁ ¦h c𐊼 o 𐋇 v¦ - 𐊣¦h k u 𐊼 1¦ ¦and¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦n l 𐊼 6 3¦ ¦us u ally¦ ¦cause¦ ¦mi ld¦ ¦symptoms¦ ,▁ ¦like¦ ¦comm on¦ ¦co ld¦ ¦and¦ / ¦or¦ ¦di ar r he a¦ .
𐋇 ¦epi dem io log ical¦ ¦hi st ory¦ : ▁( ¦1¦ )▁ ¦a¦ ¦hi st ory¦ ¦of¦ ¦travel¦ ¦or¦ ¦re si dence¦ ¦in¦ 𐋇¦w uhan¦ ¦city¦ ¦and¦ ¦sur r oun ding¦ ¦areas¦ ,▁ ¦or¦ ¦other¦ ¦comm un ities¦ ¦where¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦had¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦before¦ ¦sy m pt om¦ ¦o ns et¦ ; ▁( ¦2¦ )▁ ¦a¦ ¦hi st ory¦ ¦of¦ ¦contact¦ ¦with¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦in fe ct ious¦ ¦cases¦ ▁( ¦with¦ ¦positive¦ ¦n uc le ic¦ ¦ac id¦ ¦test¦ ) ; ▁( ¦3¦ )▁ ¦a¦ ¦hi st ory¦ ¦of¦ ¦cont ac ting¦ ¦with¦ ¦patients¦ ¦with¦ ¦fever¦ ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦from¦ 𐋇¦w uhan¦ ¦city¦ ¦and¦ ¦sur r oun ding¦ ¦areas¦ ,▁ ¦or¦ ¦other¦ ¦comm un ities¦ ¦where¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦had¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦before¦ ¦sy m pt om¦ ¦o ns et¦ ; ▁( ¦4¦ )▁ ¦a¦ ¦hi st ory¦ ¦of¦ ¦cont ac ting¦ ¦with¦ ¦cl us ter¦ ¦of¦ ¦confirmed¦ ¦cases¦ ▁( ≥ ▁ ¦2¦ ¦cases¦ ¦with¦ ¦fever¦ ¦and¦ / ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦occ ur r ed¦ ¦within¦ ¦2¦ ¦weeks¦ ¦in¦ ¦small¦ ¦areas¦ ,▁ ¦such¦ ¦as¦ ¦home¦ ,▁ ¦office¦ ,▁ ¦clas s¦ ¦of¦ ¦school¦ ,▁ ¦e t c ¦ ).
𐋇 ¦do¦ ¦you¦ ¦have¦ ¦any¦ ¦other¦ ¦ch r on ic¦ ¦like¦ ¦high¦ ¦blood¦ ¦pr ess ure¦ ¦or¦ ¦an y t hing¦ ¦like¦ ¦that¦ ?
𐋇¦b es id es¦ ,▁ ¦the¦ ¦n atur al¦ ¦k ill er¦ ¦c ell¦ ¦ac tiv ity¦ ¦in¦ ¦ba ts¦ ¦is¦ ¦supp res sed¦ ¦due¦ ¦to¦ ¦up re g ul ation¦ ¦of¦ ¦in hi b it ory¦ ¦n atur al¦ ¦k ill er¦ ¦c ell¦ ¦re ce pt or¦ 𐊣 ¦n k g 2¦ / ¦c d 𐊼 9 4¦ ¦and¦ ¦low¦ ¦exp r ess ion¦ ¦level¦ ¦of¦ ¦maj or¦ ¦hi st o co mp ati b ility¦ ¦comple x¦ ¦clas s¦ 𐋇¦i¦ ¦m ol ec u les¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦was¦ ¦ge ne t ically¦ ¦related¦ ¦to¦ ¦another¦ ¦b at¦ 𐋇¦co𐋇v¦ ,▁ ¦ter med¦ 𐋇 ¦hi p po si de ro s¦ / 𐋇¦g ha na 𐋇 k wa m¦ / ¦19¦ / ¦20 0 8¦ ,▁ ¦which¦ ¦was¦ ¦det ected¦ ¦in¦ 𐋇¦ gh an a¦ ,▁ ¦while¦ ¦ca me li ds¦ ¦have¦ ¦also¦ ¦been¦ ¦susp ected¦ ¦as¦ ¦its¦ ¦inter medi ate¦ ¦h ost¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦e vi dence¦ ¦ani m als¦ ¦can¦ ¦pas s¦ ¦the¦ ¦virus¦ ¦on¦ ¦to¦ ¦hum ans¦ ,▁ ¦ though¦ 𐋇¦b rit is h¦ ¦a u th or ities¦ ¦ad v ise¦ ¦washing¦ ¦one¦ ' ¦s¦ ¦hands¦ ¦after¦ ¦contact¦ ¦with¦ ¦ani m als¦ ,▁ ¦like¦ ¦after¦ ¦contact¦ ¦with¦ ¦other¦ ¦sur f a ces¦ ¦infected¦ ¦people¦ ¦could¦ ¦have¦ ¦t ou ch ed¦ .
𐋇¦h ong¦ 𐋇¦k ong¦ ¦recomme nds¦ ¦we ar ing¦ ¦a¦ ¦sur g ical¦ ¦mask¦ ¦when¦ ¦taking¦ ¦public¦ ¦trans port¦ ¦or¦ ¦sta ying¦ ¦in¦ ¦crow ded¦ ¦places¦ .
𐋇¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ▁( 𐊣¦who¦𐊼 )▁ ¦dec l ared¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦a¦ ¦pandemic¦ ¦on¦ 𐋇¦march¦ ¦11¦ .
𐋇¦sh e¦ ¦also¦ ¦said¦ ¦two¦ ¦of¦ ¦the¦ ¦v ic ti ms¦ ¦were¦ ¦from¦ 𐋇¦d ha ka¦ .
𐋇 ¦and¦ ¦they¦ ' ¦r e¦ ¦ha ving¦ ¦some¦ ¦fe v ers¦ ¦as¦ ¦well¦
𐋇¦even¦ ¦pl as ma¦ ¦from¦ ¦rec ov ered¦ ¦patients¦ ¦was¦ ¦prop osed¦ ¦to¦ ¦be¦ ¦used¦ ¦for¦ ¦treatment¦ .
𐋇 ¦in de ed¦ ,▁ ¦a¦ ¦cr y o¦ - 𐊣 ¦e m ¦𐊼 ¦study¦ ¦ind ic a tes¦ ¦a¦ ¦10¦ - ▁ ¦to¦ ¦20¦ - ¦fo ld¦ ¦higher¦ ¦a ff in ity¦ ¦of¦ ¦this¦ ¦b in ding¦ ¦than¦ ¦that¦ ¦between¦ ¦human¦ 𐊣 ¦a ce 𐊼 2¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ 𐋇¦s¦ ¦prote in¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦s te ro i ds¦ ¦may¦ ¦wor s en¦ ¦out c om es¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦pre fere nce¦ ¦t ow ar ds¦ ¦a¦ ¦part icul ar¦ ¦se as on¦ ¦in¦ ¦tr op ical¦ ¦c li ma tes¦ .
𐋇 ¦inv es ti ga ting¦ 𐋇¦co𐋇v¦ - ¦h ost¦ ¦inter ac tions¦ ¦in¦ ¦ani m als¦ ¦mi ght¦ ¦also¦ ¦de ri ve¦ ¦important¦ ¦in si ght¦ ¦on¦ 𐋇¦co𐋇v¦ ¦p at ho ge ne sis¦ ¦in¦ ¦hum ans¦ .
𐋇 ¦li ve¦ - ¦att en u ated¦ ¦vaccines¦ ¦have¦ ¦been¦ ¦e v a lu ated¦ ¦in¦ ¦ani mal¦ ¦m od els¦ ¦for¦ 𐊣¦sars¦𐊼 .
𐋇 ¦ar ts¦ ¦and¦ ¦c ul t ure¦ ¦se ctor¦ ¦or ga ni z ations¦ ¦att e mp ted¦ ¦to¦ ¦up ho ld¦ ¦their¦ ▁( ¦o f ten¦ ¦p ub lic ly¦ ¦f u nded¦ )▁ ¦ mission¦ ¦to¦ ¦provide¦ ¦acc ess¦ ¦to¦ ¦c ul tur al¦ ¦he ri ta ge¦ ¦to¦ ¦the¦ ¦comm unity¦ ,▁ ¦m ai nt ain¦ ¦the¦ ¦sa fety¦ ¦of¦ ¦their¦ ¦emp loy e es¦ ¦and¦ ¦the¦ ¦public¦ ,▁ ¦and¦ ¦supp ort¦ ¦ art ists¦ ¦where¦ ¦possible¦ .
𐋇 ¦currently¦ ,▁ ¦no¦ ¦de ta il ed¦ ¦study¦ ¦has¦ ¦been¦ ¦reported¦ ¦reg ar ding¦ ¦the¦ ¦imm u no log ical¦ ¦response¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦on¦ ¦one¦ ¦hand¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦infection¦ ¦ex hi bi ts¦ ¦fe at ures¦ ¦that¦ ¦are¦ ¦more¦ ¦comm on ly¦ ¦seen¦ ¦during¦ ¦infection¦ ¦with¦ ¦comm unity¦ - ¦ac qu ir ed¦ 𐊣¦h c𐊼 o𐋇vs¦ ,▁ ¦including¦ ¦the¦ ¦pre se nt ation¦ ¦of¦ ¦n on¦ - ¦speci fic¦ ,▁ ¦mi ld¦ ¦or¦ ¦even¦ ¦no¦ ¦symptoms¦ .
𐋇¦c o𐋇vs¦ ¦have¦ ¦re tur ned¦ ¦to¦ ¦the¦ ¦li me li ght¦ ¦due¦ ¦to¦ ¦the¦ ¦rec ent¦ ¦outbreak¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦the¦ 𐋇¦w h ite¦ 𐋇 ¦ho use¦ 𐋇 ¦coronavirus¦ 𐋇¦t as k¦ 𐋇 ¦force¦ ¦was¦ ¦ est ab lish ed¦ ¦on¦ ¦2 9¦ 𐋇¦january¦ .
𐋇 ¦and¦ ¦with¦ ¦your¦ ¦hi st ory¦ ¦of¦ ¦di ab e tes¦
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ 𐋇¦chinese¦ ¦a id¦ ¦has¦ ¦been¦ ¦well¦ - ¦recei ved¦ ¦in¦ ¦par ts¦ ¦of¦ 𐋇¦l at in¦ 𐋇¦a mer ic a¦ ¦and¦ 𐋇¦a f r ic a¦ . 𐋇¦on¦ ¦2¦ 𐋇¦april¦ ,▁ ¦the¦ 𐋇¦world¦ 𐋇¦b an k¦ ¦la un ch ed¦ ¦emergency¦ ¦supp ort¦ ¦op er ations¦ ¦for¦ ¦develop ing¦ ¦countries¦ .
𐋇¦this¦ ¦is¦ ¦follow ed¦ ¦by¦ ¦the¦ ¦trans c ri p tion¦ ¦of¦ ¦these¦ ¦ne ga tive¦ - ¦s en se¦ ¦sub ge no mic¦ 𐊣¦r na ¦𐊼 ¦m ol ec u les¦ ¦to¦ ¦their¦ ¦c or r esp on ding¦ ¦positive¦ - ¦s en se¦ ¦m 𐊣 r na 𐊼 s¦ .
𐋇¦the¦ ¦g lobal¦ 𐋇¦s ol id ar ity¦ ¦and¦ 𐋇¦e ur op e an¦ 𐋇 ¦dis co very¦ ¦trials¦ ¦of¦ ¦hos pi ta li zed¦ ¦people¦ ¦with¦ ¦severe¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infection¦ ¦app ly¦ ¦ad ap tive¦ ¦de si g n¦ ¦to¦ ¦rapidly¦ ¦al ter¦ ¦tri al¦ ¦p ara me t ers¦ ¦as¦ ¦resul ts¦ ¦from¦ ¦the¦ ¦four¦ ¦exp e ri m en tal¦ ¦the rap e u tic¦ ¦stra te g ies¦ ¦e mer ge¦ .
𐋇¦these¦ ¦st ati st ics¦ ¦are¦ ¦not¦ ¦ ti me b oun d¦ ¦and¦ ¦follow ¦ ¦a¦ ¦speci fic¦ ¦population¦ ¦from¦ ¦infection¦ ¦through¦ ¦case¦ ¦res o lu tion¦ .
𐋇¦in¦ ¦the¦ ¦early¦ ¦phase¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 ¦outbreak¦ ,▁ ¦a¦ ¦r an ge¦ ¦of¦ ¦p s yc hi a tr ic¦ ¦mor b id ities¦ ¦including¦ ¦per si st ent¦ ¦dep r ess ion¦ ,▁ ¦an x ie ty¦ ,▁ ¦p an ic¦ ¦att ac ks¦ ,▁ ¦p s y ch om o t or¦ ¦ex ci te ment¦ ,▁ ¦p s yc ho tic¦ ¦symptoms¦ ,▁ ¦de li ri um¦ ,▁ ¦and¦ ¦even¦ ¦su ic id ality¦ ¦were¦ ¦reported¦ .
𐋇¦w he ne ver¦ ¦possible¦ ,▁ ¦we¦ ¦will¦ ¦ try¦ ¦to¦ ¦comp are¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦with¦ 𐊣¦sars¦𐊼 ¦and¦ ¦another¦ 𐋇¦co𐋇v¦ - ¦caused¦ ¦disease¦ ,▁ 𐋇¦m id d le¦ 𐋇 ¦ea st¦ ¦respiratory¦ ¦sy nd r ome¦ ▁( 𐊣¦m ers¦ 𐊼 ,▁ ¦an¦ ¦outbreak¦ ¦in¦ ¦201 2¦ ).
𐋇¦it¦ ¦has¦ ¦att r acted¦ ¦a¦ ¦g reat¦ ¦att ention¦ ¦since¦ ¦p ub lish ed¦ .
𐋇¦this¦ ¦en z y me¦ ¦is¦ ¦essential¦ ¦to¦ ¦the¦ ¦h ost¦ ¦c ell¦ ¦to¦ ¦rep r od u ce¦ ¦the¦ ¦ rib on uc le ic¦ ¦ac id¦ ¦of¦ ¦the¦ ¦virus¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦a ff ects¦ ¦more¦ ¦el d er ly¦ ¦in di v id u als¦ ¦than¦ ¦y outh¦ ¦and¦ ¦more¦ ¦m en¦ ¦than¦ ¦women¦ ,▁ ¦and¦ ¦the¦ ¦se ver ity¦ ¦and¦ ¦death¦ ¦rate¦ ¦are¦ ¦also¦ ¦higher¦ ¦in¦ ¦el d er ly¦ ¦in di v id u al¦ ¦than¦ ¦in¦ ¦y outh¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦transmission¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦was¦ ¦consid ered¦ ¦to¦ ¦occ ur¦ ¦when¦ ¦the¦ ¦patients¦ ¦are¦ ¦se ve re ly¦ ¦ ill¦ ,▁ ¦while¦ ¦most¦ ¦transmission¦ ¦did¦ ¦not¦ ¦happ en¦ ¦at¦ ¦the¦ ¦early¦ ¦phase¦ .
𐋇 ¦rep ur p osed¦ ¦an tiv iral¦ ¦d ru gs¦ ¦make¦ ¦up¦ ¦most¦ ¦of¦ ¦the¦ 𐋇¦chinese¦ ¦research¦ ,▁ ¦with¦ ¦9¦ 𐋇 ¦phase¦ 𐊣¦i i i ¦𐊼 ¦trials¦ ¦on¦ ¦rem desivir¦ ¦across¦ ¦several¦ ¦countries¦ ¦due¦ ¦to¦ ¦report¦ ¦by¦ ¦the¦ ¦ end¦ ¦of¦ 𐋇¦april¦ .
𐋇¦j ap an¦ ¦d on ated¦ ¦one¦ ¦million¦ ¦face¦ ¦masks¦ ¦to¦ 𐋇¦w uhan¦ ,▁ 𐋇¦ tur ke y¦ ¦dis p at ch ed¦ ¦medical¦ ¦e qu i p ment¦ ,▁ 𐋇¦r us si a¦ ¦sent¦ ¦more¦ ¦than¦ ¦1 3¦ ¦t on n es¦ ¦of¦ ¦medical¦ ¦supp l ies¦ ¦to¦ 𐋇¦w uhan¦ ,▁ 𐋇¦ma la y si a¦ ¦announced¦ ¦a¦ ¦d on ation¦ ¦of¦ ¦18¦ ¦million¦ ¦medical¦ ¦g lo ves¦ ¦to¦ 𐋇¦china¦ ,▁ 𐋇¦g erm an y¦ ¦de li v ered¦ ¦various¦ ¦medical¦ ¦supp l ies¦ ¦including¦ ¦10¦ , ¦000¦ 𐋇 ¦ha z m at¦ ¦su i ts¦ ,▁ ¦and¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦d on ated¦ ¦1 7¦ . ¦8¦ ¦t ons¦ ¦of¦ ¦medical¦ ¦supp l ies¦ ¦to¦ 𐋇¦china¦ ¦and¦ ¦pro mi sed¦ ¦an¦ ¦ad di ti onal¦ ▁ $ ¦100¦ ¦million¦ ¦in¦ ¦fin an cial¦ ¦supp ort¦ ¦to¦ ¦affected¦ ¦countries¦ . 𐋇¦after¦ ¦cases¦ ¦in¦ 𐋇¦china¦ ¦see med¦ ¦to¦ ¦sta bi li z e¦ ,▁ ¦the¦ ¦country¦ ¦has¦ ¦been¦ ¦s en ding¦ ¦a id¦ ¦to¦ ¦various¦ ¦n ations¦ ¦h it¦ ¦by¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦2 2¦ 𐋇¦march¦ ,▁ ¦the¦ 𐋇 ¦associ ated¦ 𐋇¦pr ess¦ ¦reported¦ : ▁" 𐋇¦many¦ ¦people¦ ¦who¦ ¦have¦ ¦symptoms¦ ¦and¦ ¦a¦ ¦doctor¦ ' ¦s¦ ¦order¦ ¦have¦ ¦w ai ted¦ ¦hours¦ ¦or¦ ¦days¦ ¦for¦ ¦a¦ ¦test¦ ." 𐋇¦after¦ ¦the¦ ¦first¦ ¦death¦ ¦in¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦was¦ ¦reported¦ ¦in¦ 𐋇 ¦was hi ng t on¦ ¦state¦ ¦on¦ ¦2 9¦ 𐋇¦february¦ ,▁ 𐋇 ¦go ver n or¦ 𐋇¦j ay¦ 𐋇 ¦ins le e¦ ¦dec l ared¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ ,▁ ¦an¦ ¦a ction¦ ¦that¦ ¦was¦ ¦so on¦ ¦follow ed¦ ¦by¦ ¦other¦ ¦states¦ .
𐋇 ¦patients¦ ¦infected¦ ¦with¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦p res ented¦ ¦with¦ ¦comm on¦ ¦co ld¦ ¦symptoms¦ ,▁ ¦including¦ ¦h ea d ach e¦ ,▁ ¦s n ee z ing¦ ,▁ ¦ma la ise¦ ¦and¦ ¦s ore¦ - ¦th ro at¦ ,▁ ¦with¦ ¦fever¦ ¦and¦ ¦c ough¦ ¦seen¦ ¦in¦ ¦10¦ ~ ¦20¦ %▁ ¦cases¦ .
𐋇¦the¦ 𐋇¦th ur s day¦ ¦ ed ition¦ ¦of¦ 𐊣¦ nt ¦𐊼 𐋇¦ne ws¦ ,▁ ¦a¦ ¦d ai ly¦ ¦pr in ted¦ ¦in¦ 𐋇¦d ar w in¦ ,▁ ¦inc lu ded¦ ¦an¦ ¦e i ght¦ - ¦pa ge¦ ¦ins er t¦ ¦me ant¦ ¦to¦ ¦be¦ ¦c ut¦ ¦up¦ ¦and¦ ¦used¦ ¦as¦ ¦to il et¦ ¦p ap er¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦countries¦ ¦may¦ ¦have¦ ¦more¦ ¦or¦ ¦less¦ ¦res o ur ces¦ ¦than¦ 𐋇¦ita ly¦ ▁( ¦12¦ . ¦5¦ ¦int en sive¦ ¦care¦ ¦and¦ ¦inter medi ate¦ ¦care¦ ¦beds¦ ¦per¦ ¦100¦ , ¦000¦ ¦population¦ ¦in¦ ¦201 0¦ – ¦11¦ ).
𐋇 ¦since¦ ¦part ic les¦ ¦can¦ ¦p e ne tr ate¦ ¦even¦ ¦five¦ ¦sur g ical¦ ¦masks¦ ¦st ac ked¦ ¦to ge ther¦ ,▁ ¦health¦ - ¦care¦ ¦pro vi ders¦ ¦in¦ ¦d ir ect¦ ¦contact¦ ¦with¦ ¦patients¦ ¦m ust¦ ¦we ar¦ 𐋇¦n 9 5¦ ▁( ¦ser ies¦ ▁ # ▁ ¦1 8 6 0 s¦ )▁ ¦masks¦ ¦but¦ ¦not¦ ¦sur g ical¦ ¦masks¦ .
𐋇¦it¦ ¦is¦ ¦in¦ ¦m y¦ ¦ch est¦
𐋇 ¦control¦ ¦of¦ ¦public¦ ¦mo ve ment¦ ¦was¦ ¦app li ed¦ ¦in¦ ¦many¦ ¦c ities¦ ,▁ ¦and¦ ¦it¦ ¦has¦ ¦been¦ ¦es tim ated¦ ¦that¦ ¦about¦ ¦7 6 0¦ ¦million¦ ¦people¦ ▁( ¦more¦ ¦than¦ ¦h alf¦ ¦the¦ ¦population¦ )▁ ¦f ac ed¦ ¦some¦ ¦for m¦ ¦of¦ ¦out d o or¦ ¦res tric tion¦ . 𐋇¦after¦ ¦the¦ ¦outbreak¦ ¦ent ered¦ ¦its¦ ¦g lobal¦ ¦phase¦ ¦in¦ 𐋇¦march¦ ,▁ 𐋇¦chinese¦ ¦a u th or ities¦ ¦to ok¦ ¦s tric t¦ ¦measures¦ ¦to¦ ¦prevent¦ ¦the¦ ¦virus¦ ¦from¦ ▁" ¦imp or ting¦ "▁ ¦from¦ ¦other¦ ¦countries¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ )▁ ¦is¦ ¦a¦ ¦new¦ ¦disease¦ ,▁ ¦our¦ ¦a wa re ness¦ ¦and¦ ¦kno w l ed ge¦ ¦are¦ ¦g ra d u ally¦ ¦increasing¦ ¦based¦ ¦on¦ ¦the¦ ¦o ng o ing¦ ¦research¦ ¦fin di ngs¦ ¦and¦ ¦clinical¦ ¦p ra ct ice¦ ¦experie nce¦ ;▁ ¦he nce¦ ,▁ ¦the¦ ¦stra te g ies¦ ¦of¦ ¦di a g no sis¦ ¦and¦ ¦treatment¦ ¦are¦ ¦also¦ ¦cont in u ally¦ ¦up d ated¦ .
𐋇 ¦rem o te¦ ¦working¦ ¦measures¦ ¦were¦ ¦in st itu ted¦ ¦in¦ ¦several¦ 𐋇¦chinese¦ ¦regi ons¦ .
𐋇¦the¦ ¦experie nce¦ ¦from¦ 𐋇¦ita ly¦ ¦and¦ ¦the¦ ¦current¦ ¦tre nds¦ ¦in¦ ¦other¦ ¦countries¦ ¦sho w¦ ¦that¦ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦pandemic¦ ¦is¦ ¦pro gr ess ing¦ ¦rapidly¦ ¦in¦ ¦the¦ 𐊣 ¦e u¦ / ¦e ea ¦𐊼 ¦and¦ ¦the¦ 𐊣¦uk¦𐊼 .
𐋇 ¦with¦ ¦the¦ ¦or de als¦ ¦of¦ 𐊣 ¦s ar s¦ ,▁ ¦m ers¦ 𐊼 ¦and¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦a¦ ¦be tter¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦pl an¦ ¦should¦ ¦be¦ ¦in¦ ¦place¦ .
𐋇¦many¦ ¦re si de nts¦ ¦of¦ 𐋇¦w uhan¦ ¦and¦ 𐋇¦h ub e i¦ ¦have¦ ¦reported¦ ¦dis c ri m ination¦ ¦based¦ ¦on¦ ¦their¦ ¦regi onal¦ ¦o ri g in¦ .
𐋇¦a¦ ¦st ati st ical¦ ¦an al y sis¦ ¦p ub lish ed¦ ¦30¦ 𐋇¦march¦ ¦es tim ated¦ ¦that¦ ¦n umb ers¦ ¦of¦ ¦infections¦ ¦in¦ 𐋇¦ita ly¦ ¦were¦ ¦consid er ab ly¦ ¦g rea ter¦ ¦than¦ ¦the¦ ¦reported¦ ¦cases¦ .
𐋇¦on¦ ¦2 2¦ 𐋇¦march¦ ,▁ ¦after¦ ¦a¦ ¦ph one¦ ¦c all¦ ¦with¦ 𐋇¦ita li an¦ 𐋇¦prime¦ 𐋇¦minister¦ 𐋇 ¦gi u se pp e¦ 𐋇 ¦con te¦ ,▁ 𐋇¦r us si an¦ ¦president¦ 𐋇¦v la di m ir¦ 𐋇¦p ut in¦ ¦ar r an ged¦ ¦the¦ 𐋇¦r us si an¦ ¦ar m y¦ ¦to¦ ¦s end¦ ¦m il it ary¦ ¦medic s¦ ,▁ ¦speci al¦ ¦dis in fe ction¦ ¦ve h ic les¦ ,▁ ¦and¦ ¦other¦ ¦medical¦ ¦e qu i p ment¦ ¦to¦ 𐋇¦ita ly¦ .
𐋇¦the¦ 𐋇¦chinese¦ ¦government¦ ¦e nc ou ra ged¦ ¦b us in es ses¦ ¦and¦ ¦fa ct ories¦ ¦to¦ ¦r e¦ - ¦open¦ ¦on¦ ¦30¦ 𐋇¦march¦ ,▁ ¦and¦ ¦prov ided¦ ¦mo ne t ary¦ ¦s tim ul us¦ ¦p ack a ges¦ ¦for¦ ¦f ir ms¦ . 𐋇¦the¦ 𐋇¦state¦ 𐋇¦c oun ci l¦ ¦dec l ared¦ ¦a¦ ¦day¦ ¦of¦ ¦mo ur ning¦ ¦to¦ ¦beg in¦ ¦with¦ ¦a¦ ¦n ational¦ ¦three¦ - ¦min ute¦ ¦mo ment¦ ¦of¦ ¦si le nce¦ ¦on¦ ¦10¦ : ¦ 00¦ ¦4¦ 𐋇¦april¦ ,▁ ¦co in ci ding¦ ¦with¦ 𐋇¦ q i ng m ing¦ 𐋇¦f es tiv al¦ ,▁ ¦al though¦ ¦the¦ ¦central¦ ¦government¦ ¦asked¦ ¦f am il ies¦ ¦to¦ ¦p ay¦ ¦their¦ ¦r esp ects¦ ¦on line¦ ¦in¦ ¦ob s erv a nce¦ ¦of¦ ¦ph y s ical¦ ¦dis ta ncing¦ ¦as¦ ¦to¦ ¦avo id¦ ¦a¦ ¦re ne w ed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦outbreak¦ .
𐋇 ¦private¦ ¦ve h ic le¦ ¦use¦ ¦was¦ ¦b an ned¦ ¦in¦ ¦the¦ ¦city¦ .
𐋇 ¦around¦ ¦2 00¦ ¦countries¦ ¦and¦ ¦ter rit ories¦ ¦have¦ ¦had¦ ¦at¦ ¦least¦ ¦one¦ ¦case¦ .
𐋇¦the¦ 𐋇¦e ur op e an¦ 𐋇¦c en tr e¦ ¦for¦ 𐋇 ¦disease¦ 𐋇 ¦prev ention¦ ¦and¦ 𐋇 ¦control¦ ▁( 𐊣¦ ec d c¦𐊼 )▁ ¦states¦ ¦that¦ ¦while¦ ¦it¦ ¦is¦ ¦not¦ ¦ enti re ly¦ ¦cle ar¦ ¦how¦ ¦ea si ly¦ ¦the¦ ¦disease¦ ¦sprea ds¦ ,▁ ¦one¦ ¦person¦ ¦gen er ally¦ ¦inf ects¦ ¦two¦ ¦to¦ ¦three¦ ¦o thers¦ . 𐋇¦the¦ ¦virus¦ ¦sur vi ves¦ ¦for¦ ¦hours¦ ¦to¦ ¦days¦ ¦on¦ ¦sur f a ces¦ .
𐋇¦ ap art¦ ¦from¦ ¦the¦ ¦su p er¦ - ¦sprea ders¦ ,▁ ¦it¦ ¦was¦ ¦es tim ated¦ ¦that¦ ¦each¦ ¦case¦ ¦could¦ ¦gi ve¦ ¦r ise¦ ¦to¦ ¦appro xi ma tely¦ ¦two¦ ¦se co nd ary¦ ¦cases¦ ,▁ ¦with¦ ¦an¦ ¦inc ub ation¦ ¦period¦ ¦of¦ ¦4¦ ¦to¦ ¦7¦ ¦days¦ ¦and¦ ¦the¦ ¦p ea k¦ ¦of¦ ¦v iral¦ ¦lo ad¦ ¦appe ar ing¦ ¦on¦ ¦the¦ ¦1 0 th¦ ¦day¦ ¦of¦ ¦ ill ness¦ .
𐋇¦for¦ ¦this¦ ¦to¦ ¦happ en¦ ,▁ 𐊣¦h c𐊼 o𐋇vs¦ ¦have¦ ¦to¦ ¦rep lic ate¦ ¦in¦ ¦hum ans¦ ¦to¦ ¦su ffic i ent¦ ¦ext ent¦ ¦to¦ ¦al low¦ ¦the¦ ¦acc um ul ation¦ ¦of¦ ¦ad ap tive¦ ¦mut ations¦ ¦that¦ ¦c ou nt er act¦ ¦h ost¦ ¦res tric tion¦ ¦fa ct ors¦ .
𐋇¦s te ro i ds¦ ,▁ ¦as¦ ¦imm un os u pp r ess a nts¦ ,▁ ¦were¦ ¦wi de ly¦ ¦used¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ 𐊣¦sars¦𐊼 ¦to¦ ¦reduce¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦inf l am m atory¦ ¦d a ma ge¦ .
𐋇¦it¦ ¦high li gh ts¦ ¦that¦ ,▁ ¦as¦ ¦at¦ ¦15¦ 𐋇¦march¦ ¦8¦ : ¦ 00¦ ¦a¦ . ¦ m¦ . ,▁ ¦15¦ ¦other¦ 𐊣 ¦e u¦ / ¦e ea ¦𐊼 ¦countries¦ ¦and¦ ¦the¦ 𐊣¦uk¦𐊼 ¦had¦ ¦al rea dy¦ ¦reported¦ ¦a¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦com par able¦ ¦to¦ ¦that¦ ¦of¦ 𐋇¦ita ly¦ ¦j ust¦ ¦3¦ ¦weeks¦ ¦pri or¦ ¦or¦ ¦less¦ .
𐋇¦the¦ ¦outbreak¦ ¦dis ru p ted¦ ¦pl ans¦ ¦for¦ ¦the¦ ¦2020¦ 𐋇¦s um m er¦ 𐋇¦ ol y mp ics¦ ,▁ ¦which¦ ¦were¦ ¦o ri g in ally¦ ¦s ch ed ul ed¦ ¦to¦ ¦start¦ ¦at¦ ¦the¦ ¦ end¦ ¦of¦ 𐋇¦j u ly¦ ;▁ ¦the¦ 𐋇 ¦intern ational¦ 𐋇¦ ol y mp ic¦ 𐋇¦comm it te e¦ ¦announced¦ ¦on¦ ¦24¦ 𐋇¦march¦ ¦that¦ ¦the¦ ¦e v ent¦ ¦will¦ ¦be¦ ▁" ¦res ch ed ul ed¦ ¦to¦ ¦a¦ ¦d ate¦ ¦be y on d¦ ¦2020¦ ¦but¦ ¦not¦ ¦la ter¦ ¦than¦ ¦s um m er¦ ¦20 2 1¦ " . 𐋇¦ca si no s¦ ¦and¦ ¦other¦ ¦g am ing¦ ¦v en u es¦ ¦wor l d w ide¦ ¦have¦ ¦closed¦ ¦and¦ ¦li ve¦ ¦po k er¦ ¦to ur na ments¦ ¦have¦ ¦been¦ ¦e i ther¦ ¦po st po ned¦ ¦or¦ ¦can ce lled¦ .
𐋇 ¦are¦ ¦you¦ ¦ha ving¦ ¦any¦ ¦sh or t ness¦ ¦of¦ ¦brea th¦ ?
𐋇¦di ar r he a¦ ▁( ¦2 6¦ % )▁ ¦and¦ ¦s ore¦ ¦th ro at¦ ▁( ¦2 1¦ % )▁ ¦were¦ ¦also¦ ¦ob s er ved¦ ¦with¦ 𐊣¦m ers¦ 𐊼 ¦patients¦ .
𐋇¦health¦ ¦or ga ni z ations¦ ¦recomme nded¦ ¦that¦ ¦people¦ ¦co ver¦ ¦their¦ ¦m outh¦ ¦and¦ ¦n ose¦ ¦with¦ ¦a¦ ¦b ent¦ ¦el b o w¦ ¦or¦ ¦a¦ ¦t is s ue¦ ¦when¦ ¦c ou g hing¦ ¦or¦ ¦s n ee z ing¦ ,▁ ¦and¦ ¦dis p os ing¦ ¦of¦ ¦any¦ ¦t is s ue¦ ¦immedi a tely¦ .
𐋇 ¦about¦ ¦3 6 4¦ , ¦000¦ ¦people¦ ¦have¦ ¦rec ov ered¦ .
𐋇¦co ro na vi ruses¦ ¦can¦ ¦cause¦ ¦p ne um o nia¦ ▁( ¦e i ther¦ ¦d ir ect¦ ¦v iral¦ ¦p ne um o nia¦ ¦or¦ ¦se co nd ary¦ ¦b ac teri al¦ ¦p ne um o nia¦ )▁ ¦and¦ ¦b ro nc hi ti s¦ ▁( ¦e i ther¦ ¦d ir ect¦ ¦v iral¦ ¦b ro nc hi ti s¦ ¦or¦ ¦se co nd ary¦ ¦b ac teri al¦ ¦b ro nc hi ti s¦ ).
𐋇¦in¦ ¦the¦ ¦1 9 5 0 s¦ ,▁ ¦the¦ ¦human¦ ¦coronavirus¦ 𐊣 ¦o c𐊼 4 3¦ ¦beg an¦ ¦to¦ ¦di ver ge¦ ¦into¦ ¦its¦ ¦present¦ ¦ge no t y p es¦ .
𐋇 ¦before¦ ¦discus s ing¦ ¦the¦ ¦ani mal¦ ¦o ri g ins¦ ¦of¦ 𐊣¦h c𐊼 o𐋇vs¦ ,▁ ¦it¦ ¦will¦ ¦ser ve¦ ¦ us¦ ¦well¦ ¦to¦ ¦discus s¦ ¦the¦ ¦de fi ni tions¦ ¦and¦ ¦c har ac teri st ics¦ ¦of¦ ¦e v o lu ti on ary¦ ,▁ ¦n atur al¦ ,▁ ¦res erv o ir¦ ,▁ ¦inter medi ate¦ ¦and¦ ¦a mp li f ying¦ ¦hos ts¦ ¦of¦ 𐊣¦h c𐊼 o𐋇vs¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦has¦ ¦issued¦ ¦ins tr uc tions¦ ¦on¦ ¦when¦ ¦and¦ ¦how¦ ¦to¦ ¦use¦ ¦masks¦ .
𐋇 ¦another¦ ¦hospital¦ ¦was¦ ¦bu il t¦ ¦a f t er w ar ds¦ ,▁ 𐋇 ¦le is he ns han¦ 𐋇¦hospital¦ ,▁ ¦to¦ ¦ha nd le¦ ¦ad di ti onal¦ ¦patients¦ .
𐋇¦on¦ ¦6¦ 𐋇¦february¦ ¦2020¦ ,▁ ¦our¦ ¦t ea m¦ ¦had¦ ¦p ub lish ed¦ ¦a¦ ¦rap id¦ ¦ad v ice¦ ¦guid e line¦ ¦for¦ ¦di a g no sis¦ ¦and¦ ¦treatment¦ ¦of¦ ¦2019¦ ¦no ve l¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n 𐋇 co 𐋇 v¦ )▁ ¦infection¦ ,▁ ¦and¦ ¦this¦ ¦guid e line¦ ¦prov ided¦ ¦our¦ ¦experie nce¦ ¦and¦ ¦make¦ ¦well¦ ¦re fere nce¦ ¦for¦ ¦fi gh ting¦ ¦against¦ ¦this¦ ¦pandemic¦ ¦wor l d w ide¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦has¦ ¦fe at ures¦ ¦that¦ ¦are¦ ¦simil ar¦ ¦to¦ ¦both¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ / 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦the¦ ¦four¦ ¦comm unity¦ - ¦ac qu ir ed¦ 𐊣¦h c𐊼 o𐋇vs¦ .
𐋇 ¦their¦ ¦guid el ines¦ ¦th us¦ ¦ad v ise¦ ¦that¦ ¦any¦ ¦pre gn ant¦ ¦person¦ ¦admitted¦ ¦to¦ ¦hospital¦ ¦with¦ ¦a¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infection¦ ¦should¦ ¦recei ve¦ ¦at¦ ¦least¦ ¦10¦ ¦days¦ ¦of¦ ¦prop h y l ac tic¦ ¦low¦ - ¦m ol ec ul ar¦ - ¦we i ght¦ ¦he par in¦ ¦after¦ ¦being¦ ¦dis c har ged¦ ¦from¦ ¦the¦ ¦hospital¦ .
𐋇¦the¦ ¦o ri g in¦ ¦and¦ ¦inter medi ate¦ ¦h ost¦
𐋇¦for¦ ¦those¦ ¦who¦ ¦do¦ ¦not¦ ,▁ ¦the¦ ¦time¦ ¦from¦ ¦development¦ ¦of¦ ¦symptoms¦ ¦to¦ ¦death¦ ¦has¦ ¦been¦ ¦between¦ ¦6¦ ¦and¦ ¦4 1¦ ¦days¦ ,▁ ¦with¦ ¦the¦ ¦most¦ ¦comm on¦ ¦being¦ ¦14¦ ¦days¦ .
𐋇¦a¦ ¦small¦ ¦study¦ ¦inv ol ving¦ ¦6¦ ¦confirmed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦mo thers¦ ¦sh ow ed¦ ¦no¦ ¦ind ic ation¦ ¦of¦ 𐊣 ¦s ar s¦ - ¦cov ¦𐊼 - ¦19¦ ¦in¦ ¦their¦ ¦ne w b or ns¦ '▁ ¦th ro a ts¦ ¦or¦ ¦ser um¦ ¦but¦ ¦antib odies¦ ¦were¦ ¦present¦ ¦in¦ ¦ne o na tal¦ ¦blood¦ ¦ser a¦ ¦samples¦ ,▁ ¦including¦ 𐋇¦i g 𐋇 m¦ ¦in¦ ¦two¦ ¦of¦ ¦the¦ ¦inf a nts¦ .
𐋇¦in¦ ¦patients¦ ¦with¦ ¦severe¦ ¦cases¦ ,▁ ¦the¦ ¦level¦ ¦of¦ 𐋇¦ d¦ - ¦di m er¦ ,▁ ¦a¦ ¦fi b r in¦ ¦de g ra d ation¦ ¦produc t¦ ¦present¦ ¦in¦ ¦the¦ ¦blood¦ ,▁ ¦was¦ ¦e le v ated¦ ,▁ ¦and¦ ¦l y mp h oc y te¦ ¦c oun t¦ ¦was¦ ¦pro g res si ve ly¦ ¦reduc ed¦ .
𐋇¦on¦ ¦2 3¦ 𐋇¦january¦ ,▁ ¦in¦ ¦rea ction¦ ¦to¦ ¦the¦ ¦central¦ ¦a u th or ities¦ '▁ ¦decision¦ ¦to¦ ¦imple ment¦ ¦a¦ ¦trans por t ation¦ ¦b an¦ ¦in¦ 𐋇¦w uhan¦ ,▁ 𐊣¦who¦𐊼 ¦rep res en ta tive¦ 𐋇 ¦ga u d en¦ 𐋇 ¦ga le a¦ ¦rem ar ked¦ ¦that¦ ¦while¦ ¦it¦ ¦was¦ ▁" ¦c er ta in ly¦ ¦not¦ ¦a¦ ¦recomme nd ation¦ ¦the¦ 𐊣¦who¦𐊼 ¦has¦ ¦made¦ " ,▁ ¦it¦ ¦was¦ ¦also¦ ▁" ¦a¦ ¦very¦ ¦important¦ ¦ind ic ation¦ ¦of¦ ¦the¦ ¦comm it ment¦ ¦to¦ ¦cont ain¦ ¦the¦ ¦epi demic¦ ¦in¦ ¦the¦ ¦place¦ ¦where¦ ¦it¦ ¦is¦ ¦most¦ ¦conc en tr ated¦ "▁ ¦and¦ ¦called¦ ¦it¦ ▁" ¦un p r ec ed ented¦ ¦in¦ ¦public¦ ¦health¦ ¦hi st ory¦ " . 𐋇¦on¦ ¦30¦ 𐋇¦january¦ ,▁ ¦follow ing¦ ¦confir m ation¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦out s ide¦ 𐋇¦china¦ ¦and¦ ¦the¦ ¦increase¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦in¦ ¦other¦ ¦countries¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦dec l ared¦ ¦the¦ ¦outbreak¦ ¦a¦ 𐋇 ¦public¦ 𐋇¦health¦ 𐋇 ¦emergency¦ ¦of¦ 𐋇 ¦intern ational¦ 𐋇 ¦conc ern¦ ▁( 𐊣¦p he i c¦𐊼 ),▁ ¦the¦ ¦si x th¦ 𐊣¦p he i c¦𐊼 ¦since¦ ¦the¦ ¦me as ure¦ ¦was¦ ¦first¦ ¦inv o ked¦ ¦during¦ ¦the¦ ¦20 0 9¦ ¦sw ine¦ ¦fl u¦ ¦pandemic¦ .
𐋇¦these¦ ¦the rap ies¦ ¦include¦ ¦current¦ ¦and¦ ¦po t enti al¦ ¦tre at ments¦ ¦with¦ ¦an tiv iral¦ ¦d ru gs¦ ,▁ ¦imm un os u pp r ess a nts¦ ,▁ ¦s te ro i ds¦ ,▁ ¦pl as ma¦ ¦from¦ ¦rec ov ered¦ ¦patients¦ ,▁ 𐋇¦chinese¦ ¦medic ine¦ ,▁ ¦and¦ ¦p s yc ho log ical¦ ¦supp ort¦ .
𐋇 ¦several¦ ¦rec ent¦ ¦stud ies¦ ¦based¦ ¦on¦ ¦me ta ge no mic¦ ¦se que ncing¦ ¦have¦ ¦su gg es ted¦ ¦that¦ ¦a¦ ¦group¦ ¦of¦ ¦e nd a ng ered¦ ¦small¦ ¦m am m als¦ ¦known¦ ¦as¦ ¦pa ng ol ins¦ ▁( 𐋇¦ma ni s¦ ¦j av an ic a¦ )▁ ¦could¦ ¦also¦ ¦ har b o ur¦ ¦an ce stra l¦ ¦be t a¦ - 𐋇¦c o𐋇vs¦ ¦related¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦they¦ ¦are¦ ¦wi de ly¦ ¦dist rib u ted¦ ¦across¦ ¦the¦ 𐋇¦m id d le¦ 𐋇 ¦ea st¦ ¦and¦ 𐋇¦a f r ic a¦ .
𐋇¦if¦ ¦you¦ ¦continue¦ ¦to¦ ¦have¦ ¦high¦ ¦fe v ers¦
𐋇¦prime¦ 𐋇¦minister¦ 𐋇 ¦gi u se pp e¦ 𐋇 ¦con te¦ ¦said¦ ,▁" 𐋇¦in¦ ¦the¦ ¦outbreak¦ ¦areas¦ ,▁ ¦en try¦ ¦and¦ ¦ex it¦ ¦will¦ ¦not¦ ¦be¦ ¦prov ided¦ .
𐋇¦the¦ ¦so ur ce¦ ¦acc u sed¦ 𐋇¦r us si a¦ ¦of¦ ¦e mb ar king¦ ¦on¦ ¦a¦ ▁" ¦ge op ol itical¦ ¦and¦ ¦di p lo ma tic¦ "▁ ¦c har m¦ ¦off en sive¦ .
𐋇¦in¦ ¦addition¦ ,▁ ¦the¦ ¦requir e ments¦ ¦for¦ ¦s uc c ess f ul¦ ¦h ost¦ ¦sw it ch es¦ ¦and¦ ¦the¦ ¦imp lic ations¦ ¦of¦ ¦virus¦ ¦e v o lu tion¦ ¦on¦ ¦disease¦ ¦se ver ity¦ ¦are¦ ¦also¦ ¦high li gh ted¦ .
𐋇¦sa les¦ ¦w ent¦ ¦up¦ ¦in¦ ¦a¦ ▁" ¦s har p¦ ¦increase¦ "▁ ¦last¦ ¦week¦ ,▁ ¦according¦ ¦to¦ ¦a¦ 𐋇¦w o ol w or th s¦ ¦s po k esp er s on¦ .
𐋇 ¦through¦ ¦different¦ ¦pa th wa ys¦ ,▁ ¦the¦ ¦virus¦ ¦ind u ces¦ ¦the¦ ¦exp r ess ion¦ ¦of¦ ¦inf l am m atory¦ ¦fa ct ors¦ ,▁ ¦m atur ation¦ ¦of¦ ¦de nd ri tic¦ ¦ce lls¦ ,▁ ¦and¦ ¦sy nt he sis¦ ¦of¦ ¦typ e¦ 𐋇¦i¦ ¦inter f er ons¦ ▁( 𐊣¦i f n 𐊼 s¦ )▁ ¦which¦ ¦li m it¦ ¦the¦ ¦sprea ding¦ ¦of¦ ¦the¦ ¦virus¦ ¦and¦ ¦acc el er ate¦ ¦m ac r op ha ge¦ ¦p ha g oc y t o sis¦ ¦of¦ ¦v iral¦ ¦an ti ge ns¦ .
𐋇 ¦among¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦acc ess ory¦ ¦prote ins¦ ,▁ 𐊣 ¦or f 𐊼 8¦ ¦has¦ ¦been¦ ¦th ought¦ ¦to¦ ¦be¦ ¦important¦ ¦in¦ ¦ad a pt ation¦ ¦to¦ ¦hum ans¦ ,▁ ¦as¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦related¦ ¦b at¦ ¦vi ruses¦ ¦were¦ ¦isol ated¦ ¦but¦ ¦found¦ ¦to¦ ¦en co de¦ ¦di ver g ent¦ 𐊣 ¦or f 𐊼 8¦ ¦prote ins¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦prov in cial¦ - ¦level¦ ¦ad m in is tr ators¦ ¦of¦ ¦the¦ 𐋇¦comm u ni st¦ 𐋇 ¦par ty¦ ¦of¦ 𐋇¦china¦ ▁( 𐊣¦c p c¦𐊼 )▁ ¦were¦ ¦dis m is sed¦ ¦over¦ ¦their¦ ¦ha nd l ing¦ ¦of¦ ¦the¦ ¦quarantine¦ ¦e f for ts¦ ¦in¦ 𐋇 ¦central¦ 𐋇¦china¦ ,▁ ¦a¦ ¦sig n¦ ¦of¦ ¦dis co nt ent¦ ¦with¦ ¦the¦ ¦pol itical¦ ¦ est ab lish ment¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦in¦ ¦those¦ ¦regi ons¦ .
𐋇¦in¦ ¦the¦ 𐊣¦us ¦𐊼 ¦there¦ ¦is¦ ¦also¦ ¦the¦ ¦recomme nd ation¦ ¦that¦ ¦ne w b or ns¦ ¦and¦ ¦mo thers¦ ¦should¦ ¦be¦ ¦te m por ari ly¦ ¦se par ated¦ ¦un ti l¦ ¦transmission¦ - ¦based¦ ¦pr ec a u tions¦ ¦are¦ ¦dis co nt in u ed¦ ,▁ ¦and¦ ¦that¦ ¦where¦ ¦this¦ ¦is¦ ¦not¦ ¦possible¦ ¦the¦ ¦ne w b or n¦ ¦should¦ ¦be¦ ¦ ke p t¦ ¦2¦ ¦me tr es¦ ¦a way¦ ¦from¦ ¦the¦ ¦mo ther¦ .
𐋇¦re por ts¦ ¦from¦ 𐋇¦february¦ ▁( ¦when¦ ¦the¦ ¦maj or ity¦ ¦of¦ ¦the¦ ¦cases¦ ¦had¦ ¦still¦ ¦been¦ ¦con f ined¦ ¦to¦ 𐋇¦china¦ )▁ ¦have¦ ¦d oc um ented¦ ¦ra ci st¦ ¦s enti ments¦ ¦exp res sed¦ ¦in¦ ¦various¦ ¦gr ou ps¦ ¦wor l d w ide¦ ¦of¦ 𐋇¦chinese¦ ¦people¦ ¦d es er ving¦ ¦the¦ ¦virus¦ ¦or¦ ¦recei ving¦ ¦what¦ ¦has¦ ¦been¦ ¦clai med¦ ¦as¦ ¦j us ti fied¦ ¦re t rib u tion¦ .
𐋇¦in¦ ¦this¦ ¦s en se¦ ,▁ ¦the¦ ¦lo nger¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦outbreak¦ ¦pers ists¦ ¦and¦ ¦the¦ ¦more¦ ¦people¦ ¦that¦ ¦it¦ ¦inf ects¦ ,▁ ¦the¦ ¦g rea ter¦ ¦cha nce¦ ¦that¦ ¦it¦ ¦will¦ ¦f ul ly¦ ¦ad ap t¦ ¦to¦ ¦hum ans¦ .
𐋇¦this¦ ¦v ari ab ility¦ ¦is¦ ¦also¦ ¦likely¦ ¦to¦ ¦be¦ ¦si gni fic a ntly¦ ¦a ff ec ting¦ ¦reported¦ ¦case¦ ¦f at ality¦ ¦ra tes¦ ,▁ ¦which¦ ¦are¦ ¦likely¦ ¦to¦ ¦be¦ ¦si gni fic a ntly¦ ¦over¦ - ¦es tim ated¦ ¦in¦ ¦some¦ ¦countries¦ .
𐋇 ¦com par ab ly¦ ,▁ ¦the¦ ¦mor t ality¦ ¦of¦ 𐊣¦sars¦𐊼 ¦by¦ 𐋇 ¦no ve mber¦ ¦20 0 2¦ ¦was¦ ¦10¦ %▁ ¦of¦ ¦8¦ , ¦ 0 9 6¦ ¦confirmed¦ ¦cases¦ .
𐋇¦many¦ ¦of¦ 𐋇¦china¦ ' ¦s¦ ¦ne ar ly¦ ¦3 00¦ ¦million¦ ¦rural¦ ¦mi gr ant¦ ¦workers¦ ¦have¦ ¦been¦ ¦stra nded¦ ¦at¦ ¦home¦ ¦in¦ ¦in l and¦ ¦prov in ces¦ ¦or¦ ¦tra pp ed¦ ¦in¦ 𐋇¦h ub e i¦ ¦pro vi nce¦ . 𐋇¦in¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦more¦ ¦than¦ ¦10¦ ¦million¦ 𐋇¦a mer ic ans¦ ¦l ost¦ ¦their¦ ¦jo b s¦ ¦and¦ ¦app li ed¦ ¦for¦ ¦government¦ ¦a id¦ .
𐋇 ¦clinical¦ ¦ma ni f est ations¦ ¦of¦ 𐊣¦m ers¦ 𐊼 ¦re se mb le¦ ¦those¦ ¦of¦ 𐊣¦sars¦𐊼 ,▁ ¦c har ac teri zed¦ ¦by¦ ¦pro g res sive¦ ¦ac ute¦ ¦p ne um o nia¦ .
𐋇 ¦conta in ment¦ ¦is¦ ¦under ta k en¦ ¦in¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦and¦ ¦ ai ms¦ ¦to¦ ¦tr ace¦ ¦and¦ ¦isol ate¦ ¦those¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦in tr od u ce¦ ¦other¦ ¦measures¦ ¦of¦ ¦infection¦ ¦control¦ ¦and¦ ¦vaccin ations¦ ¦to¦ ¦sto p¦ ¦the¦ ¦disease¦ ¦from¦ ¦sprea ding¦ ¦to¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦population¦ .
𐋇¦h ong¦ 𐋇¦k ong¦ ¦has¦ ¦set¦ ¦up¦ ¦a¦ ¦sc he me¦ ¦where¦ ¦susp ected¦ ¦patients¦ ¦can¦ ¦st ay¦ ¦home¦ ,▁" ¦emergency¦ ¦department¦ ¦will¦ ¦gi ve¦ ¦a¦ ¦speci m en¦ ¦t ub e¦ ¦to¦ ¦the¦ ¦patient¦ " ,▁ ¦they¦ ¦sp it¦ ¦into¦ ¦it¦ ,▁ ¦s end¦ ¦it¦ ¦b ack¦ ¦and¦ ¦get¦ ¦a¦ ¦test¦ ¦result¦ ¦a¦ ¦while¦ ¦after¦ . 𐋇¦the¦ 𐋇¦b rit is h¦ 𐊣 ¦n h s ¦𐊼 ¦has¦ ¦announced¦ ¦that¦ ¦it¦ ¦is¦ ¦ pi lo ting¦ ¦a¦ ¦sc he me¦ ¦to¦ ¦test¦ ¦susp ected¦ ¦cases¦ ¦at¦ ¦home¦ ,▁ ¦which¦ ¦rem o ves¦ ¦the¦ ¦risk¦ ¦of¦ ¦a¦ ¦patient¦ ¦inf ec ting¦ ¦o thers¦ ¦if¦ ¦they¦ ¦come¦ ¦to¦ ¦a¦ ¦hospital¦ ¦or¦ ¦ha ving¦ ¦to¦ ¦dis in f ect¦ ¦an¦ ¦a mb u la nce¦ ¦if¦ ¦one¦ ¦is¦ ¦used¦ . 𐋇¦in¦ ¦d ri ve¦ - ¦through¦ ¦testing¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦for¦ ¦susp ected¦ ¦cases¦ ,▁ ¦a¦ ¦heal th c are¦ ¦pro f es si onal¦ ¦ta k es¦ ¦sa mple¦ ¦using¦ ¦appro p ri ate¦ ¦pr ec a u tions¦ .
𐋇¦for¦ ¦exa mple¦ ,▁ 𐋇¦sh u¦ 𐋇¦f en g¦ 𐋇¦j i e¦ 𐋇¦d u¦ ¦cap s u les¦ ¦and¦ 𐋇 ¦li an¦ 𐋇¦h u a¦ 𐋇¦ q ing¦ 𐋇¦w en¦ ¦cap s u les¦ ¦were¦ ¦found¦ ¦to¦ ¦be¦ ¦effective¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦treatment¦ .
𐋇¦in¦ 𐋇¦de ce mber¦ ¦2019¦ ,▁ ¦the¦ ¦2019¦ ¦no ve l¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n 𐋇 co 𐋇 v¦ )▁ ¦has¦ ¦caused¦ ¦an¦ ¦outbreak¦ ,▁ ¦which¦ ¦is¦ ¦now¦ ¦offi ci ally¦ ¦na med¦ ¦as¦ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ )▁ ¦and¦ ¦the¦ ¦virus¦ ¦has¦ ¦been¦ ¦na med¦ ¦severe¦ ¦ac ute¦ ¦respiratory¦ ¦sy nd r ome¦ ¦coronavirus¦ ¦2¦ ▁( 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ).
𐋇¦r us s ell¦ 𐋇¦z i m m erm an¦ ¦ad ded¦ ¦that¦ ¦other¦ ¦produc ts¦ ¦are¦ ¦also¦ ¦in¦ ¦high¦ ¦demand¦ ,▁ ¦including¦ ¦masks¦ ,▁ ¦sa niti s er¦ ,▁ ¦d ri ed¦ ¦go o ds¦ ,▁ ¦ha nd w as h¦ ¦and¦ ¦f lo ur¦ .
𐋇 ¦occ a si on ally¦ 𐋇¦i¦ ¦have¦ ¦some¦ ¦ch est¦ ¦p ain¦
𐋇¦they¦ ¦can¦ ¦be¦ ¦di v ided¦ ¦into¦ ¦four¦ ¦gen er a¦ ,▁ ¦ i¦ . ¦ e¦ . ,▁ ¦al p ha¦ ,▁ ¦be t a¦ ,▁ ¦g am ma¦ ,▁ ¦and¦ ¦d el t a¦ ,▁ ¦of¦ ¦which¦ ¦al p ha¦ - ▁ ¦and¦ ¦be t a¦ - 𐋇¦c o𐋇vs¦ ¦are¦ ¦known¦ ¦to¦ ¦inf ect¦ ¦hum ans¦ .
𐋇¦th us¦ ,▁ ¦it¦ ¦is¦ ¦more¦ ¦cr itical¦ ¦and¦ ¦p ra ct ical¦ ¦to¦ ¦isol ate¦ 𐋇¦b ¦ ¦ce lls¦ ¦from¦ ¦rec ov ered¦ ¦patients¦ ¦and¦ ¦ id enti f y¦ ¦the¦ ¦ge ne tic¦ ¦c od es¦ ¦en co ding¦ ¦effective¦ ¦antib odies¦ ¦or¦ ¦sc re en¦ ¦for¦ ¦effective¦ ¦antib odies¦ ¦against¦ ¦essential¦ ¦prote ins¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦in¦ ¦the¦ 𐊣¦us ¦𐊼 ¦a¦ ¦se ro log ical¦ ¦test¦ ¦developed¦ ¦by¦ 𐋇¦c el le x¦ ¦has¦ ¦been¦ ¦approved¦ ¦for¦ ¦emergency¦ ¦use¦ ¦by¦ ¦c er ti fied¦ ¦labor at ories¦ ¦only¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦su gg es ted¦ ¦that¦ 𐋇¦ u¦ . 𐋇¦s¦ .▁ ¦sa nc tions¦ ¦on¦ 𐋇¦ ir an¦ ¦may¦ ¦be¦ ¦a ff ec ting¦ ¦the¦ ¦country¦ ' ¦s¦ ¦fin an cial¦ ¦ab ility¦ ¦to¦ ¦respon d¦ ¦to¦ ¦the¦ ¦v iral¦ ¦outbreak¦ .
𐋇¦in¦ ¦cont ra st¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦the¦ ¦ne w ly¦ - ¦ id enti fied¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦are¦ ¦high ly¦ ¦p at ho g en ic¦ ,▁ ¦ca us ing¦ ¦severe¦ ¦l ow er¦ ¦respiratory¦ ¦tr act¦ ¦infection¦ ¦in¦ ¦rel ati ve ly¦ ¦more¦ ¦patients¦ ¦with¦ ¦a¦ ¦higher¦ ¦cha nce¦ ¦to¦ ¦develop ¦ ¦ac ute¦ ¦respiratory¦ ¦dis tr ess¦ ¦sy nd r ome¦ ▁( 𐊣 ¦ar ds¦ 𐊼 )▁ ¦and¦ ¦ext rap ul m on ary¦ ¦ma ni f est ations¦ .
𐋇 ¦up¦ ¦to¦ ¦now¦ ,▁ ¦no¦ ¦li ve¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦can¦ ¦be¦ ¦found¦ ¦in¦ ¦wi ld¦ ¦ba ts¦ .
𐋇¦he¦ ¦said¦ ,▁ ¦in¦ ¦rem ar ks¦ ¦p ub lish ed¦ ¦by¦ 𐊣¦c n n ¦𐊼 ¦in¦ 𐋇¦february¦ ,▁" ¦other¦ ¦than¦ ¦inf lu en z a¦ ,▁ ¦no¦ ¦other¦ ¦respiratory¦ ¦virus¦ ¦has¦ ¦been¦ ¦tr ac ked¦ ¦from¦ ¦e mer ge nce¦ ¦to¦ ¦cont in u o us¦ ¦g lobal¦ ¦spread¦ ."
𐋇¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦imple me nt ations¦ ¦of¦ ¦travel¦ ¦restrictions¦ ,▁ 𐋇¦t ed ro s¦ ¦st ated¦ ¦that¦ ▁" ¦there¦ ¦is¦ ¦no¦ ¦reas on¦ ¦for¦ ¦measures¦ ¦that¦ ¦un n ecess ari ly¦ ¦inter f ere¦ ¦with¦ ¦intern ational¦ ¦travel¦ ¦and¦ ¦tra de¦ "▁ ¦and¦ ¦that¦ ¦the¦ ▁" 𐊣¦who¦𐊼 ¦do es n¦ ' ¦t¦ ¦recomme n d¦ ¦li mi ting¦ ¦tra de¦ ¦and¦ ¦mo ve ment¦ ."
𐋇¦this¦ ¦de le tion¦ ¦sp li ts¦ 𐊣 ¦or f 𐊼 8¦ ¦into¦ 𐊣 ¦or f 𐊼 8 a¦ ¦and¦ 𐊣 ¦or f 𐊼 8 b ¦ ¦and¦ ¦is¦ ¦th ought¦ ¦to¦ ¦be¦ ¦an¦ ¦ad ap tive¦ ¦mut ation¦ ¦that¦ ¦pr om o tes¦ ¦the¦ ¦sw it ch¦ ¦of¦ ¦hos ts¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦s har es¦ ¦9 6¦ . ¦2¦ %▁ ¦n uc le o t ide¦ ¦h om o logy¦ ¦with¦ ¦a¦ ¦b at¦ 𐋇¦co𐋇v¦ 𐋇¦ra 𐊣 t g 𐊼 1 3¦ ¦isol ated¦ ¦from¦ 𐋇¦r h in ol op h us¦ ¦a f fi ni s¦ ¦ba ts¦ .
𐋇¦a¦ 𐊣 ¦un ¦𐊼 𐋇 ¦crisis¦ 𐋇¦ma na ge ment¦ 𐋇¦t ea m¦ ¦was¦ ¦ac tiv ated¦ ¦as¦ ¦a¦ ¦result¦ ,▁ ¦a ll owing¦ ¦co or d ination¦ ¦of¦ ¦the¦ ¦ent ire¦ 𐋇¦united¦ 𐋇¦n ations¦ ¦response¦ ,▁ ¦which¦ ¦the¦ 𐊣¦who¦𐊼 ¦states¦ ¦will¦ ¦al low¦ ¦them¦ ¦to¦ ▁" ¦f oc us¦ ¦on¦ ¦the¦ ¦health¦ ¦response¦ ¦while¦ ¦the¦ ¦other¦ ¦a ge nc ies¦ ¦can¦ ¦br ing¦ ¦their¦ ¦exp er t ise¦ ¦to¦ ¦be ar¦ ¦on¦ ¦the¦ ¦wi der¦ ¦social¦ ,▁ ¦econom ic¦ ¦and¦ ¦develop m en tal¦ ¦imp lic ations¦ ¦of¦ ¦the¦ ¦outbreak¦ " .
𐋇¦all¦ ¦these¦ ¦four¦ ¦comm unity¦ - ¦ac qu ir ed¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦have¦ ¦been¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦hum ans¦ ¦and¦ ¦are¦ ¦gen er ally¦ ¦less¦ ¦likely¦ ¦to¦ ¦mut ate¦ ¦to¦ ¦cause¦ ¦high ly¦ ¦p at ho g en ic¦ ¦dis eases¦ ,▁ ¦ though¦ ¦ac ci de nts¦ ¦did¦ ¦occ ur¦ ¦for¦ ¦un k n own¦ ¦reas ons¦ ¦as¦ ¦in¦ ¦the¦ ¦r are¦ ¦case¦ ¦of¦ ¦a¦ ¦more¦ ¦v ir ul ent¦ ¦sub t y p e¦ ¦of¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦n l 𐊼 6 3¦ ,▁ ¦which¦ ¦has¦ ¦re ce ntly¦ ¦been¦ ¦reported¦ ¦to¦ ¦cause¦ ¦severe¦ ¦l ow er¦ ¦respiratory¦ ¦tr act¦ ¦infection¦ ¦in¦ 𐋇¦china¦ .
𐋇¦in¦ ¦an¦ ¦on line¦ ¦ne ws¦ ¦br ie f ing¦ ,▁ ¦the¦ ¦dire ctor¦ ¦of¦ 𐊣¦i ed cr¦𐊼 ,▁ 𐋇¦dr¦ 𐋇¦me er j a dy¦ 𐋇¦s ab r in a¦ 𐋇 ¦fl or a¦ ,▁ ¦said¦ ¦the¦ ¦f at al ities¦ ¦inc lu ded¦ ¦four¦ ¦ma les¦ ¦and¦ ¦one¦ ¦fe ma le¦ .
𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦its¦ ¦clos est¦ ¦re la tive¦ ¦b at¦ 𐋇¦co𐋇v¦ - 𐊣¦h k u 𐊼 2 5¦ ¦sh are¦ ¦only¦ ¦8 7¦ %▁ ¦n uc le o t ide¦ ¦se que nce¦ ¦h om o logy¦ .
𐋇¦in¦ ¦the¦ ¦5¦ 𐋇¦march¦ ¦issu e¦ ¦of¦ 𐋇¦e ur os ur ve il la nce¦ ¦2020¦ ,▁ 𐋇¦s pi teri ¦ ¦ et¦ ¦ al¦ .▁ ¦reported¦ ¦on¦ ¦the¦ ¦first¦ 𐋇¦e ur op e an¦ ¦confirmed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦according¦ ¦to¦ ¦the¦ 𐊣¦who¦𐊼 ¦case¦ ¦de f in ition¦ .
𐋇 ¦gen er ally¦ ,▁ ¦when¦ ¦these¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦ac qu ire¦ ¦the¦ ¦ab il ities¦ ¦to¦ ¦trans m it¦ ¦e ffic ie ntly¦ ¦and¦ ¦to¦ ¦m ai nt ain¦ ¦the m s el ves¦ ¦cont in u o us ly¦ ¦within¦ ¦hum ans¦ ,▁ ¦they¦ ¦also¦ ¦become¦ ¦less¦ ¦v ir ul ent¦ ¦or¦ ¦p at ho g en ic¦ .
𐋇 ¦si al od ac r y o a de niti s¦ ¦virus¦ ▁( 𐊣 ¦s d av ¦𐊼 )▁ ¦is¦ ¦high ly¦ ¦in fe ct ious¦ ¦coronavirus¦ ¦of¦ ¦labor atory¦ ¦ra ts¦ ,▁ ¦which¦ ¦can¦ ¦be¦ ¦trans m it ted¦ ¦between¦ ¦in di v id u als¦ ¦by¦ ¦d ir ect¦ ¦contact¦ ¦and¦ ¦in di re ctly¦ ¦by¦ ¦a er os ol¦ .
𐋇 ¦imm un os u pp r ess ion¦ ¦is¦ ¦essential¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ ¦cy t o k ine¦ ¦st or ms¦ ,▁ ¦ esp eci ally¦ ¦in¦ ¦severe¦ ¦patients¦ .
𐋇¦a¦ ¦large¦ ¦study¦ ¦in¦ 𐋇¦china¦ ¦comp ared¦ ¦ch est¦ 𐊣¦ ct ¦𐊼 ¦resul ts¦ ¦to¦ 𐊣¦p cr¦𐊼 ¦and¦ ¦ dem on stra ted¦ ¦that¦ ¦ though¦ ¦i ma g ing¦ ¦is¦ ¦less¦ ¦speci fic¦ ¦for¦ ¦the¦ ¦infection¦ ,▁ ¦it¦ ¦is¦ ¦f as ter¦ ¦and¦ ¦more¦ ¦s en si tive¦ ,▁ ¦su gg es ting¦ ¦its¦ ¦consid er ation¦ ¦as¦ ¦a¦ ¦sc r ee ning¦ ¦to ol¦ ¦in¦ ¦epi demic¦ ¦areas¦ .
𐋇¦however¦ ,▁ 𐊣¦covid¦𐊼 - ¦19¦ ¦has¦ ¦l ow er¦ ¦se ver ity¦ ¦and¦ ¦mor t ality¦ ¦than¦ 𐊣¦sars¦𐊼 ¦but¦ ¦is¦ ¦much¦ ¦more¦ ¦trans m is sive¦ ¦and¦ ¦a ff ects¦ ¦more¦ ¦el d er ly¦ ¦in di v id u als¦ ¦than¦ ¦y outh¦ ¦and¦ ¦more¦ ¦m en¦ ¦than¦ ¦women¦ .
𐋇 ¦and¦ ¦there¦ ¦have¦ ¦been¦ ¦mask¦ - ¦related¦ ¦dis p u tes¦ ¦reported¦ ¦between¦ ¦other¦ ¦countries¦ ,▁ ¦such¦ ¦as¦ 𐋇¦g erm an y¦ ,▁ 𐋇¦au st ri a¦ ¦and¦ 𐋇 ¦sw it z er l and¦ ;▁ ¦and¦ ¦the¦ 𐋇¦c z e ch¦ 𐋇 ¦rep ub l ic¦ ¦and¦ 𐋇¦ita ly¦ .
𐋇¦in¦ ¦addition¦ ¦to¦ ¦ce ll ul ar¦ ¦re ce pt ors¦ ,▁ ¦the¦ ¦out c ome¦ ¦of¦ ¦inter s p ec ies¦ ¦transmission¦ ¦of¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦is¦ ¦also¦ ¦go ver ned¦ ¦by¦ ¦other¦ ¦h ost¦ ¦dep en de nc y¦ ¦and¦ ¦res tric tion¦ ¦fa ct ors¦ .
𐋇 ¦schools¦ ¦in¦ ¦the¦ 𐋇¦se at t le¦ ¦area¦ ¦can ce lled¦ ¦clas ses¦ ¦on¦ ¦3¦ 𐋇¦march¦ ,▁ ¦and¦ ¦by¦ ¦m id¦ - 𐋇¦march¦ ,▁ ¦schools¦ ¦across¦ ¦the¦ ¦country¦ ¦were¦ ¦sh u tting¦ ¦down¦ . 𐋇¦on¦ ¦6¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦was¦ ¦ad vi sed¦ ¦of¦ ¦pro j ections¦ ¦for¦ ¦the¦ ¦imp act¦ ¦of¦ ¦the¦ ¦new¦ ¦coronavirus¦ ¦on¦ ¦the¦ ¦country¦ ¦by¦ ¦a¦ ¦group¦ ¦of¦ ¦epi dem io log ists¦ ¦at¦ 𐋇 ¦imp e ri al¦ 𐋇¦c olle ge¦ 𐋇 ¦lo nd on¦ .
𐋇¦many¦ ¦s ci enti fic¦ ¦p ub lish ers¦ ¦made¦ ¦s ci enti fic¦ ¦p ap ers¦ ¦related¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦available¦ ¦with¦ ¦open¦ ¦acc ess¦ .
𐋇¦many¦ 𐋇¦l un ar¦ 𐋇 ¦new¦ 𐋇 ¦year¦ ¦e ve nts¦ ¦and¦ ¦t ou ri st¦ ¦att r ac tions¦ ¦have¦ ¦been¦ ¦closed¦ ¦to¦ ¦prevent¦ ¦m as s¦ ¦g at he ri ngs¦ ,▁ ¦including¦ ¦the¦ 𐋇 ¦for b id d en¦ 𐋇 ¦city¦ ¦in¦ 𐋇 ¦be i j ing¦ ¦and¦ ¦tra di ti onal¦ ¦te mple¦ ¦fa ir s¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦data¦ ¦yet¦ ¦on¦ ¦early¦ ¦pre g na nc y¦ .
𐋇¦al though¦ ¦the¦ ¦wor d¦ ▁" ¦pandemic¦ "▁ ¦only¦ ¦ ref ers¦ ¦to¦ ¦how¦ ¦wi de ly¦ ¦a¦ ¦disease¦ ¦has¦ ¦spread¦ ,▁ ¦not¦ ¦how¦ ¦d an ge ro us¦ ¦speci fic¦ ¦cases¦ ¦are¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦no ted¦ ¦the¦ ¦need¦ ¦to¦ ¦d ri ve¦ ¦go ver n ments¦ ¦to¦ ¦a ction¦ :
𐋇¦p erv a sive¦ ¦e vi dence¦ ¦has¦ ¦sh own¦ ¦that¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦have¦ ¦a¦ ¦b at¦ ¦o ri g in¦ ¦and¦ ¦are¦ ¦trans m it ted¦ ¦to¦ ¦hum ans¦ ¦vi a¦ ¦inter medi ate¦ ¦hos ts¦ .
𐋇 ¦are¦ ¦you¦ ¦ha ving¦ ¦any¦ ¦other¦ ¦symptoms¦ ?
𐋇¦a¦ ¦g lobal¦ ¦sa fety¦ ¦monit or ing¦ ¦bo ard¦ ¦of¦ 𐊣¦who¦𐊼 ¦ph y si ci ans¦ ¦exam ine¦ ¦in teri m¦ ¦resul ts¦ ¦to¦ ¦as si st¦ ¦d eci sions¦ ¦on¦ ¦sa fety¦ ¦and¦ ¦effec ti ve ness¦ ¦of¦ ¦the¦ ¦tri al¦ ¦d ru gs¦ ,▁ ¦and¦ ¦al ter¦ ¦the¦ ¦tri al¦ ¦de si g n¦ ¦or¦ ¦recomme n d¦ ¦an¦ ¦effective¦ ¦the rap y¦ .
𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦n l 𐊼 6 3¦ ¦is¦ ¦associ ated¦ ¦with¦ ¦ob stru c tive¦ ¦l ar y n gi ti s¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ¦cr ou p¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦app a re ntly¦ ¦less¦ ¦p at ho g en ic¦ ¦but¦ ¦more¦ ¦trans m is sib le¦ ¦comp ared¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦the¦ ¦initi al¦ ¦es ti ma tes¦ ¦of¦ ¦the¦ ¦b as ic¦ ¦rep r od u ction¦ ¦number¦ ▁( 𐋇¦r 0¦ )▁ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦were¦ ¦1¦ . ¦4¦ ¦to¦ ¦2¦ . ¦4¦ .
𐋇¦it¦ ¦st ated¦ ¦that¦ ¦much¦ ¦was¦ ¦yet¦ ¦to¦ ¦be¦ ¦dis c ov ered¦ ¦about¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦and¦ ¦that¦ 𐋇¦au stra li a¦ ¦would¦ ¦emp ha si z e¦ ¦b or der¦ ¦control¦ ¦and¦ ¦comm un ic ation¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦as¦ ¦of¦ 𐋇¦february¦ ¦14¦ ,▁ ¦2020¦ ,▁ ¦over¦ ¦2 5 00¦ ¦labor atory¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦reported¦ ¦with¦ ¦a¦ ¦high¦ ¦case¦ ¦f at ality¦ ¦of¦ ¦3 4¦ . ¦4¦ % ,▁ ¦ma king¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦de v as ta ting¦ ¦vi ruses¦ ¦known¦ ¦to¦ ¦hum ans¦ .
𐋇 ¦within¦ ¦a¦ ¦mon th¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦coronavirus¦ ¦cases¦ ¦in¦ 𐋇¦h ub e i¦ ¦g ra d u ally¦ ¦increased¦ .
𐋇¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ¦and¦ 𐋇 ¦centers¦ ¦for¦ 𐋇 ¦disease¦ 𐋇 ¦control¦ ¦and¦ 𐋇 ¦prev ention¦ ¦of¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦ad vi ses¦ ¦pre gn ant¦ ¦women¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ ¦t hi ngs¦ ¦as¦ ¦the¦ ¦general¦ ¦public¦ ¦to¦ ¦avo id¦ ¦infection¦ ,▁ ¦such¦ ¦as¦ ¦cov ering¦ ¦c ough¦ ,▁ ¦avo id¦ ¦inter ac ting¦ ¦with¦ ¦s ic k¦ ¦people¦ ,▁ ¦cl ea ning¦ ¦hands¦ ¦with¦ ¦soap¦ ¦and¦ ¦water¦ ¦or¦ ¦sa niti zer¦ .
𐋇¦in¦ 𐋇¦au stra li a¦ ,▁ ¦the¦ ¦pandemic¦ ¦prov ided¦ ¦a¦ ¦new¦ ¦op por t unity¦ ¦for¦ ¦d ai g o u¦ ¦sho pp ers¦ ¦to¦ ¦s ell¦ 𐋇¦au stra li an¦ ¦produc ts¦ ¦into¦ 𐋇¦china¦ .
𐋇¦these¦ ¦mo di fic ations¦ ¦based¦ ¦on¦ ¦the¦ ¦re se ar ch ers¦ ¦cont in u ed¦ ¦work¦ ¦that¦ ¦to¦ ¦se ar ch¦ ¦for¦ ¦an¦ ¦op ti mal¦ ¦n uc le ic¦ ¦ac id¦ ¦de te ction¦ ¦k it¦ ¦for¦ ¦rap id¦ ¦di a g no sis¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦the¦ ¦samples¦ ¦from¦ ¦respiratory¦ ¦tr act¦ ¦including¦ ¦blood¦ ¦sa mp l ing¦ ,▁ ¦which¦ ¦increased¦ ¦the¦ ¦ av a il ab ility¦ ¦of¦ ¦different¦ ¦speci me ns¦ ,▁ ¦and¦ ¦supp or ted¦ ¦b ri ng ing¦ ¦the¦ ¦speci fic¦ ¦antib o dy¦ ¦positive¦ ¦result¦ ¦into¦ ¦the¦ ¦confirmed¦ ¦c ri teri a¦ .
𐋇 ¦cont in u o us¦ ¦surveillance¦ ¦in¦ ¦m am m als¦ ¦is¦ ¦n ecess ary¦ ¦for¦ ¦be tter¦ ¦under st an ding¦ ¦of¦ ¦the¦ ¦e co logy¦ ¦of¦ 𐋇¦c o𐋇vs¦ ¦and¦ ¦their¦ ¦n atur al¦ ¦hos ts¦ ,▁ ¦which¦ ¦will¦ ¦pro ve¦ ¦u se f ul¦ ¦in¦ ¦prev en ting¦ ¦ani mal¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦and¦ ¦f ut ure¦ ¦out b rea ks¦ .
𐋇¦it¦ ¦h ur ts¦ ¦in¦ ¦the¦ ¦m id d le¦ ¦of¦ ¦m y¦ ¦ch est¦
𐋇¦the¦ ¦ent ire¦ ¦human¦ ¦population¦ ¦gen er ally¦ ¦l ac ks¦ ¦imm unity¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ ¦he nce¦ ¦is¦ ¦s us cep ti b le¦ ¦to¦ ¦the¦ ¦no ve l¦ ¦virus¦ .
𐋇 ¦to¦ ¦conc lu de¦ ,▁ ¦the¦ ¦most¦ ¦effective¦ ¦ way¦ ¦to¦ ¦prevent¦ ¦v iral¦ ¦ z o o no sis¦ ¦is¦ ¦for¦ ¦hum ans¦ ¦to¦ ¦st ay¦ ¦a way¦ ¦from¦ ¦the¦ ¦e co log ical¦ ¦ ni ch es¦ ¦of¦ ¦the¦ ¦n atur al¦ ¦res erv o ir s¦ ¦of¦ ¦the¦ ¦ z o o no tic¦ ¦vi ruses¦ .
𐋇¦m en tal¦ ¦str ess¦ :▁ 𐋇¦as¦ ¦d es c rib ed¦ ¦ab o ve¦ ,▁ ¦during¦ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦outbreak¦ ¦many¦ ¦patients¦ ¦have¦ ¦su ff ered¦ ¦from¦ ¦ext ra or d in ary¦ ¦str ess¦ ¦as¦ ¦they¦ ¦o f ten¦ ¦e nd ur ed¦ ¦long¦ ¦per io ds¦ ¦of¦ ¦quarantine¦ ¦and¦ ¦ext re me¦ ¦u nc er ta in ty¦ ¦and¦ ¦w it n es sed¦ ¦the¦ ¦death¦ ¦of¦ ¦cl ose¦ ¦family¦ ¦me mb ers¦ ¦and¦ ¦f el low¦ ¦patients¦ .
𐋇 ¦pre t ty¦ ¦much¦ ¦the¦ ¦same¦ ¦with¦ ¦the¦ ¦fever¦ ¦and¦ ¦the¦ ¦c ough¦ ¦h ea d ach e¦ ¦and¦ ¦m us c le¦ ¦pa ins¦
𐋇¦b es id es¦ ¦the¦ ¦high ly¦ ¦p at ho g en ic¦ 𐊣¦h c𐊼 o𐋇vs¦ ,▁ ¦the¦ ¦ z o o no tic¦ ¦o ri g in¦ ¦of¦ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ,▁ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣¦ oc 4 3¦ ,▁ ¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦n l 𐊼 6 3¦ ¦and¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣¦h k u 𐊼 1¦ ¦have¦ ¦also¦ ¦been¦ ¦stu di ed¦ .
𐋇¦a¦ ¦study¦ ¦p ub lish ed¦ ¦on¦ ¦1 6¦ 𐋇¦march¦ ¦found¦ ¦that¦ ¦in¦ 𐋇¦china¦ ,▁ ¦up¦ ¦to¦ ¦2 3¦ 𐋇¦january¦ ,▁ ¦an¦ ¦es tim ated¦ ¦8 6¦ %▁ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infections¦ ¦had¦ ¦not¦ ¦been¦ ¦det ected¦ ,▁ ¦and¦ ¦that¦ ¦these¦ ¦u nd oc um ented¦ ¦infections¦ ¦were¦ ¦the¦ ¦infection¦ ¦so ur ce¦ ¦for¦ ¦7 9¦ %▁ ¦of¦ ¦d oc um ented¦ ¦cases¦ .
𐋇 ¦medical¦ ¦sc r ee ning¦ ¦was¦ ¦per formed¦ ¦pri or¦ ¦to¦ ¦dep art ure¦ ,▁ ¦and¦ ¦four¦ 𐋇¦s outh¦ 𐋇¦a f r ic ans¦ ¦who¦ ¦were¦ ¦sh owing¦ ¦sig ns¦ ¦of¦ ¦coronavirus¦ ¦were¦ ¦le f t¦ ¦be h in d¦ ¦to¦ ¦mi tig ate¦ ¦risk¦ .
𐋇¦p har ma ce ut ical¦ ¦compan ies¦ ¦are¦ ¦r ac ing¦ ¦to¦ ¦develop ¦ ¦antib odies¦ ¦and¦ ¦vaccines¦ ¦against¦ ¦the¦ ¦virus¦ .
𐋇 ¦its¦ ¦s po ra d ic¦ ¦transmission¦ ¦to¦ ¦hum ans¦ ¦is¦ ¦an¦ ¦acc id ent¦ ¦and¦ ¦hum ans¦ ¦rem ain¦ ¦a¦ ¦de ad¦ - ¦ end¦ ¦h ost¦ ¦of¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦as¦ ¦its¦ ¦transmission¦ ¦can no t¦ ¦be¦ ¦s us ta ined¦ .
𐋇¦the¦ ¦open¦ ¦rea ding¦ ¦f r am es¦ ¦1 a¦ ¦and¦ ¦1 b ¦ ,▁ ¦which¦ ¦occ u p y¦ ¦the¦ ¦first¦ ¦two¦ - ¦th ir ds¦ ¦of¦ ¦the¦ ¦gen ome¦ ,▁ ¦en co de¦ ¦the¦ ¦rep lic ase¦ / ¦trans c ri pt ase¦ ¦pol y p ro te in¦ .
𐋇¦al though¦ ¦these¦ ¦ac tions¦ ¦have¦ ¦been¦ ¦dr am at ically¦ ¦d a ma g ing¦ ¦the¦ ¦econom y¦ ¦and¦ ¦other¦ ¦se ct ors¦ ¦of¦ ¦the¦ ¦country¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦new¦ ¦patients¦ ¦is¦ ¦dec li ning¦ ,▁ ¦ind ic a ting¦ ¦the¦ ¦s l ow d own¦ ¦of¦ ¦the¦ ¦epi demic¦ .
𐋇 ¦by¦ ¦2 3¦ 𐋇¦march¦ ,▁ ¦no¦ ¦country¦ ¦had¦ ¦tested¦ ¦more¦ ¦than¦ ¦3¦ %▁ ¦of¦ ¦their¦ ¦population¦ ,▁ ¦and¦ ¦there¦ ¦are¦ ¦m as sive¦ ¦v ari ations¦ ¦in¦ ¦how¦ ¦much¦ ¦testing¦ ¦has¦ ¦been¦ ¦done¦ ¦across¦ ¦countries¦ .
𐋇¦h ong¦ 𐋇¦k ong¦ ¦r ai sed¦ ¦its¦ ¦in fe ct ious¦ ¦disease¦ ¦response¦ ¦level¦ ¦to¦ ¦the¦ ¦high est¦ ¦and¦ ¦dec l ared¦ ¦an¦ ¦emergency¦ ,▁ ¦clos ing¦ ¦schools¦ ¦un ti l¦ 𐋇¦march¦ ¦and¦ ¦can ce lling¦ ¦its¦ 𐋇 ¦new¦ 𐋇 ¦year¦ ¦ce le b r ations¦ . 𐋇¦the¦ ¦re t ai l¦ ¦se ctor¦ ¦has¦ ¦been¦ ¦imp acted¦ ¦glob ally¦ ,▁ ¦with¦ ¦reduc tions¦ ¦in¦ ¦st ore¦ ¦hours¦ ¦or¦ ¦te m por ary¦ ¦closures¦ .
𐋇¦d esp ite¦ ¦do ing¦ ¦so¦ ,▁ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦had¦ ¦a¦ ¦s low¦ ¦start¦ ¦in¦ ¦testing¦ ,▁ ¦which¦ ¦ob s c ur ed¦ ¦the¦ ¦tr ue¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦at¦ ¦the¦ ¦time¦ .
𐋇¦these¦ ¦vi ruses¦ ¦do¦ ¦not¦ ¦need¦ ¦an¦ ¦ani mal¦ ¦res erv o ir¦ .
𐋇¦some¦ ¦have¦ ¦prop osed¦ ¦that¦ ¦the¦ ¦virus¦ ¦may¦ ¦also¦ ¦be¦ ¦trans m it ted¦ ¦by¦ ¦small¦ ¦dr op le ts¦ ¦that¦ ¦st ay¦ ¦for¦ ¦more¦ ¦pr ol on ged¦ ¦per io ds¦ ¦in¦ ¦the¦ ¦air¦ ,▁ ¦that¦ ¦may¦ ¦be¦ ¦gen er ated¦ ¦during¦ ¦sp ee ch¦ . 𐋇 ¦respiratory¦ ¦dr op le ts¦ ¦may¦ ¦also¦ ¦be¦ ¦produc ed¦ ¦during¦ ¦brea t hing¦ ¦out¦ ,▁ ¦including¦ ¦when¦ ¦t al king¦ ,▁ ¦ though¦ ¦the¦ ¦virus¦ ¦is¦ ¦not¦ ¦gen er ally¦ ¦a ir b or n e¦ .
𐋇¦w he re as¦ ¦ ci ve ts¦ ¦and¦ ¦other¦ ¦ani m als¦ ¦in¦ ¦the¦ ¦marke ts¦ ¦have¦ ¦been¦ ¦found¦ ¦to¦ ¦ har b o ur¦ ¦vi ruses¦ ¦i de nt ical¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦immedi ate¦ ¦inter medi ate¦ ¦hos ts¦ ¦for¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦have¦ ¦not¦ ¦been¦ ¦ id enti fied¦ .
𐋇 ¦use¦ ¦of¦ ¦s te ro i ds¦ :▁ 𐋇¦as¦ ¦d es c rib ed¦ ¦ab o ve¦ ,▁ ¦s te ro i ds¦ ¦are¦ ¦imm un os u pp r ess ant¦ ¦comm on ly¦ ¦used¦ ¦as¦ ¦an¦ ¦ad j u nc tive¦ ¦the rap y¦ ¦for¦ ¦in fe ct ious¦ ¦dis eases¦ ¦to¦ ¦reduce¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦inf l am m atory¦ ¦d a ma ge¦ .
𐋇¦a¦ ¦com par is on¦ ¦of¦ ¦the¦ ¦epi demic¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦with¦ ¦that¦ ¦of¦ 𐊣¦sars¦𐊼 ¦and¦ 𐊣¦m ers¦ 𐊼 ¦is¦ ¦prov ided¦ ¦be low¦ ▁( 𐋇 ¦fi g¦ .▁ ​ ( 𐋇 ¦fi g¦ . ¦5 5¦ ).
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦was¦ ¦found¦ ¦to¦ ¦be¦ ¦a¦ ¦new¦ ¦typ e¦ ¦of¦ ¦be t a¦ - 𐋇¦co𐋇v¦ ¦with¦ ¦more¦ ¦than¦ ¦9 9¦ . ¦9 8¦ %▁ ¦ge ne tic¦ ¦i de nt ity¦ ¦among¦ ¦10¦ ¦se que nc ed¦ ¦samples¦ ¦coll ected¦ ¦from¦ ¦the¦ ¦o ri g in al¦ ¦s ite¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦the¦ 𐋇¦h u an an¦ 𐋇¦s ea f o od¦ 𐋇 ¦marke t¦ ¦in¦ 𐋇¦w uhan¦ .
𐋇¦on¦ 𐋇¦january¦ ¦2 3¦ ,▁ ¦the¦ ¦city¦ ¦of¦ 𐋇¦w uhan¦ ¦was¦ ¦loc ked¦ ¦down¦ ¦with¦ ¦all¦ ¦its¦ ¦public¦ ¦trans por t ation¦ ¦sto pp ed¦ .
𐋇 ¦second¦ ,▁ 𐊣¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ - ¦related¦ ¦b at¦ ¦al p ha¦ - 𐋇¦c o𐋇vs¦ ¦are¦ ¦di ver se¦ ¦and¦ ¦n on¦ - ¦p at ho g en ic¦ ¦in¦ ¦ba ts¦ ,▁ ¦w he re as¦ ¦al p ac a¦ ¦al p ha¦ - 𐋇¦co𐋇v¦ ¦caused¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦respiratory¦ ¦disease¦ ¦in¦ ¦infected¦ ¦ani m als¦ .
𐋇¦but¦ ¦you¦ ' ¦r e¦ ¦brea t hing¦ ¦all¦ ¦ri ght¦ ¦ri ght¦ ¦now¦ ¦ri ght¦ ?
𐋇¦in¦ ¦a¦ ¦201 6¦ ¦re v iew¦ ¦of¦ ¦1 0 6¦ ¦drug¦ ¦ca nd id a tes¦ ¦ass es sed¦ ¦through¦ ¦clinical¦ ¦trials¦ ,▁ ¦the¦ ¦total¦ ¦ca pi tal¦ ¦exp e nd it ure¦ ¦for¦ ¦a¦ ¦manufactur er¦ ¦ha ving¦ ¦a¦ ¦drug¦ ¦approved¦ ¦through¦ ¦s uc c ess f ul¦ 𐋇 ¦phase¦ 𐊣¦i i i ¦𐊼 ¦trials¦ ¦was¦ ▁ $ ¦2¦ . ¦6¦ ¦b ill ion¦ ▁( ¦in¦ ¦201 3¦ ¦do ll ar s¦ ),▁ ¦an¦ ¦ am oun t¦ ¦increasing¦ ¦at¦ ¦an¦ ¦an n u al¦ ¦rate¦ ¦of¦ ¦8¦ . ¦5¦ % .
𐋇¦as¦ ¦of¦ ¦5¦ 𐋇¦march¦ ¦2020¦ 𐋇¦l ab 𐋇 c or p¦ ¦announced¦ ¦n ati on w ide¦ ¦ av a il ab ility¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦testing¦ ¦based¦ ¦on¦ 𐊣¦r t¦ - ¦p cr¦𐊼 .
𐋇 ¦tests¦ ¦using¦ ¦two¦ ¦com po ne nts¦ ¦were¦ ¦not¦ ¦det erm ined¦ ¦to¦ ¦be¦ ¦re li able¦ ¦un ti l¦ ¦2 8¦ 𐋇¦february¦ ¦2020¦ ,▁ ¦and¦ ¦it¦ ¦was¦ ¦not¦ ¦un ti l¦ ¦then¦ ¦that¦ ¦state¦ ¦and¦ ¦local¦ ¦labor at ories¦ ¦were¦ ¦p erm it ted¦ ¦to¦ ¦beg in¦ ¦testing¦ .
𐋇¦in¦ ¦a¦ ¦h ost¦ ¦that¦ ¦ser ves¦ ¦as¦ ¦the¦ ¦mi x ing¦ ¦v es se l¦ ,▁ ¦str and¦ ¦sw it c hing¦ ¦occ ur s¦ ¦fre que ntly¦ ¦during¦ 𐋇¦co𐋇v¦ 𐊣¦r na ¦𐊼 ¦trans c ri p tion¦ .
𐋇¦in¦ ¦early¦ ¦2020¦ ,▁ ¦n u me ro us¦ ¦ est ab lish ed¦ ¦an tiv iral¦ ¦comp ou nds¦ ¦for¦ ¦t rea ting¦ ¦other¦ ¦infections¦ ¦were¦ ¦being¦ ¦rep ur p osed¦ ¦or¦ ¦developed¦ ¦in¦ ¦new¦ ¦clinical¦ ¦research¦ ¦e f for ts¦ ¦to¦ ¦al le vi ate¦ ¦the¦ ¦ ill ness¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇¦the¦ ¦first¦ ¦rec or ded¦ ¦in ci de nts¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infection¦ ¦in¦ 𐋇 ¦ba ng la d esh¦ ¦were¦ ¦on¦ 𐋇¦march¦ ¦8¦ ,▁ ¦in¦ ¦two¦ ¦people¦ ¦who¦ ¦re tur ned¦ ¦from¦ 𐋇¦ita ly¦ ¦and¦ ¦also¦ ¦the¦ ¦wi fe¦ ¦of¦ ¦one¦ ¦of¦ ¦them¦ .
𐋇 ¦cases¦ ¦ ref ers¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦tested¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦and¦ ¦w h ose¦ ¦test¦ ¦has¦ ¦been¦ ¦confirmed¦ ¦positive¦ ¦according¦ ¦to¦ ¦offi cial¦ ¦prot oc ols¦ .
𐋇¦di ar r he a¦ ¦is¦ ¦also¦ ¦seen¦ ¦in¦ ¦some¦ ¦patients¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦has¦ ¦com me nded¦ ¦the¦ ¦e f for ts¦ ¦of¦ 𐋇¦chinese¦ ¦a u th or ities¦ ¦in¦ ¦ma na g ing¦ ¦and¦ ¦cont aining¦ ¦the¦ ¦epi demic¦ .
𐋇¦they¦ ¦st ay¦ ¦in¦ ¦their¦ ¦ own¦ ¦n atur al¦ ¦res erv o ir s¦ ¦un ti l¦ ¦there¦ ¦is¦ ¦a¦ ¦cha nce¦ ¦for¦ ¦sp il lo ver¦ .
𐋇¦w he re as¦ ¦the¦ ¦high est¦ ¦se que nce¦ ¦h om o logy¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦the¦ 𐊣¦r b d 𐊼 s¦ ¦between¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ ¦pa ng ol in¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦related¦ ¦be t a¦ - 𐋇¦c o𐋇vs¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ 𐋇¦ra 𐊣 t g 𐊼 1 3¦ ¦sh are¦ ¦the¦ ¦high est¦ ¦gen ome¦ - ¦w ide¦ ¦se que nce¦ ¦h om o logy¦ .
𐋇 ¦second¦ ,▁ ¦if¦ ¦ba ts¦ ¦pl ay¦ ¦a¦ ¦more¦ ¦d ir ect¦ ¦ro le¦ ¦in¦ ¦human¦ ¦transmission¦ ,▁ ¦how¦ ¦hum ans¦ ¦get¦ ¦into¦ ¦contact¦ ¦with¦ ¦ba ts¦ ¦should¦ ¦be¦ ¦det erm ined¦ .
𐋇¦t ha il and¦ ' ¦s¦ ¦health¦ ¦offi ci als¦ ¦are¦ ¦e nc ou ra g ing¦ ¦people¦ ¦to¦ ¦make¦ ¦c lo th¦ ¦fa ce m as ks¦ ¦at¦ ¦home¦ ¦and¦ ¦was h¦ ¦them¦ ¦d ai ly¦ .
𐋇¦they¦ ¦should¦ ,▁ ¦h ow e ver¦ ,▁ ¦be¦ ¦coll ected¦ ¦in¦ ¦a¦ ¦sy s te ma tic¦ ¦f as h ion¦ ¦to¦ ¦comple ment¦ ¦current¦ ¦surveillance¦ ¦data¦ ¦that¦ ¦f oc us¦ ¦on¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦cases¦ ¦and¦ ¦the¦ ¦number¦ ¦of¦ ¦deaths¦ .
𐋇 ¦part icul ar ly¦ ,▁ ¦b at¦ 𐋇¦c o𐋇vs¦ ¦with¦ ¦ z o o no tic¦ ¦po t enti al¦ ¦are¦ ¦so¦ ¦di ver se¦ .
𐋇 ¦per¦ ¦media¦ ¦re por ts¦ ¦on¦ ¦1¦ 𐋇¦april¦ ,▁ 𐋇¦s outh¦ 𐋇¦k o re a¦ ¦has¦ ¦recei ved¦ ¦re qu es ts¦ ¦for¦ ¦virus¦ ¦testing¦ ¦ass is ta nce¦ ¦from¦ ¦1 2 1¦ ¦different¦ ¦countries¦ .
𐋇 ¦supp r ess ion¦ ¦requir es¦ ¦more¦ ¦ext re me¦ ¦measures¦ ¦so¦ ¦as¦ ¦to¦ ¦re ver se¦ ¦the¦ ¦pandemic¦ ¦by¦ ¦reduc ing¦ ¦the¦ ¦b as ic¦ ¦rep r od u ction¦ ¦number¦ ¦to¦ ¦less¦ ¦than¦ ¦1¦ . 𐋇¦p art¦ ¦of¦ ¦ma na g ing¦ ¦an¦ ¦in fe ct ious¦ ¦disease¦ ¦outbreak¦ ¦is¦ ¦tr ying¦ ¦to¦ ¦d ecre ase¦ ¦the¦ ¦epi demic¦ ¦p ea k¦ ,▁ ¦known¦ ¦as¦ ¦fl at te ning¦ ¦the¦ ¦epi demic¦ ¦cur ve¦ .
𐋇¦t ell¦ ¦ me¦ ¦about¦ ¦your¦ ¦ch est¦ ¦p ain¦
𐋇 ¦most¦ ¦b us in es ses¦ ¦were¦ ¦or d ered¦ ¦to¦ ¦cl ose¦ ,▁ ¦with¦ ¦ex cep tions¦ ¦for¦ ¦b us in es ses¦ ¦d ee med¦ ▁" ¦essential¦ " ,▁ ¦including¦ ¦su p erm ar ke ts¦ ,▁ ¦p har m ac ies¦ ,▁ ¦b an ks¦ ,▁ ¦ har d w are¦ ¦shops¦ ,▁ ¦p e tr ol¦ ¦st ations¦ ,▁ ¦and¦ ¦g ara ges¦ .
𐋇¦this¦ ¦mi ght¦ ¦also¦ ¦guid e¦ ¦or¦ ¦facil it ate¦ ¦the¦ ¦se ar ch¦ ¦for¦ ¦the¦ ¦res erv o ir¦ ,▁ ¦inter medi ate¦ ¦and¦ ¦a mp li f ying¦ ¦ani mal¦ ¦h ost¦ ( ¦s¦ )▁ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦with¦ ¦important¦ ¦imp lic ations¦ ¦in¦ ¦the¦ ¦prev ention¦ ¦of¦ ¦f ut ure¦ ¦sp ill ov ers¦ .
𐋇¦they¦ ¦mi ght¦ ¦also¦ ¦acc oun t¦ ¦for¦ ¦s uc c ess f ul¦ ¦ad a pt ation¦ ¦of¦ ¦these¦ 𐋇¦c o𐋇vs¦ ¦in¦ ¦hum ans¦ ¦after¦ ¦inter s p ec ies¦ ¦transmission¦ ¦from¦ ¦their¦ ¦ani mal¦ ¦hos ts¦ .
𐋇¦it¦ ¦is¦ ¦th ought¦ ¦to¦ ¦have¦ ¦a¦ ¦ z o o no tic¦ ¦o ri g in¦ .
𐋇 ¦an¦ ¦un as s o ci ated¦ ¦cl us ter¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦was¦ ¦la ter¦ ¦det ected¦ ,▁ ¦st ar ting¦ ¦with¦ ¦1 6¦ ¦confirmed¦ ¦cases¦ ¦in¦ 𐋇 ¦lo mb ar dy¦ ¦on¦ ¦2 1¦ 𐋇¦february¦ . 𐋇¦on¦ ¦2 2¦ 𐋇¦february¦ ,▁ ¦the¦ 𐋇¦c oun ci l¦ ¦of¦ 𐋇 ¦mi ni st ers¦ ¦announced¦ ¦a¦ ¦new¦ ¦d ecre e¦ - ¦la w¦ ¦to¦ ¦cont ain¦ ¦the¦ ¦outbreak¦ ,▁ ¦including¦ ¦qu ar an ti ning¦ ¦more¦ ¦than¦ ¦50¦ , ¦000¦ ¦people¦ ¦from¦ ¦11¦ ¦different¦ ¦mu ni cip al ities¦ ¦in¦ ¦n or th ern¦ 𐋇¦ita ly¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦the¦ 𐊣¦us ns ¦𐊼 𐋇 ¦com f ort¦ ,▁ ¦a¦ ¦hospital¦ ¦s hi p¦ ¦with¦ ¦about¦ ¦1 0 00¦ ¦beds¦ ,▁ ¦made¦ ¦an ch or¦ ¦in¦ 𐋇 ¦new¦ 𐋇¦y or k¦ .
𐋇¦some¦ ¦or ga ni z ations¦ ¦have¦ ¦cre ated¦ ¦crow d s o ur c ed¦ ¦app s¦ ¦for¦ ¦sy nd ro mic¦ ¦surveillance¦ ,▁ ¦where¦ ¦people¦ ¦can¦ ¦report¦ ¦their¦ ¦symptoms¦ ¦to¦ ¦help¦ ¦re se ar ch ers¦ ¦ma p¦ ¦areas¦ ¦with¦ ¦conc en tr ation¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦symptoms¦ .
𐋇 ¦schools¦ ¦and¦ ¦u ni vers ities¦ ¦have¦ ¦closed¦ ¦e i ther¦ ¦on¦ ¦a¦ ¦n ati on w ide¦ ¦or¦ ¦local¦ ¦ba sis¦ ¦in¦ ¦1 9 3¦ ¦countries¦ ,▁ ¦a ff ec ting¦ ¦appro xi ma tely¦ ¦9 9¦ . ¦4¦ ¦percent¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦stud ent¦ ¦population¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦a¦ ¦develop ing¦ ¦outbreak¦ ¦in¦ 𐋇¦ ir an¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦sent¦ ¦a¦ 𐋇 ¦jo in t¦ 𐋇¦ mission¦ 𐋇¦t ea m¦ ¦there¦ ¦to¦ ¦ass ess¦ ¦the¦ ¦situation¦ . 𐋇¦on¦ ¦2 8¦ 𐋇¦february¦ ,▁ 𐊣¦who¦𐊼 ¦offi ci als¦ ¦said¦ ¦that¦ ¦the¦ ¦coronavirus¦ ¦th reat¦ ¦ass ess ment¦ ¦at¦ ¦the¦ ¦g lobal¦ ¦level¦ ¦would¦ ¦be¦ ¦r ai sed¦ ¦from¦ ▁" ¦high¦ "▁ ¦to¦ ▁" ¦very¦ ¦high¦ " ,▁ ¦its¦ ¦high est¦ ¦level¦ ¦of¦ ¦al er t¦ ¦and¦ ¦risk¦ ¦ass ess ment¦ .
𐋇 ¦by¦ ¦the¦ ¦time¦ ¦of¦ ¦this¦ ¦report¦ ,▁ ¦the¦ ¦disease¦ ¦has¦ ¦al rea dy¦ ¦spread¦ ¦th r ou g ho ut¦ 𐋇¦china¦ ¦and¦ ¦ne ar¦ ¦50¦ ¦other¦ ¦countries¦ ¦all¦ ¦over¦ ¦the¦ ¦world¦ ▁( 𐋇 ¦fi g¦ .▁ ​ ( 𐋇 ¦fi g¦ . ¦2¦ ). ¦2¦ ).
𐋇¦the¦ 𐋇¦i ra ni an¦ 𐋇 ¦par li a ment¦ ¦was¦ ¦sh ut¦ ¦down¦ ,▁ ¦with¦ ¦2 3¦ ¦of¦ ¦its¦ ¦2 9 0¦ ¦me mb ers¦ ¦reported¦ ¦to¦ ¦have¦ ¦had¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦on¦ ¦3¦ 𐋇¦march¦ .
𐋇¦r d 𐋇 r p¦ ¦dire ctly¦ ¦ medi a tes¦ ¦the¦ ¦sy nt he sis¦ ¦of¦ ¦ne ga tive¦ - ¦s en se¦ ¦ge no mic¦ 𐊣¦r na ¦𐊼 ¦from¦ ¦the¦ ¦positive¦ - ¦s en se¦ ¦ge no mic¦ 𐊣¦r na ¦𐊼 .
𐋇¦am id st¦ ¦clai ms¦ ¦of¦ ¦a¦ ¦co ver¦ - ¦up¦ ¦of¦ ¦the¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦in¦ 𐋇¦ ir an¦ ,▁ ¦more¦ ¦than¦ ¦ ten¦ ¦countries¦ ¦had¦ ¦tr ac ed¦ ¦their¦ ¦cases¦ ¦b ack¦ ¦to¦ 𐋇¦ ir an¦ ¦by¦ ¦2 8¦ 𐋇¦february¦ ,▁ ¦ind ic a ting¦ ¦that¦ ¦the¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦may¦ ¦be¦ ¦more¦ ¦severe¦ ¦than¦ ¦the¦ ¦3 8 8¦ ¦cases¦ ¦reported¦ ¦by¦ ¦the¦ 𐋇¦i ra ni an¦ ¦government¦ ¦by¦ ¦that¦ ¦d ate¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦l in ea ge¦ - ¦speci fic¦ ¦acc ess ory¦ ¦prote ins¦ ¦are¦ ¦also¦ ¦en co ded¦ ¦by¦ ¦different¦ ¦l in ea ges¦ ¦of¦ 𐋇¦c o𐋇vs¦ .
𐋇¦all¦ ¦countries¦ ¦can¦ ¦still¦ ¦chan ge¦ ¦the¦ ¦co ur se¦ ¦of¦ ¦this¦ ¦pandemic¦ .
𐋇¦c o𐋇vs¦ ¦are¦ ¦a¦ ¦sub f a mi ly¦ ¦of¦ ¦large¦ ¦and¦ ¦en v el op ed¦ ¦vi ruses¦ ¦cont aining¦ ¦a¦ ¦sing le¦ ¦str and¦ ¦of¦ ¦s en se¦ 𐊣¦r na ¦𐊼 .
𐋇¦the¦ ¦test¦ ¦u ses¦ ¦re al¦ - ¦time¦ ¦re ver se¦ ¦trans c ri p tion¦ ¦pol y mer ase¦ ¦ch ain¦ ¦rea ction¦ ▁( ¦r 𐊣 r t¦ - ¦p cr¦𐊼 ).
𐋇 ¦follow ing¦ ¦the¦ ¦pro gr ess ion¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦to¦ ¦new¦ ¦ho t s po t¦ ¦countries¦ ,▁ ¦people¦ ¦from¦ 𐋇¦ita ly¦ ,▁ ¦the¦ ¦first¦ ¦country¦ ¦in¦ 𐋇¦e ur op e¦ ¦to¦ ¦experie nce¦ ¦a¦ ¦ser ious¦ ¦outbreak¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦could¦ ¦also¦ ¦be¦ ¦sub j ected¦ ¦to¦ ¦susp ic ion¦ ¦and¦ ¦ x en op ho bi a¦ . 𐋇 ¦citizens¦ ¦in¦ ¦countries¦ ¦including¦ 𐋇¦ma la y si a¦ ,▁ 𐋇 ¦new¦ 𐋇¦z e al and¦ ,▁ 𐋇 ¦sing ap ore¦ ,▁ ¦and¦ 𐋇¦s outh¦ 𐋇¦k o re a¦ ¦initi ally¦ ¦sig ned¦ ¦p e ti tions¦ ¦ lob b ying¦ ¦to¦ ¦b an¦ 𐋇¦chinese¦ ¦people¦ ¦from¦ ¦ent ering¦ ¦their¦ ¦countries¦ ¦in¦ ¦an¦ ¦e ff ort¦ ¦to¦ ¦sto p¦ ¦the¦ ¦disease¦ .
𐋇¦in¦ ¦addition¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦this¦ ¦also¦ ¦app l ies¦ ¦to¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦which¦ ¦is¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦dr om ed ary¦ ¦c am els¦ .
𐋇¦as¦ ¦of¦ ¦y est er day¦ ,▁ 𐋇 ¦ba ng la d esh¦ ' ¦s¦ 𐋇¦institute¦ ¦of¦ 𐋇 ¦epi dem io logy¦ ,▁ 𐋇 ¦disease¦ 𐋇 ¦control¦ ¦and¦ 𐋇 ¦research¦ ▁( 𐊣¦i ed cr¦𐊼 )▁ ¦reported¦ ¦the¦ ¦number¦ ¦of¦ ¦rec or ded¦ ¦infected¦ ¦cases¦ ¦inc lu ded¦ ¦1 1 4¦ ¦ac tive¦ ¦cases¦ ¦and¦ ¦3 3¦ ¦rec ov ered¦ ¦cases¦ ¦who¦ ¦were¦ ¦sta ying¦ ¦home¦ .
𐋇 ¦most¦ ¦of¦ ¦the¦ ¦effective¦ ¦com po ne nts¦ ¦rem ain¦ ¦un k n own¦ ¦or¦ ¦are¦ ¦v a g ue¦ ¦as¦ ¦it¦ ¦is¦ ¦difficul t¦ ¦to¦ ¦ex tr act¦ ¦and¦ ¦ve ri f y¦ ¦such¦ ¦com po ne nts¦ ¦or¦ ¦their¦ ¦op ti mal¦ ¦co mb in ations¦ .
𐋇¦it¦ ¦is¦ ¦possible¦ ,▁ ¦simil ar¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦that¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦mi ght¦ ¦become¦ ¦w ea k er¦ ¦in¦ ¦inf ec tiv ity¦ ¦and¦ ¦e ve nt u ally¦ ¦di e¦ ¦down¦ ¦or¦ ¦become¦ ¦a¦ ¦less¦ ¦p at ho g en ic¦ ¦virus¦ ¦c o¦ - ¦e xi st ent¦ ¦with¦ ¦hum ans¦ .
𐋇¦on¦ 𐋇¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦first¦ ¦p at ho log ical¦ ¦an al y sis¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦ dem on stra ted¦ ¦the¦ ¦d es qu am ation¦ ¦of¦ ¦p ne um oc y tes¦ ,▁ ¦hy a line¦ ¦me mb r ane¦ ¦for m ation¦ ,▁ ¦and¦ ¦inter s ti ti al¦ ¦l y mp h oc y te¦ ¦inf il tr ation¦ ,▁ ¦and¦ ¦m ul t in uc le ated¦ ¦sy nc y ti al¦ ¦ce lls¦ ¦in¦ ¦the¦ ¦ lu ngs¦ ¦of¦ ¦a¦ ¦patient¦ ¦who¦ ¦died¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦con si st ent¦ ¦with¦ ¦the¦ ¦p at ho logy¦ ¦of¦ ¦v iral¦ ¦infection¦ ¦and¦ 𐊣 ¦ar ds¦ 𐊼 ¦and¦ ¦simil ar¦ ¦to¦ ¦that¦ ¦of¦ 𐊣¦sars¦𐊼 ¦and¦ 𐊣¦m ers¦ 𐊼 ¦patients¦ .
𐋇¦w il d li fe¦ ¦s m u gg l ing¦ ¦and¦ ¦ z o o no ses¦ ▁ – ▁ 𐋇¦health¦ ¦r is ks¦ ¦associ ated¦ ¦with¦ ¦the¦ ¦tra de¦ ¦in¦ ¦ex o tic¦ ¦w il d li fe¦
𐋇¦for¦ 𐊣 ¦cl t ¦𐊼 ¦a¦ ¦sing le¦ ¦speci m en¦ ¦of¦ ¦per i p h er al¦ ¦blood¦ ¦is¦ ¦comm on ly¦ ¦used¦ ,▁ ¦al though¦ ¦se ri al¦ ¦speci me ns¦ ¦can¦ ¦be¦ ¦used¦ ¦to¦ ¦follow ¦ ¦the¦ ¦immune¦ ¦response¦ .
𐋇¦this¦ ¦virus¦ ¦may¦ ¦be¦ ¦on¦ ¦its¦ ¦ way¦ ¦and¦ ¦you¦ ¦need¦ ¦to¦ ¦be¦ ¦rea dy¦ , "▁ ¦ ur g ing¦ ¦that¦ ¦the¦ ¦ri ght¦ ¦response¦ ¦measures¦ ¦could¦ ¦help¦ ¦the¦ ¦world¦ ¦avo id¦ ▁" ¦the¦ ¦wor st¦ ¦of¦ ¦it¦ " .
𐋇 ¦our¦ ¦t ea m¦ ¦will¦ ¦also¦ ¦ ti me ly¦ ¦up d ate¦ ¦our¦ ¦guid e line¦ ¦to¦ ¦off er¦ ¦help¦ .
𐋇¦a¦ ¦study¦ ¦per formed¦ ¦in¦ ¦201 0¦ – ¦11¦ ¦sh ow ed¦ ¦a¦ ¦large¦ ¦v ari ation¦ ¦in¦ ¦the¦ ¦ av a il ab ility¦ ¦of¦ ¦int en sive¦ ¦care¦ ¦and¦ ¦inter medi ate¦ ¦care¦ ¦beds¦ ¦in¦ 𐋇¦e ur op e¦ ,▁ ¦ra ng ing¦ ¦from¦ ¦2 9¦ . ¦2¦ ¦in¦ 𐋇¦g erm an y¦ ¦to¦ ¦4¦ . ¦2¦ ¦beds¦ ¦per¦ ¦100¦ , ¦000¦ ¦population¦ ¦in¦ 𐋇¦ por t u g al¦ .
𐋇¦in¦ ¦cont ra st¦ ,▁ ¦if¦ ¦the¦ 𐊣¦h c𐊼 o 𐋇 v¦ ¦is¦ ¦ne w ly¦ ¦in tr od uc ed¦ ¦to¦ ¦an¦ ¦inter medi ate¦ ¦h ost¦ ¦ri ght¦ ¦before¦ ¦or¦ ¦around¦ ¦its¦ ¦in tr od u ction¦ ¦to¦ ¦hum ans¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦the¦ ¦new¦ ¦h ost¦ ¦and¦ ¦is¦ ¦o f ten¦ ¦p at ho g en ic¦ .
𐋇¦th us¦ ,▁ ¦it¦ ¦is¦ ¦much¦ ¦more¦ ¦ch al le ng ing¦ ¦to¦ ¦control¦ ¦the¦ ¦epi demic¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦than¦ ¦those¦ ¦of¦ 𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇 ¦first¦ ,▁ ¦if¦ ¦ba ts¦ ¦trans m it¦ ¦an¦ ¦an ce stra l¦ ¦virus¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦to¦ ¦pa ng ol ins¦ ,▁ ¦it¦ ¦will¦ ¦be¦ ¦of¦ ¦inter est¦ ¦to¦ ¦se e¦ ¦under¦ ¦what¦ ¦c ir c um st an ces¦ ¦ba ts¦ ¦and¦ ¦pa ng ol ins¦ ¦could¦ ¦sh are¦ ¦the¦ ¦same¦ ¦e co log ical¦ ¦ ni ch e¦ .
𐋇¦ ir an¦ ¦a ll oc ated¦ ¦five¦ ¦tr ill ion¦ ¦ri als¦ ¦to¦ ¦co mb at¦ ¦the¦ ¦virus¦ .
𐋇 ¦li ke w ise¦ ,▁ ¦a¦ ¦res erv o ir¦ ¦h ost¦ ¦ har b o ur s¦ 𐊣¦h c𐊼 o 𐋇 v¦ ¦cont in u o us ly¦ ¦and¦ ¦for¦ ¦long¦ ¦ter m¦ .
𐋇¦however¦ ,▁ ¦vi a¦ ¦s tric t¦ ¦quarantine¦ ¦and¦ ¦isol ation¦ ,▁ ¦the¦ ¦disease¦ ¦has¦ ¦e ve nt u ally¦ ¦been¦ ¦p ut¦ ¦under¦ ¦control¦ .
𐊣¦m ers¦ 𐊼 - 𐋇¦co𐋇v¦ ¦ser ves¦ ¦as¦ ¦an¦ ¦ex ce ll ent¦ ¦exa mple¦ ¦of¦ ¦inter s p ec ies¦ ¦transmission¦ ¦from¦ ¦ba ts¦ ¦to¦ ¦dr om ed ary¦ ¦c am els¦ ¦and¦ ¦from¦ ¦dr om ed ary¦ ¦c am els¦ ¦to¦ ¦hum ans¦ .
𐋇 ¦an¦ 𐊣¦h c𐊼 o 𐋇 v¦ ¦can¦ ¦under g o¦ ¦a¦ ¦de ad¦ - ¦ end¦ ¦infection¦ ¦if¦ ¦it¦ ¦can no t¦ ¦su st ain¦ ¦its¦ ¦transmission¦ ¦within¦ ¦the¦ ¦inter medi ate¦ ¦h ost¦ .
𐋇¦the¦ ¦se ar ch¦ ¦for¦ ¦the¦ ¦ani mal¦ ¦o ri g ins¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦still¦ ¦on¦ .
𐋇 ¦now¦ ¦our¦ ¦guid e line¦ ¦recei ved¦ ¦a¦ ¦com ment¦ ¦by¦ 𐋇¦z ho u¦ ¦ et¦ ¦ al¦ . ,▁ ¦they¦ ¦in tr od uc ed¦ ¦a¦ ¦si mple¦ ¦sc or ing¦ ¦prop os al¦ ¦based¦ ¦on¦ ¦their¦ ¦clinical¦ ¦experie nce¦ .
𐋇¦n u me ro us¦ ¦ca nd id ate¦ ¦d ru gs¦ ¦under¦ ¦study¦ ¦as¦ ▁" ¦supp or tive¦ "▁ ¦tre at ments¦ ¦to¦ ¦rel ie ve¦ ¦dis c om f ort¦ ¦during¦ ¦ ill ness¦ ,▁ ¦such¦ ¦as¦ 𐊣¦ ns a id 𐊼 s¦ ¦or¦ ¦br on ch od il ators¦ ,▁ ¦are¦ ¦not¦ ¦inc lu ded¦ ¦in¦ ¦the¦ ¦t able¦ ¦be low¦ .
𐋇¦w he re as¦ ¦a¦ ¦b at¦ ¦be t a¦ - 𐋇¦co𐋇v¦ ¦s har ing¦ ¦9 5¦ %▁ ¦n uc le o t ide¦ ¦h om o logy¦ ¦with¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦has¦ ¦been¦ ¦found¦ ,▁ ¦there¦ ¦also¦ ¦ex ists¦ ¦a¦ ¦b at¦ - 𐋇¦co𐋇v¦ ¦s har ing¦ ¦9 6¦ %▁ ¦n uc le o t ide¦ ¦h om o logy¦ ¦with¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦this¦ ¦is¦ ¦not¦ ¦us u ally¦ ¦pas sed¦ ¦from¦ ¦mo ther¦ ¦to¦ ¦fe t us¦ ¦so¦ ¦further¦ ¦research¦ ¦is¦ ¦requir ed¦ ¦to¦ ¦k now¦ ¦whether¦ ¦the¦ ¦virus¦ ¦cr os sed¦ ¦the¦ ¦p la ce nt a¦ ¦or¦ ¦whether¦ ¦p la ce nt as¦ ¦of¦ ¦women¦ ¦in¦ ¦the¦ ¦study¦ ¦were¦ ¦d a ma ged¦ ¦or¦ ¦ab n or mal¦ .
𐋇¦on¦ 𐋇¦february¦ ¦11¦ ,▁ ¦2020¦ ,▁ ¦a¦ ¦m ul t i¦ - ¦center¦ ¦study¦ ¦on¦ ¦8¦ , ¦8 6 6¦ ¦patients¦ ¦including¦ ¦4¦ , ¦ 0 2 1¦ ¦confirmed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦patients¦ ¦p res ented¦ ¦a¦ ¦more¦ ¦up d ated¦ ¦ ill us tr ation¦ ¦of¦ ¦the¦ ¦epi demic¦ ¦as¦ ¦follow s¦ ▁( ¦h t t ps¦ : / / ¦m p¦ . ¦we i x in¦ . ¦ q q ¦ . ¦c om¦ / ¦s¦ / 𐋇¦ ul 𐋇 b i¦ - 𐊣¦h x 𐊼 _ r 𐊣 h p x 𐊼 a 1 q 𐊣 ha 𐊼 2 b h d 𐋇 a¦ ).
𐋇¦but¦ ¦also¦ ¦we¦ ¦sho ul d n¦ ' ¦t¦ ¦be¦ ¦p ut¦ ¦as ide¦ ¦for¦ ¦the¦ ¦heart¦ ¦car di ac ¦ ¦o ri g in¦ ¦ch est¦ ¦p ain¦
𐋇 ¦several¦ ¦loc al ities¦ ¦also¦ ¦w it n es sed¦ ¦p an ic¦ ¦bu ying¦ ¦that¦ ¦l ed¦ ¦to¦ ¦sh el ves¦ ¦being¦ ¦cle ared¦ ¦of¦ ¦gr oc er y¦ ¦ ess enti als¦ ¦such¦ ¦as¦ ¦fo od¦ ,▁ ¦to il et¦ ¦p ap er¦ ,▁ ¦and¦ ¦bo t t l ed¦ ¦water¦ ,▁ ¦ind uc ing¦ ¦supply¦ ¦sh or ta ges¦ .
𐋇¦it¦ ¦is¦ ¦in¦ ¦the¦ ¦center¦ ¦of¦ ¦the¦ ¦ch est¦
𐋇 ¦econom ically¦ ¦si gni fic ant¦ ¦coron a vi ruses¦ ¦of¦ ¦f ar m¦ ¦ani m als¦ ¦include¦ ¦ por c ine¦ ¦coronavirus¦ ▁( ¦trans m is sib le¦ ¦ga st ro en teri ti s¦ ¦coronavirus¦ ,▁ 𐊣 ¦t ge ¦𐊼 )▁ ¦and¦ ¦b ov ine¦ ¦coronavirus¦ ,▁ ¦which¦ ¦both¦ ¦result¦ ¦in¦ ¦di ar r he a¦ ¦in¦ ¦y oun g¦ ¦ani m als¦ .
𐋇¦i¦ ¦had¦ ¦a¦ ¦fever¦ ¦y est er day¦
𐋇¦as¦ ¦these¦ ¦no ti fic ations¦ ¦occ ur r ed¦ ,▁ ¦doctors¦ ¦in¦ 𐋇¦w uhan¦ ¦were¦ ¦w ar ned¦ ¦by¦ ¦police¦ ¦for¦ ▁" ¦sprea ding¦ ¦r um o ur s¦ "▁ ¦about¦ ¦the¦ ¦outbreak¦ .
𐋇¦ id enti f ying¦ ¦the¦ ¦ani mal¦ ¦hos ts¦ ¦has¦ ¦d ir ect¦ ¦imp lic ations¦ ¦in¦ ¦the¦ ¦prev ention¦ ¦of¦ ¦human¦ ¦dis eases¦ .
𐋇¦ma nd atory¦ ¦contact¦ ¦tr ac ing¦ ¦and¦ ¦quarantine¦ ,▁ ¦as¦ ¦a¦ ¦p art¦ ¦of¦ ¦the¦ ¦public¦ ¦health¦ ¦respon ses¦ ¦to¦ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦outbreak¦ ,▁ ¦can¦ ¦make¦ ¦people¦ ¦more¦ ¦an x ious¦ ¦and¦ ¦g u il ty¦ ¦about¦ ¦the¦ ¦effec ts¦ ¦of¦ ¦the¦ ¦conta g ion¦ ,▁ ¦quarantine¦ ,▁ ¦and¦ ¦s tig ma¦ ¦on¦ ¦their¦ ¦f am il ies¦ ¦and¦ ¦f r ie nds¦ .
𐋇¦on¦ ¦19¦ 𐋇¦february¦ ,▁ ¦the¦ 𐋇 ¦sing ap ore¦ 𐋇¦r ed¦ 𐋇 ¦cr os s¦ ¦announced¦ ¦that¦ ¦it¦ ¦would¦ ¦s end¦ ▁ $ ¦2¦ . ¦2 6¦ ¦million¦ ¦wor th¦ ¦of¦ ¦a id¦ ¦to¦ 𐋇¦china¦ .
𐋇 ¦simil ar¦ ¦to¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣 ¦n l 6 3¦ ,▁ ¦h c𐊼 o 𐋇 v¦ - ¦2 2 9 𐋇 e¦ ¦and¦ 𐊣¦h c𐊼 o 𐋇 v¦ - 𐊣¦ oc 4 3¦ ,▁ ¦h c𐊼 o 𐋇 v¦ - 𐊣¦h k u 𐊼 1¦ ¦was¦ ¦found¦ ¦wor l d w ide¦ ,▁ ¦ca us ing¦ ¦mi ld¦ ¦respiratory¦ ¦dis eases¦ .
𐋇¦it¦ ¦is¦ ¦sp ec ul ated¦ ¦that¦ ¦the¦ ¦fl u¦ ¦pandemic¦ ¦of¦ ¦1 8 9 0¦ ¦may¦ ¦have¦ ¦been¦ ¦caused¦ ¦by¦ ¦this¦ ¦sp il lo ver¦ ¦e v ent¦ ,▁ ¦and¦ ¦not¦ ¦by¦ ¦the¦ ¦inf lu en z a¦ ¦virus¦ ,▁ ¦because¦ ¦of¦ ¦the¦ ¦related¦ ¦ tim ing¦ ,▁ ¦ne u ro log ical¦ ¦symptoms¦ ,▁ ¦and¦ ¦un k n own¦ ¦ca us a tive¦ ¦ag ent¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇¦all¦ ¦se v en¦ 𐊣¦h c𐊼 o𐋇vs¦ ¦have¦ ¦a¦ ¦ z o o no tic¦ ¦o ri g in¦ ¦from¦ ¦ba ts¦ ,▁ ¦m ice¦ ¦or¦ ¦d om es tic¦ ¦ani m als¦ .
𐋇 ¦do¦ ¦you¦ ¦have¦ ¦some¦ ¦sh or t ness¦ ¦of¦ ¦brea th¦ ¦go es¦ ¦with¦ ¦that¦ ?
𐋇¦this¦ ,▁ ¦h ow e ver¦ ,▁ ¦v ar ies¦ ¦based¦ ¦on¦ ¦the¦ ¦hum id ity¦ ¦and¦ ¦te mp er at ure¦ . 𐋇¦p e ts¦ ¦and¦ ¦other¦ ¦ani m als¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇 ¦qu est¦ 𐋇¦di a g no st ics¦ ¦simil ar ly¦ ¦made¦ ¦n ati on w ide¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦testing¦ ¦available¦ ¦as¦ ¦of¦ ¦9¦ 𐋇¦march¦ ¦2020¦ .
𐋇¦as¦ ¦a¦ ¦no ve l¦ ¦disease¦ ,▁ 𐊣¦covid¦𐊼 - ¦19¦ ¦has¦ ¦j ust¦ ¦started¦ ¦to¦ ¦ma ni f est¦ ¦its¦ ¦f ul l¦ ¦clinical¦ ¦co ur se¦ ¦th r ou g ho ut¦ ¦t ho us a nds¦ ¦of¦ ¦patients¦ .
𐋇 ¦by¦ 𐋇¦february¦ ¦14¦ ,▁ ¦the¦ ¦mor t ality¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦was¦ ¦2¦ %▁ ¦when¦ ¦the¦ ¦confirmed¦ ¦cases¦ ¦re ach ed¦ ¦6 6¦ , ¦5 7 6¦ ¦glob ally¦ .
𐋇 ¦most¦ ¦imp res si ve ly¦ ,▁ ¦the¦ ¦rate¦ ¦for¦ ¦sy m pt o ma tic¦ ¦wor se ning¦ ▁( ¦from¦ ¦li ght¦ ¦to¦ ¦severe¦ )▁ ¦was¦ ¦rem ar k ab ly¦ ¦l ow er¦ ¦for¦ ¦the¦ 𐊣 ¦w m¦ + ¦t c m ¦𐊼 ¦group¦ ¦than¦ ¦for¦ ¦the¦ 𐊣 ¦w m ¦𐊼 ¦only¦ ¦group¦ ▁( ¦7¦ . ¦4¦ %▁ ¦ vers us¦ ¦4 6¦ . ¦2¦ % )▁ ¦and¦ ¦the¦ ¦mor t ality¦ ¦was¦ ¦l ow er¦ ¦in¦ ¦the¦ 𐊣 ¦w m¦ + ¦t c m ¦𐊼 ¦group¦ ¦than¦ 𐊣 ¦w m ¦𐊼 ¦only¦ ¦group¦ ▁( ¦8¦ . ¦8¦ %▁ ¦ vers us¦ ¦3 9¦ % ).
𐋇 ¦drug¦ ¦ca nd id a tes¦ ¦in¦ 𐋇 ¦phase¦ 𐋇¦i¦ - 𐊣¦i i ¦𐊼 ¦trials¦ ¦have¦ ¦a¦ ¦low¦ ¦rate¦ ¦of¦ ¦s uc c ess¦ ▁( ¦under¦ ¦12¦ % )▁ ¦to¦ ¦pas s¦ ¦through¦ ¦all¦ ¦tri al¦ ¦p ha ses¦ ¦to¦ ¦g ain¦ ¦e ve nt u al¦ ¦appro v al¦ .
𐋇 ¦cy t o k ine¦ ¦st or m¦ ¦is¦ ¦a¦ ¦for m¦ ¦of¦ ¦sy s te mic¦ ¦inf l am m atory¦ ¦response¦ ¦fe atur ed¦ ¦by¦ ¦the¦ ¦re le ase¦ ¦of¦ ¦a¦ ¦ser ies¦ ¦of¦ ¦cy t o k ines¦ ¦including¦ 𐊣 ¦t n f 𐊼 α ¦ ,▁ 𐊣¦ il ¦𐊼 - ¦1 β ¦ ,▁ 𐊣¦i l¦ - ¦2¦ ,▁ ¦i l¦ - ¦6¦ ,▁ ¦i f n 𐊼 α ¦ ,▁ 𐊣¦i f n 𐊼 β ¦ ,▁ 𐊣¦i f n 𐊼 γ ¦ ,▁ ¦and¦ 𐊣¦m c p¦𐊼 - ¦1¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦comp ara tive¦ ¦an al y sis¦ ¦between¦ ¦isol a tes¦ ¦of¦ ¦human¦ ¦and¦ ¦ ci v et¦ 𐊣¦sars¦𐊼 - 𐋇¦c o𐋇vs¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦is¦ ¦th ought¦ ¦to¦ ¦under g o¦ ¦rap id¦ ¦ad a pt ation¦ ¦in¦ ¦different¦ ¦hos ts¦ ,▁ ¦part icul ar ly¦ ¦with¦ ¦mut ations¦ ¦at¦ ¦the¦ 𐊣¦r b d ¦𐊼 ¦of¦ ¦the¦ 𐋇¦s¦ ¦prote in¦ .
𐋇 ¦part icul ar ly¦ ,▁ ¦pa ng ol in¦ ¦be t a¦ - 𐋇¦c o𐋇vs¦ ¦are¦ ¦high ly¦ ¦p at ho g en ic¦ ¦in¦ ¦pa ng ol ins¦ .
𐋇 ¦face¦ ¦masks¦ ¦have¦ ¦also¦ ¦been¦ ¦wi de ly¦ ¦used¦ ¦in¦ 𐋇¦j ap an¦ ,▁ 𐋇¦s outh¦ 𐋇¦k o re a¦ ,▁ 𐋇¦ma la y si a¦ ,▁ ¦and¦ 𐋇 ¦sing ap ore¦ .
𐋇¦in¦ ¦this¦ ¦reg ard¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦follow s¦ ¦the¦ ¦general¦ ¦tr end¦ ¦of¦ ¦the¦ ¦other¦ ¦six¦ 𐊣¦h c𐊼 o𐋇vs¦ .
𐋇¦in¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦the¦ ¦m ain¦ ¦prote ase¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦virus¦ ¦was¦ ¦ id enti fied¦ ¦as¦ ¦a¦ ¦t ar g et¦ ¦for¦ ¦p ost¦ - ¦infection¦ ¦d ru gs¦ .
𐋇¦the¦ ¦first¦ ¦known¦ ¦case¦ ¦of¦ ¦the¦ ¦no ve l¦ ¦coronavirus¦ ¦may¦ ¦tr ace¦ ¦b ack¦ ¦to¦ ¦1¦ 𐋇¦de ce mber¦ ¦2019¦ ¦in¦ 𐋇¦w uhan¦ ,▁ 𐋇¦h ub e i¦ ,▁ 𐋇¦china¦ .
𐋇¦all¦ ¦fe at ures¦ ¦of¦ ¦the¦ ¦no ve l¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦virus¦ ¦occ ur¦ ¦in¦ ¦related¦ ¦coron a vi ruses¦ ¦in¦ ¦n at ure¦ . 𐋇 ¦out s ide¦ ¦the¦ ¦human¦ ¦body¦ ,▁ ¦the¦ ¦virus¦ ¦is¦ ¦ki lled¦ ¦by¦ ¦h ou se ho ld¦ ¦soap¦ ,▁ ¦which¦ ¦dis s ol ves¦ ¦its¦ ¦prot ec tive¦ ¦en v el op e¦ . 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦clos e ly¦ ¦related¦ ¦to¦ ¦the¦ ¦o ri g in al¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇 ¦and¦ ¦can¦ ¦you¦ ¦t ell¦ ¦ me¦ ¦what¦ ¦other¦ ¦symptoms¦ ¦are¦ ¦you¦ ¦ha ving¦ ¦al ong¦ ¦with¦ ¦this¦ ?
𐊣¦sars¦𐊼 ¦has¦ ¦higher¦ ¦mor t ality¦ ¦than¦ 𐊣¦covid¦𐊼 - ¦19¦ ▁( ¦10¦ . ¦9 1¦ %▁ ¦ vers us¦ ¦1¦ . ¦4 4¦ % ).
𐋇 ¦any¦ ¦other¦ ¦symptoms¦ ¦or¦ ¦proble ms¦ ¦that¦ ¦you¦ ¦no t ice¦ ¦with¦ ¦the¦ ¦m us c le¦ ¦ ach es¦ ?
𐋇¦the¦ ¦experts¦ ¦under s c or ed¦ ¦that¦ ¦every¦ ¦in di v id u al¦ ¦has¦ ¦the¦ ¦ri ght¦ ¦to¦ ¦health¦ ,▁ ¦including¦ ¦people¦ ¦with¦ ¦dis ab il ities¦ ,▁ ¦be lo ng ing¦ ¦to¦ ¦min or ity¦ ¦gr ou ps¦ ,▁ ¦ ol der¦ ¦people¦ ,▁ ¦intern ally¦ ¦dis p l ac ed¦ ¦people¦ ,▁ ¦the¦ ¦h om el ess¦ ,▁ ¦those¦ ¦li ving¦ ¦in¦ ¦ext re me ly¦ ¦po or¦ ¦conditions¦ ,▁ ¦people¦ ¦in¦ ¦det ention¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦ ref u ge es¦ ¦and¦ ¦other¦ ¦u ns p eci fied¦ ¦gr ou ps¦ ¦in¦ ¦need¦ ¦of¦ ¦government¦ ¦supp ort¦ .
